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INTRODUCTION 
EXPRESSION, STRUCTURE AND FUNCTION 
OF INTERMEDIATE FILAMENTS 
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EXPRESSION, STRUCTURE AND FUNCTION OF 
INTERMEDIATE FILAMENTS 
I. Introduction 
Intermediate filaments (IFs) represent a group of cytoskeletal structures of 
about 10 nm in diameter which, along with microtubules (25 nm) and 
microfilaments (5 nm), occur in the cytoplasm of virtually all mammalian cells. 
They constitute networks extending from the nucleus to the cell membrane. A 
single IF consists of 20000-30000 protein subunits and has a length of 
approximately 40 \im. The IF proteins are encoded by a large multigene family 
and can be divided into five different subtypes on the basis of gene structure 
and sequence homology (see below). The different types of IF subunits are 
expressed in a developmentally regulated and tissue-specific fashion. This 
highly conserved specificity of expression suggests that each type of subunit 
plays an important role in cellular differentiation. However, whereas the 
involvement of microtubules and microfilaments in a variety of processes such 
as cell division, locomotion, protoplasmic streaming, cellular polarity and 
anchorage has been demonstrated, the functions of cytoplasmic intermediate 
filaments have long remained elusive and are only beginning to be elucidated. 
Here we will review the principles that govern IF expression and assembly, and 
finally discuss the possible functions of these structures. 
II. The IF gene family: gene structure and evolution 
The IF proteins are encoded by a large (>40 genes) family of closely related 
genes. The vertebrate cytoplasmic IF proteins have been divided into four types 
on the basis of gene structure and sequence homology (table I). IF proteins of 
the same type share at least 50% amino acid sequence identity, different types 
are 25-30% homologous. The acidic and basic epidermal keratins form types I 
and Π, respectively, vimentin, desmin, GFAP and peripherin form type III, the 
neurofilaments, a-intemexin and nestin represent type IV (reviews: 20, 51, 53, 
62, 89, 117, 119, 135, 154, 165). The lamins (type V), which form a 
karyoskeletal structure at the nucleoplasmic surface of the inner nuclear 
membrane instead of a cytoplasmic network, constitute the only non-
cytoplasmic IF type (51, 62, 65, 89, 114, 117, 119, 135). 
The gene structure of all five classes of IFs has been analyzed (reviewed in 137; 
fig 1). Diagnostic features for members of the IF gene family are the tripartite 
protein domain structure combined with a central rod domain subdivided into 
11 
Table I. Classification of IF subunits 
CELL TYPE 
epithelial cells 
epithelial cells 
mesenchymal 
cells 
muscle cells 
peripheral 
nervous system 
glial cells and 
astrocytes 
most neurons 
neuroepithelial 
stem cells 
central nervous 
system 
nucleated cells 
IF PROTEIN 
acidic keratins 
basic keratins 
vimentin 
desmin 
peripherin 
GFAP 
(glial fibrillary 
acidic protein) 
neurofilament 
proteins (NF-L, 
NF-M, NF-H) 
nestin 
cx-internexin 
lamins (A/C 
andB) 
SEQUENCE 
TYPE 
I 
11 
III 
III 
III 
HI 
IV 
IV 
IV 
V 
SIZE 
(kD) 
40-60 
50-70 
55 
53 
57 
53 
68, 145, 
200 
200 
66 
60,67, 
70 
α-helical coils (designated 1A, IB, 2A and 2B). Lamin genes contain several 
features which distinguish them from the cytoplasmic IF genes (39, 62, 72, 
114, 137). They contain six additional heptad sequences in coil IB, never 
observed in vertebrate cytoplasmic IFs. They possess a nuclear localization 
signal in the tail region that directs the lamin protein to the nuclear 
compartment, and a C-terminal sequence motif which serves as a recognition 
signal for three successive post-translational modifications and is involved in 
membrane association (72, 77, 88, 114). Both types of signal sequences are 
absent from cytoplasmic IF proteins. 
IF genes of types I-III show striking similarity in the intron/exon pattern in the 
central rod domain (fig 1). In contrast, intron positions in the tail domains 
show no obvious similarities between different vertebrate IF types (21, 137). 
The strong conservation of intron positions between the lamin genes (type V) 
and the vertebrate cytoplasmic IF genes in the central rod domain, reveals a 
common ancestry of lamins and IF proteins (fig 1). The archetype cytoplasmic 
IF gene probably arose from a lamin-like ancestor through deletion of the two 
signal sequences found in lamins only, via creation of a splice site and 
introduction of a stopcodon (38, 39, 136, 137). This resulted in cytoplasmic IFs 
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h e a d 
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Figure 1. Summary of intron positions in the IF gene family (taken from 137) The tripartite structural 
organization of (he proteins is indicated at the lop Residue numbers for the variable head and tail domains arc 
given at the sides Hatched box in coil IB represents the extra 42 residues unique to lamins and invertebrate 
cytoplasmic IFs, as indicated by a plus Solid arrowheads intron positions conserved along all IF genes, open 
arrowheads: non-related intron positions, Helix nn invertebrate IF gene, Branch cephalochordate (vertebrate) IF 
gene 
which carried the extra six heptads in coil lb of the rod domain. Invertebrate 
cytoplasmic IFs still contain this segment. This transition possibly took place as 
early as at the origin of the deuterostomic branch of the metazoan kingdom. 
Evolution of the vertebrate cytoplasmic IFs involved deletion of this region via 
creation of a new splice acceptor site. 
The vertebrate type III genes are more closely related to invertebrate IF genes 
than are the keratins, indicating that the keratins arose later than type III IFs. 
Given the much higher diversity of keratin genes (> 30 genes) they evolved at a 
faster rate than type ΠΙ genes (21, 38, 39, 136, 137). 
Neurofilament and nestin genes (type IV) are totally different with regard to 
number and position of introns. It is most likely that the progenitor of these 
genes has first lost its introns and gained new ones via a mRNA-mediated 
transposition event (38, 137). 
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III. IF expression patterns and regulation of IF gene expression 
Expression patterns 
The occurrance of IFs is widespread. All types of IF are present in primitive 
vertebrates. Many differentiated cell types of invertebrates (e.g. molluscs, 
arthropods) and simple metazoa contain IFs (136, 137). There is an increasing 
number of reports describing expression of IF-like proteins in fungi, plants and 
unicellular organisms (12, 13, 35, 172, 173). The nuclear lamina seems to be a 
universal feature of eukaryotes (94, 137) and must have emerged early in 
evolution, possibly during the transition from the prokaryotic stage. Indeed, the 
biochemical identification of yeast lamins (61) implies that nuclear lamins are a 
very early acquisition of eukaryotic life. 
Lamin В is constitutively expressed in eukaryotic cells, indicating that it fulfils 
housekeeping functions (51, 62, 114, 120). This view is sustained by 
experimental data (106). In contrast, all other types of IF subunits are 
expressed in a developmentally regulated and highly tissue-specific fashion 
(table I). In differentiated cells, keratins are generally expressed in cells of 
epithelial origin, while neurofilaments, perpherin, nestin and α-intemexin are 
expressed in neuronal cells, glial fibrillary acidic protein in astrocytes, desmin 
in striated and most smooth muscle cells, and vimentin mainly in cells of 
mesenchymal origin (reviews: 20, 51, 53, 62, 89, 117, 119, 135, 154, 155, 
165). 
IF subunits can be coexpressed with subunits of the same or another type, 
especially during differentiation and development. In cells of neuronal origin, 7 
different type III and IV cytoplasmic IF proteins (the neuron-specific IFs and 
vimentin) have been identified to date. There are at least 30 keratin genes (type 
I and II), all of which are expressed in specific epithelial cells at specific 
developmental stages (53, 109, 154). Since both types of keratins are essential 
for keratin IF assembly, type I and II keratin subunits are expressed pairwise. 
Different pairs are expressed in a tissue-specific, differentiation-specific, and 
developmental-specific fashion (109, 154). 
Of all individual IF subunits, vimentin displays the most complex and least 
restricted expression pattern. Depending on cell type, vimentin expression can 
preceed expression of any other type of IF subunit, it can be transiently 
coexpressed, or it can remain present next to other types of IF in the fully 
differentiated cell (89, 154, 165). In addition, vimentin expression is induced in 
most cultured cells (127, 128, 147). 
The expression patterns of vertebrate IF proteins are conserved to the extend 
that they constitute a useful tool for determining the origin of tumor cells in 
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cancer diagnosis (115). 
Regulation of IF gene expression 
Regulation of IF expression takes place primarily at the transcriptional level. 
Regulatory elements involved in tissue-specific gene expression by controling 
the rate of transcription either positively or negatively have been identified for 
many IF genes, mainly by transfection studies (14, 17, 19, 24, 26, 36, 49, 50, 
82, 83, 90, 97, 100, 116, 124, 127, 142, 145, 160, 162, 176). Binding sites of 
nuclear proteins have been mapped by DNase I footpnnting analyses combined 
with gel retardation assays for a variety of IF gene promoters (including 
keratins, 97; peripherin, 36, 162; a-intemexin, 26; vimentin, 49, 90, 139, 160; 
and GFAP, 17). As in most eukaryotic genes, the vast majority of regulatory 
elements is located in the 5' flanking regions. For most IF genes, it has been 
shown that relatively short stretches of 5' flanking region (~ 100 to 1000 bp) 
can confer tissue-specific expression on a heterologous marker gene in cultured 
cells, and cell type-specific enhancers have been identified in a number of these 
regions (e.g. 17, 19, 82, 100). This allows the targeting of heterologous 
proteins or mutant IF subunits to specific cell types in transgenic mice, using IF 
gene promoter regions. However, intragenic enhancers have been found in a 
number of cases (NF-L gene, 14; GFAP gene, 142; keratin 18 gene, 116). 
While most regulatory elements of IF genes appear to have a positive effect on 
transcription, several silencers have been identified (peripherin gene, 162; NF-
L, NF-M, and NF-Η genes, 145; desmin gene, 100; vimentin gene, 49, 90, 127, 
139). All of these are located in the 5' flanking region of the gene and interact 
with positive control elements. 
In the human (50, 138, 139) and hamster vimentin promoter (90, 127), which 
are 80% homologous, two silencers have been identified, but their sequence and 
position are different for each species. The chicken vimentin promoter (60 % 
homology with human and hamster promoters) also contains two negative 
elements (49, 144) which do not appear to correspond to the human and 
hamster silencers with respect to position and sequence. The silencers identified 
in the hamster vimentin promoter (located at 741-712 bp and 655-635 bp 
upstream of the transcription initiation site; 90), which have been shown to 
interact with transacting factors, are involved in down-regulation of vimentin 
expression in epithelial cells by down-regulating the enhancing activity of a 
double AP-l/jun binding site (90, 127). The role of the human silencers (from 
-853 to -795 bp and -322 to -277 bp) has not yet been elucidated. The most 
upstream chicken promoter silencer (from -605 to -583 bp) is probably 
involved in down-regulation of vimentin expression during myogenesis (49). 
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There is an inverse relationship between the concentration in muscle tissue of 
the 95 kD nuclear protein (also present in nonmuscle cells) that binds to this 
silencer and vimentin gene transcription. The sequence of the second silencer 
(between -484 and -460 bp) matches the first one and probably plays a similar 
role. A similar but not identical sequence is present in the hamster and human 
vimentin promoter. 
In the chicken promoter, an antisilencer is located upstream of these elements 
(160). There is a direct correlation between the binding efficiency of the 140 
kD protein that binds to this element, and vimentin expression. It has been 
speculated that in mesenchymal cells the activity of the chicken silencers is 
overcome by the antisilencer. 
Regardless of embryonic origin, most cells initiate vimentin expression when 
cultured. This induction is probably mediated by the double AP-l/jun binding 
site located at -700 bp in the hamster and human vimentin promoter, which can 
also activate heterologous genes in tissue-culture (127, 139). This property of 
the vimentin promoter has been used to efficiently establish mammalian cell 
lines. Immortalization of all tested cell types was achieved by transfection with 
constructs containing the vimentin promoter fused to the SV40 large Τ antigen 
(128, 147). Using transgenic mice, it has been demonstrated that 3.2 kb of 
vimentin 5' flanking region contains most if not all of the regulatory elements 
necessary for correctly regulated expression (126). 
In summary, the vimentin promoter is subject to complex control. It is 
composed of multiple positive and negative elements which can effect basal 
transcription and growth factor induction (49, 50, 90, 124, 127, 138, 139, 160) 
and which together control the complex developmentally regulated and cell 
type-specific expression of the vimentin gene. 
Specific keratin genes are expressed in specific subgroups of epithelial cell 
types. For example, suprabasal cells of stratified epithelia express keratins 6 
and 16, keratins 3 and 12 are found in cornea, keratins 8 and 18 in simple 
epithelia, etc. (83, 97, 109) . Although there is a general lack of extensive 
homology between 5' flanking regions of the keratin genes, small sequence 
elements involved in epithelial cell type-specific expression have been identified 
in some cases. For example a 10 bp palindromic sequence first identified in the 
human kl4 gene binds a keratinocyte specific factor and occurs in several 
keratinocyte-specific genes (97). Similarly, short sequences binding muscle-
specific transcription factors (including MyoDl, MEF1, and MEF2) and 
functioning as enhancers in many muscle-specific genes, are also present in the 
5' flanking region of the muscle-specific IF gene, desmin (100, 125). 
It is not clear to what extend IF genes expressed in the same cell type utilize 
(combinations of) the same transcriptional factors. Regulatory elements 
16 
common to the different neurofilament genes or resembling those of other IF 
genes expressed in neurons have not (yet) been identified. However, a 10 bp 
sequence motif first identified in the hamster desmin and vimentin promoter, 
also occurs in the promoters of all other type III IF genes in a similar position 
(36). For the GFAP (17) and the peripherin promoter (36, 162) it has been 
shown that this sequence functions as a nuclear protein binding site. Deletion of 
this sequence results in a complete loss of hamster desmin promoter activity 
(Pieper, unpublished results). 
For most IF genes there is a wealth of data concerning the identificaton of 
known, Ъавіс' regulatory elements on the basis of sequence homology and 
functional assays, such as Spi boxes, SV40 enhancer core sequences, AP-1 and 
AP-2 binding sites, Oct-1 binding sites, etc. It has become clear that the co­
operative interaction of general-, tissue-specific- and IF gene-specific 
regulatory elements and factors determine the final, unique expression pattern 
of each IF gene (117). 
For vimentin and keratin gene expression, many factors, including complex 
ones such as cell shape, cell-cell interactions and growth rate, have been 
identified which affect the levels of IF gene expression in cultured cells, either 
positively or negatively (e.g. 15, 16, 31). The precise mechanisms of action of 
these factors are largely unknown. Induction of keratin expression by vitamin 
A (43, 86, 87, 158), EGF (87), estrogen (140), and of vimentin expression by 
TPA and certain growth factors (50, 138) takes place at the transcriptional 
level. However, the effects of vitamin A and EGF are relatively slow and 
indirect (87). In contrast, the vimentin gene is an early responder to growth 
stimulation and does not require the products of other growth factor-inducible 
genes (50). 
Keratin expression is modulated at least at one additional level. Keratin IFs are 
obligatory heteropolymers (32, 69, 156), and therefore at least one subunit of 
each subfamily (type I and type II) is expressed in any epithelial tissue, 
resulting in cell type-specific combinations of keratins (53, 109). Since type I 
and II keratins expressed as pairs are found in equimolar amounts within cells, 
their levels of expression must be regulated. It is not yet clear to what extend 
regulatory sequences contribute to this process. Some keratin genes of the same 
type are closely linked in the genome (19, 98, 141) but the expression patterns 
of the individual genes in these loci may be completely different. By 
manipulation of keratin expression levels through transfection of different 
types of keratin genes into both epithelial and nonepithelial cells, it has been 
shown that the fate of keratin subunits of one type is determined by the 
presence and amounts of subunits of the other type (40, 64, 95). While the 
polymerized subunits are very stable, rapid degredation of overexpressed 
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keratin (either endogenous or exogenous) occurs, resulting in the 
reestablishment of normal 1:1 type I/type II ratios. In contrast, type III, Г and 
V IF genes can be overexpressed both in cultured cells (e.g. 102, 110, 123, 
126) and transgenic mice (22, 84, 93, 111, 126) without affecting endogenous 
expression levels. 
IV. Structure of IF proteins 
The main structural features of IF subunits have been derived from the 
primary sequence of a large number of IF proteins (reviews: 89, 119, 154). 
The predominantly linear IF subunits consist of three distinct domains: a 
central α-helical 'rod' of conserved length (~ 310 amino acid residues; 356 
residues for type V), conserved secundary structure and (in part) sequence, 
flanked by non-helical N-terminal ('head') and C-terminal ('tail') domains. The 
conserved central rod is characterized by its helical conformation, interrupted 
by three short non-helical linkers. The resulting four α-helical subdomains are 
designated coil 1A (N-terminal end of the rod), IB, 2A and 2B (C-terminal 
end). The primary sequence in the helical regions follows the heptad rule, i.e. 
comprises sets of seven amino acid residues, free of residues that disrupt a-
helical structure, and with hydrophobic residues at positions 1 and 4. This 
typically results in the formation of α-helical coiled-coil dimers. 
Sequence similarity between all types of IFs only exists at both ends of the 
central domain, while along most of the helical rod conservation of the heptad 
principle rather than actual sequences is found. Recently is has become clear 
that these end regions play a pivotal role in IF subunit dimerization and IF 
assembly (see section VI). 
In contrast to the rod domain, the non-helical terminal domains display large 
differences in size, sequence, chemical characteristics and conformation 
between different types of IF proteins. Since IF subunits have also diverged 
with respect to their developmental expression pattern, it is generally assumed 
that the end domains -at least to some extend- specify the functional diversity of 
the IF gene family (89, 135, 154). 
Although all IF proteins share a highly conserved secundary structure, their 
physicochemical properties can be quite different (154). 
V. IF assembly 
Intermediate filaments are assembled from monomeric protein subunits. 
Association starts with the formation of the coiled-coil molecule from two 
monomers via lateral interaction between the rod domains, which are aligned in 
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parallel and in axial register. Hydrofobic interactions between the residues at 
heptad positions 1 and 4 stabilize this dimer (119, 154, 159). In contrast to all 
other types of IF, keratin filaments are obligatory composed of heterodimers, 
consisting of a type I and a type II subunit (31, 69, 156). In addition, keratin 
dimers are not capable of coassembly with dimers of IF types III-IV (64, 67, 
89, 105). In agreement with this notion, keratin (types I and II) and vimentin 
(type ΙΠ) networks segregate into distinct networks when they are coexpressed 
(64, 1132-134). For keratin and vimentin, it has been shown that recognition of 
IF type is exerted at the level of dimer formation and depends on the presence 
of the helices IB and 2B in the rod domain (105). The neurofilament (NF) 
subunits NF-M and NF-Η are also unable to form homopolymers, but 
coassemble with NF-L subunits (101, 163). Type III IF subunits and NF-L not 
only assemble into homopolymeric structures, but also copolymerize with type 
III and IV IF subunits into heteropolymers (89, 101, 154). Lamin subunits 
(type V) do not coassemble with IF subunits I-IV (102, 114). 
The second step in IF assembly is interaction between two dimers, resulting in 
the formation of a tetramer. This four chain complex represents the smallest 
stable IF polymer in solution and constitutes the basic building block of 
intermediate filaments (32, 56, 78, 103, 135; for a different view see 157). 
Within it, the dimers are probably arranged in an antiparallel fashion and are 
staggered by 15-20 nm (58, 129, 166), eventually leading to the formation of 
apolar IFs. The tetramers assemble into higher order structures via different 
hierarchical levels of subfilaments. Via protofilaments (2-3 nm) and 
protofibrils (4.5 nm) cytoplasmic IFs (8-10 nm) are formed in a number of 
poorly characterized steps (103, 154, 159). 
While the rod domains are involved in lateral interactions, the terminal head 
and tail domains protrude from the filament backbone. Thus, they might 
specify subunit specific functions and interact with other cytoplasmic IFs (89, 
91, 154). In addition, they might be involved in longitudinal head-to-tail 
interaction between tetramers (114, 173). 
In vitro assembly studies with chicken lamin В have revealed that lamins, like 
cytoplasmic IFs, form parallel, unstaggered dimers. However, these dimers 
associate longitudinally and form polar polymers which then associate laterally 
to form filamentous structures (73). 
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VI. The role of IF domains in IF assembly 
Experimental approaches 
The roles of the different IF subunit domains in IF assembly have been 
investigated mainly by expressing mutant subunits and subsequently studying 
their assembly characteristics, either in vitro (expression in E. coli, 
polymerization in test tube) or in vivo (transfection of gene constructs into 
cultured cells). While in vitro reconstitution and polymerization studies 
combined with electron microscopy have provided a wealth of data on IF 
structure and assembly, they sometimes contradict results obtained in vivo. For 
instance, keratin homodimers can be obtained in vitro (130a), type III deletion 
mutants incapable of in vivo IF formation yield IFs in vitro (e.g. 42, 68), 
polymorphic fornis of IF and their assembly intermediates are generated (2, 
18), and lamins can be assembled into 10 nm filaments in vitro only (2). This is 
due to the fact that experimental conditions, such as pH, temperature, ionic 
strength, and IF subunit concentration greatly affect the assembly process. 
IF subunit mutants which have been generated and tested in vivo via 
transfection of gene constructs into various cell types include deletion mutants, 
substitution mutants, hybrid gene constructs composed of IF genes of the same 
or a different type, and combinations of all of these mutations. A potential 
limitation in studies with recombinant mutant IF proteins is the problem of 
conformational changes associated with deletions, or the combination of 
sequences which normally are not adjacent. 
Recently, addition of series of synthetic peptides derived from IF rod (70, 92), 
tail (18), or head (76) domains to preformed IFs or soluble IF subunits has 
been used to identify sequences involved in IF assembly, structure, and 
stabilization. These studies overcome the limitations mentioned above. In 
addition, they allow discrimination of sequences involved in dimer and/or 
tetramer formation from sequence motifs involved in higher order IF 
assembly. Addition of antibodies recognizing specific, known IF epitopes to 
soluble IF subunits and subsequent analysis of the process of IF assembly has 
also been used to identify the role of specific sequence motifs (e.g. 18, 79, 92). 
Anti-idiotypic antibodies have been used to detect complementarity between 
type III IF epitopes and protein domains involved in the anchorage of IFs to 
various membranous organelles (37, 118) or in self-association of IF proteins 
(91). 
Overexpression of a desmoplakin protein domain, containg a coil IB-like 
sequence motif, was used to demonstrate its specific binding to IFs (153). 
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Functions of IF domains 
The importance of the rod domain in IF assembly has been amply 
demonstrated. Nearly all IF proteins share two sequence motifs located at the 
N- and C-terminal ends of the rod (coil 1A and coil 2B). These highly 
conserved end domains are involved in IF subunit dimerization. Their removal 
causes gross alterations in cytoplasmic IF and lamin structure, disruption of 
preexisting filaments upon coexpression, renders the mutated subunit incapable 
of homopolymeric assembly, etc. (3, 4, 25, 30, 32, 33, 34, 63, 99, 103, 118, 
132-134, 175). 
Using the experimental approaches described above, it could be demonstrated 
that coil 1A of the rod domain interacts with the highly conserved sequence 
motif (SYRRXF) in the head domain of type III IFs (76). The C-terminal half 
of the rod domain also interacts with this N-terminal motif (166). These 
interactions are probably instrumental in determining the staggered, 
antiparallel arrangement of the IF dimers and the ordered assembly of 
tetramers to IFs (76, 166). The interaction of the consensus sequence motif at 
the end of coil 2B with other sites along the IF molecule (e.g. the C-terminal 
domain, see 91) is essential for proper protofilament alignment and IF stability 
(92). Molecular sorting of different IF types depends on the presence of the 
helices IB and 2B (105). 
In summary, specific sequences in the rod domain are required for formation 
and stabilization of the dimer, recognition of IF type, and are involved in 
higher order assembly by directing alignment and stagger of the tetramers via 
interaction with domains in the rod or in the terminal IF domains (135). 
The non-helical end domains of the IF subunit are also involved in the assembly 
process, since isolated rod domains are incapable of assembling into IFs. 
Aminoterminally deleted type III (85, 132) and lamin subunits (108) retain 
their ability to form tetramers and copolymerize with intact IF subunits, but 
are incapable of de novo homopolymeric IF formation. Mutation of the 
strongly conserved sequence motif at the end of the head domain of type ΙΠ IFs 
is sufficient to render IF subunits assembly incompetent (74, 134). Integration 
of N-terminal deletion- or substitution mutant subunits into preexisting IF 
causes distortion or disruption of these filaments (74, 134). As discussed above, 
interactions between the N-terminal domain and the central rod are required 
for higher order polymerization. 
The N-terminal domains of desmin and vimentin are involved in organizing the 
IF network since they bind to ankyrin and thereby anchor the IFs to the plasma 
membrane (59, 60). 
The proximal region of the C-terminal tail domain of desmin and vimentin 
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subunits interacts with lamin В, thereby connecting the IF system with the 
nucleus (61). The distal part of the tail domain of type III IFs associates with 
coil 2B during IF assembly and thereby contributes to the lateral packing of the 
filaments (91). 
Deletion studies suggest that the role of the tail domain may differ for the 
various types of IF. Type III subunits missing the entire tail domain are no 
longer capable of de novo homopolymeric IF assembly in vivo, but retain the 
ability to coassemble into preexisting type III IFs (42, 133, 134). Depending on 
the ratio of mutant to wild-type subunits, this can result in distortion or 
disruption of the preexisting filaments. In contrast, coexpression of tail-less 
type I and type II keratin subunits resulted in the formation of extended 
cytoplasmic IF networks (10, 103). GFAP subunits missing the complete tail 
region are incapable of in vitro IF formation (131), while similar keratin (68), 
desmin (133) and vimentin subunits (42) do assemble into IFs in vitro. The 
effects of tail-truncated NF-L subunits on wild-type IF were different from 
those obtained with tail-truncated NF-M (63, 175). 
Surprisingly, tail-less keratin formed extensive IF bundels in the nucleoplasm 
(10). Expression of tail-deleted vimentin also resulted in nuclear localization of 
a portion of the mutant protein, but only in an aggregated, non-fibrillar form 
(42). These results may suggest a possible structural function of the tail 
domain. Lack of interaction between the tail domain and certain cytoplasmic 
structures could explain these observations. 
The lamin tail region contains a localization signal that directs the subunits to 
the nucleus and sequences necessary for association to the nuclear membrane 
(72, 77, 88, 114). Deletions in this domain can result in structural changes of 
the nuclear envelope and cytoplasmic localization of mutant lamin (72, 102). 
VII. Post-translational control and dynamics of IF assembly 
The variable end domains of each type of IF chain, including the lamins, are 
the major sites for postsynthetic modifications (154, 165). Phosphorylation 
plays a major role in IF organization and structure (46, 149). The reversible 
assembly-disassembly of cytoplasmic IFs during mitosis is regulated by a 
common mechanism involving enzymatic phosphorylation of specific sites 
within the N-terminal domain (6, 7, 28, 29, 47, 48, 57). This site-specific 
phosphorylation renders the IF subunit polymerization incompetent and causes 
depolymerization of the filaments. Reassembly correlates with 
dephosphorylation. Depending on IF type, several kinases (e.g. kinase C, 
cAMP-dependent kinase, Ca2+/calmodulin-dependent kinase; 6, 7, 46, 149) can 
be involved in the phosphorylation process. For instance, when cells enter 
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mitosis vimentin disassembles via hyperphosphorylation by p34cdc25 bm 
despite their concomitant hyperphosphorylation, keratins type I and II are not 
substrates for this enzyme (28). 
Similar to what is observed for the cytoplasmic IFs, the mitotic breakdown of 
the nuclear lamina is caused by a transient phosphorylation of both end domains 
of lamins A (72, 104, 121, 122). 
Phosphorylation of cytoplasmic IF proteins at sites in the C-terminal domain 
(e.g. as occurs for the neurofilament proteins) is not linked to disassembly, but 
may have entirely different functions. This sustains the ideas about the 
importance of the head domain in IF assembly. 
Limited proteolysis, deimination, glycosylation, and isoprenylation (lamins) of 
IF subunit end domains also influence the process of IF formation (89, 135, 
154, 166). 
Lamin С arises from the lamin A gene, probably as a result of differential 
splicing, and lacks the C-terminal signal sequences (CaaX box) which is 
successively the target for isoprenylation of a cysteine, proteolytic removal of 
the three C-terminal amino acids, and carboxyl-methylation of the 
isoprenylated cysteine (114). 
Except during mitosis, the unpolymerized pool of IF proteins is very small 
(151). However, there is a continuous assembly of IF subunits into existing 
filaments. This assembly occurs both at the со- and the post-translational levels 
(80). In the first pathway, nascent proteins are directly assembled into IFs 
during translation. This is reflected in the association of nascent type III IF 
chains with intact IFs in cell free preparations, and by the linkage of vimentin 
mRNA location and the assembly of vimentin. In the post-translational 
incorporation pathway, the newly synthesized IF protein enters a small pool of 
soluble subunits from which it is incorporated into existing IFs. A dynamic 
equilibrium exists between the soluble pool and polymerized filaments (80, 
107, 113, 143, 155, 171). For vimentin it has been shown that both pathways 
occur in the same cell, but the ratio of newly synthesized subunits in the soluble 
pool to the fraction of nascent vimentin subunits attached to the cytoskeleton 
during translation varies strongly between cell types (80). 
Dynamic aspects of IF assembly can be studied directly by transfection of gene 
constructs (e.g. 113, 143) or microinjection of biotinylated IF protein (107, 
170, 171). Depending on IF- and cell type, either vectorial IF assembly takes 
place, in which case IFs grow from the nucleus to the cell membrane, or 
subunit exchange occurs along the entire length of the pre-existing filaments 
(113, 135, 149, 155). 
In gene transfer experiments, newly synthesized IF protein becomes rapidly 
incorporated into endogenous IFs, allowing disruption of these filaments by 
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expression of mutant, assembly-incompetent IF subunits (3, 4, 8, 25, 30, 32-34, 
63,99, 103, 119, 132-134, 175). 
VIII. Functions of IFs 
Given the ubiquity and abundance of IF proteins, it is surprising that their 
function has remained elusive. Their common structure implies a shared 
function, while IF heterogeneity and cell type-specific expression suggest that 
IF functions are tailored to the needs of specific cells or tissues. Cytoplasmic 
intermediate filaments clearly do not fulfill a household function, since several 
cell lines and some cell types in vivo do not contain any IF network. Moreover, 
disruption of IF networks in cultured cells by various means does not affect cell 
morphology, motility, or division (review: 89). This has led to the assumption 
that the functions of IFs must be manifested at the level of the tissue or organ as 
a whole, possibly in providing mechanical strength, cellular organization and 
architecture (89, 154). In agreement with this notion, keratin filaments are 
attached to the cell-cell junctions known as desmosomes, and to the cell-
extracellular matrix adherence junctions known as hemidesmosomes, in many 
epithelial cell types. Through these connections, the keratin IF networks of 
neighbouring cells are effectively linked and constitute a supracellular system 
which might act to strengthen the epithelial sheet against mechanical insult. 
Moreover, vimentin IFs display unique viscoelastic properties allowing them to 
resist breakage and become even stronger under stresses that would rupture 
other cytoskeletal networks (81). However, disruption of vimentin filaments 
during early embryogenesis in Xenopus by expression of a dominant-negative 
vimentin subunit (30) or keratin networks via injection of antibodies in 
preimplantation mouse embryos (45) did not result in detectable abnormalities. 
Furthermore, inactivation of both keratin 8 allelles in embryonic stem cells did 
not inhibit differentiation into yolk sac-like embryoid bodies (11). 
The biological role of the lamins is much better understood than that of the 
cytoplasmic IFs. They impart integrity to the nuclear envelope, and provide a 
foundation for DNA replication (72, 114). This is illustrated by the finding that 
lamin-depleted Xenopus nuclei are fragile and fail to synthesize DNA (106). 
Lamins A and C, which are functionally equivalent, participate in anchoring the 
chromatin to the nuclear periphery, lamin В is responsible for connecting the 
nuclear lamina to the nuclear membrane (53, 65, 89, 114). 
While expression of lamin A in murine EC cells which normally do not express 
this protein in the undifferentiated state produced no detectable phenotype 
(123), disruption of the nuclear lamina of cultured cells by expression of 
mutant lamin A is lethal (102; McKeon, pers. comm.). 
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Many different general and more specialized funcions of cytoplasmic IFs have 
been suggested, but only some of these are supported by experimental evidence. 
Since IFs connect the plasma membrane to the nuclear lamina (59), which in 
tum interacts with chromatin (114), a role in signal transduction is conceivable, 
but has remained unproven. Similarly, the concept of IFs having nuclear 
functions through direct binding to DNA of proteolytically generated IF rod 
domains, which thus would be involved in regulation of gene expression and 
DNA replication (148, 166) has not been sustained by experimental data. 
Several more specialized functions of IFs have been demonstrated using 
cultured cells. IFs can serve as a cytoplasmic scaffold to which cytosolic 
constituents such as translated mRNA (96, 150; however, see 75), translation 
factors (177), prosomes (a class of small cytoplasmic RNP complexes; 66), 
polyribosomes active in viral protein systhesis (112), and protein kinase С 
(152) associate. Vimentin filaments form a cage-like structure that encircle 
lipid droplets during adipocyte conversion in 3T3 cells, thereby possibly 
stabilizing them (52), and have been implicated in intracellular transport of 
cholesterol (5). Furthermore, it was recently demonstrated that the human 
vimentin gene is capable of suppressing the transformed phenotype of 
chemically transformed BHK-SN-10 cells (44). 
By suppression of GFAP expression in a differentiating astrocytoma cell line it 
has been shown that these IFs are required for the formation of stable 
astrocytic processes in response to neurons (174). 
Blocking phosphorylation of desmin by injection of antibodies against kinase A 
inhibited in vitro fusion of myoblasts to myotubes (161), while complete 
disruption of desmin and vimentin IF in a myogenic cell line by expressing a 
mutant desmin subunit had no effect on myogenesis (146). This suggests that 
the phosphorylation-induced disassembly of longitudinally oriented desmin, but 
maybe not its subsequent redeployment to the I-Z-I bands, is essential for 
myoblast fusion. 
Breakdown of neurofilaments in cultured cells is associated with increased 
chromatin rotation in interphase nuclei (71). 
Developing embryos and transgenic mice represent useful model systems to 
study in vivo IF functions. Ectopic- or overexpression of IFs in transgenic mice 
(1, 22, 30, 41, 84, 93, 111, 126), specific interference with in vivo IF assembly 
by microinjection of IF-specific antibodies (reviewed in 89) or anti-sense RNA 
into zygotes or developing embryos (164), disruption of IF networks in 
transgenic mice or embryonic cells by expression of dominant-negative mutant 
IF subunits (30, 34, 42, 54, 167, 169), and inactivation of IF genes via 
homologous recombination in embryo stem cells (11) have contributed to 
understanding IF functions. 
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Variation of IF density does not seem to influence IF function. Tissue-specific 
or ectopic (111) overexpression in transgenic mice of various IF proteins 
(including keratins 14 (168), 18 (1), and 19 (9); desmin (126), vimentin (22; in 
Xenopus embryos: 30), a vimentin-desmin hybrid protein (93), and NF-L (84)) 
has, apart form cataract formation (22, 41, 111), not resulted in detectable 
abnormalities. Overexpression in cortical hair cells of a type II hair keratin 
resulted in accumulation of excess type II keratin aggregates, which caused 
abnormalities in keratin organization leading to brittleness and hair breakage 
(130). 
Injection of keratin antisense RNA into Xenopus oocytes rendered these 
incapable of normal development (164). Conversely, injection of antibodies 
directed against keratin had no effect (45). 
IF networks can be disrupted in a dominant-negative fashion by expression of 
IF gene constructs containing modifications or deletions in the carboxy-
terminal part of the central α-helical rod domain (see section VI). Interaction 
of the mutant- and wildtype IF subunits results in disassembly of preexisting IF 
networks and inhibits de novo IF formation. Using this approach, a functional 
role for vimentin and desmin filaments during in vitro myogenesis (146) or 
vimentin in Xenopus embryogenesis (30) could not be demonstrated. In 
contrast, disruption of keratin IFs in F9 embryonal cells inhibited the 
appearance of visceral endodermal cells in differentiating aggregate culture 
(167). 
The most convincing evidence for a structural function of IFs comes from 
recent studies on expression of dominant-negative, truncated human keratin 
subunits in transgenic mice (33, 54, 55, 169). Tissue-specific expression in the 
basal layer of stratified epithelial cells of a mutant keratin 14 subunit resulted 
in disruption of the keratin network and basal cell cytolysis (169). This 
impaired development and maintainance of stratified squamous epithelial tissue. 
These transgenic mice exhibited the morphological and biochemical features of 
epidermolysis bullosa simplex (EBS), an autosomal human genetic skin disease. 
The severity of the phenotype in mice was dependent on the expression level of 
the transgene and correlated to the degree of keratin IF disruption in the basal 
cells, and in cultured keratinocytes derived from the transgenic mice (34, 169). 
Cell rupture appeared to involve three factors: keratin filament Pertubation, 
physical trauma, and the columnar shape of the basal cell. When transgenic and 
human EBS cells were cultured, the cells flattened and cytolysis no longer 
occurred (34, 54). Similarly, during wound healing recovering basal cells were 
flattened and escaped cytolysis. Suprabasal cells expressed significant levels of 
mutant and basal keratins but remained unaffected, again indicating that 
cytolysis was dependent on more factors than mutant keratin expression alone. 
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Cytolysis still occurred when no insoluble cytoplasmic protein aggregates were 
generated and tonofilament clumping was absent (34). 
Expression of a truncated human keratin 10 gene in transgenic mice (55) gave 
rise to skin with the morphological and biochemical characteristics of another 
human genetic skin disease, epidermolytic hyperkeratosis (EH). In both cases, 
analysis of the appropriate pair of keratin genes (EBS: keratins 5 and 14; EH: 
keratins 1 and 10) of EBS (33) and EH patients (23, 27) revealed point 
mutations in the highly conserved amino or carboxyl ends of the rod domain of 
one of the keratin subunits. 
It has become apparent that some cytoplasmic IPs play a role in maintaining the 
architectural framework of a cell in the context of its tissue. It remains to be 
established to what extend this function is shared by the different types of 
intermediate filaments and what other tissue-specific and more general 
functions they fulfil. Future studies, aimed at mutating, knocking out, or 
exchanging the various types of IF in mouse embryo stem cells will clarify 
these issues. 
IX. Outline of this thesis 
The investigations described in this thesis were aimed at identifying the 
mechanisms that rule vimentin and desmin expression, and thereby intermediate 
filament formation. Furthermore, the functional roles of desmin and vimentin 
IFs in the context of intact tissues were examined in transgenic mice through 
expression of various IF gene constructs and disruption of endogenous vimentin 
networks. 
In chapters two and three, we describe the identification of regulatory elements 
involved in transcriptional control of desmin and vimentin gene expression in 
various cell lines. 
In chapters four, five, and eight we demonstrate that the 5' flanking region of 
the hamster vimentin gene can be used to drive expression of IF gene constructs 
in a tissue-specific fashion in transgenic mice, and is sufficient for induction of 
gene expression in tissue culture. Except for cataract formation (chapter six), 
tissue-specific expression of a hybrid vimentin/desmin gene (chapter four) or 
expression of the muscle-specific IF subunit desmin in nonmuscle cells (chapter 
five) in transgenic mice did not interfere with normal differentiation and 
development. 
By expressing mutant desmin subunits in cultured cells (chapters seven and 
eight) and transgenic mice (chapter eight), we have identified IF subunit 
domains essential in type ΠΙ intermediate filament assembly. Disruption of 
vimentin networks in transgenic mice by expression of a dominant-negative 
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desmin subunit did not result in detectable abnormalities (chapter eight). 
A summary of the main conclusions from the experiments described in chapters 
two to eight is provided in chapter nine. 
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Upstream regions of the hamster desmin and vimentin genes 
regulate expression during in vitro myogenesis 
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Varying lengths of the hamster desnin and vimentin promoter 
regions were fused to the bacterial chloramphenicol acetyl-
transferase gene. These constructs were transfected into two 
different myogenic cell lines, T984 and C2C12. In both cell 
lines an increase in endogenous desmin expression takes place 
upon myogenesis. A region between -89 and +25 bp relative 
to the desmin transcription initiation site directs high-level 
tissue- and stage-specific expression upon in ritro myogenesis. 
At the myoblast stage, C2C12 cells appeared to express both 
desmin and vimentin, whereas in T984 myoblasts only vimen-
tin expression was detected. Although vimentin is expressed 
during all stages of myogenesis, a strong decrease in vimen-
tin expression occurs during differentiation of C2C12 cells. 
Vimentin-CAT constructs followed the endogenous expression 
pattern, showing that this down-regulation is mediated by 5' 
flanking sequences. Vimentin promoter activity is modulated 
by at least two separate regions, both in myogenic and in поп-
myogenic cell lines. 
Key words intermediate filaments/intermediate filament genes/m 
vitro myogenesis/upstream DNA sequence 
Introduction 
Intermediate filaments (IFs) are unique cytoskeletal structures 
of 7-12 nm in diameter which occur in the cytoplasm of most 
eukaryotic cells The members of this large multigene family of 
proteins can be divided into four major subfamilies on the basis 
of their biochemical and immunological properties (Lazandes, 
1982, Steinen et al, 1985, Traub, 1985) the acidic (type I) and 
basic (type Π) cytokeratms, which are specific for epithelial cells, 
vimentin and desmin, glial fibrillary acidic protein (type Ш) and 
the three neurofilament polypeptides (type IV) All IF proteins 
are expressed in a developmentally regulated and tissue-specific 
manner Recently it has been established that on the basis of 
substantial amino acid homology the laimns A and С may be 
mcluded m the IF protein family (Fisher et al, 1986) 
For most classes of IFs, very little is known about the regula­
tory mechanisms underlying their expression The evidence to 
date suggests that IF subumt expression is regulated mainly at 
the transcriptional- and/or post-transcnptional level, but not at 
the level of translation (e g Blikstad and Lazandes, 1983, 
Capetanaki et al, 1983, 1984, ìoramoetal , 1984, Ngai et al, 
1984, Nelson and Lazandes, 1985, Lilienbaum et al , 1986) 
Vimentin is expressed m cells of mesenchymal origin and in 
most cells in tissue culture, whereas m other cases vimentui is 
present in tissues during immature stages of development and 
öfter precedes the appearance of the cell type-specific IF subumt 
(for review see Traub, 1985) Desmin is expressed m adult car-
diac, skeletal and smooth muscle cells (Lazandes, 1980, 1982, 
Schmid et al, 1982) Regulation of desmin expression is stage-
and tissue-specific, since it is induced dunng terminal develop-
ment of, for example, skeletal muscle cell differentiation (Ben-
nett et al , 1979, Gard and Lazandes, 1980) 
The detailed chaiactenzation of the hamster desmin and vimen-
tin genes (Quax et al, 1983, 1985) allows regulatory features 
governing muscle-specific versus non-muscle specific IF expres-
sion at the molecular level to be investigated 
An important component of eukaryotic gene regulation is form-
ed by oj-acting DNA sequences upstream from the transcrip-
tion initiation site, these sequences are required for transcription 
and contain elements that control development- and/or tissue-
specific expression (e g Breathnach and Chambón, 1981, Dynan 
and Tjian, 1985) We have identified DNA sequences within the 
upstream region of the desmin gene which are important in stage-
and tissue-specific expression, as reflected in myogenic develop-
ment We fused the desmin promoter region to the bacterial 
chloramphenicol acetyltransferase (CAT) gene (Gorman et al , 
1982) The latter gene is used in transient transfection assays as 
a marker to demonstrate transcriptional activity of the upstream 
sequences We performed expenments on two myogenic cell 
lines T984 (Jakob et al, 1978, Caravatti et al, 1982) and C2C12 
(Blau et al, 1983) C2C12 cells have been used to study muscle-
specific regulation of a number of genes due to their extensive 
and rapid differentiation into myotubes (Blau et al, 1985, 
Hardeman et al, 1986, Mmty and Kedes, 1986, Mmty et al, 
1986, Silberstein et al, 1986) In order to gain more insight in-
to the mechanisms that regulate desmin and vimentin co-
expression dunng myogenesis, and to localize regulatory elements 
in the promoter region of the vimentin gene, we also transfected 
vimentin-CAT hybnds into these cells Our results show that 
the desmin promoter region harbors a cii-acting regulatory ele-
ment that determines tissue- and stage-specific expression The 
flanking region of the vimentin gene contains at least two separate 
regulatory elements 
Results 
Differentiation-related expression mediated by the upstream 
region of the desmin gene in 7984 myogenic cells 
The myogenic mouse teratocarcinoma skeletal muscle cell line 
T984 can be induced to differentiate by switching to a mitogen-
deficient medium when the cells reach confluency Within 7 days, 
multinucleated myotubes are formed which express the 
charactenstic markers of skeletal muscle (Jakob et al , 1978, 
Caravatti et al , 1982) 
T984 cells were first screened for desmin and vunentin ex-
pression m different stages of differentiation by unmunofiuore-
scence microscopy and Western blotting, using monoclonal and 
polyclonal antibodies respectively (Figure 1) It appeared that 
T984 myoblasts do not express desmin before they reach con-
fluency Upon differentiation into myotubes, desmin expression 
and assembly into intermediate filaments is observed (Figure 1A) 
After the cells have reached confluency, some mononucleated 
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T984 
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Desmin Vimentin 
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a b с d 
Fig. 1. Screening of T984 cells for desmin and vimentin expression dunng differentiation by immunofluorescence microscopy and Western blotting. (A) 
Immunofluorescent staining of T984 myoblasts (top) and myotubes (bottom) Left: cells incubated with monoclonal desmin antibodies, right: cells incubated 
with monoclonal vimentin antibodies Incubation with polyclonal antibodies yielded identical results (not shown) (B) Western blotting of whole cell 
homogenates. prepared from subconfluent cultures of T984 myoblasts (lane c), and from T984 cultures which have been allowed to differentiate into myotubes 
for 7 days (lane d) Equal amounts of protein were loaded onto each lane. For comparison, a BHK cell extract was used (lanes a and b). Lane a was 
incubated with desmin antibodies only, lanes b - d were incubated with desmin antibodies and thereafter with vimentin antibodies The faint bands in lane с 
were not observed after incubation with desmin antibodies and represent vimentin breakdown products 
myoblasts can also be seen to express desmin. On the other hand, 
vimentin is expressed during all stages of T984 differentiation. 
Western blotting of whole cell extracts with polyclonal antibodies 
against desmin and vimentin confirmed these observations: 
desmin expression could be detected in myotubes only, whereas 
vimentin is expressed throughout myogenesis (Figure IB). 
In order to identify DNA sequences within the 5' flanking 
regions of the desmin and vimentin genes that are required for 
expression, we constructed a series of plamids in which decreas­
ing lengths of 5' flanking region were fused to the bacterial CAT 
marker gene (Gorman et al., 1982). These desmin-CAT and 
vimentin—CAT hybrids (Figure 2) were transfected into prolif­
erating T984 myoblasts and, in parallel, into multinucleated 
myotubes. CAT expression levels of the transfected cells were 
measured relative to the level of CAT activity present in cells 
transfected in parallel with pSV2CAT, a vector containing the 
SV40 early promoter. 
When myoblasts were assayed for transient expression 48 h 
after transfection, no desmin-CAT expression could be detected 
(Figure ЗА). Transfection of T984 myotubes yielded desmin-
CAT expression levels that reached values of —50% ofthat of 
pSV2CAT-transfected myotubes (Figure ЗА). There were no 
significant differences between CAT expression levels of the in­
dividual desmin-CAT constructs, indicating that the region from 
—89 to +25 contains muscle-specific regulatory sequences which 
confer developmental control of desmin expression. 
Vimemin-CAT expression levels remained at a constant level 
during differentiation. Deletion of sequences upstream from 
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lOûbp 
V iment in CAT 
Fig, 2. Schematic representation of desmin and vimentin promoter-CAT hybrids Details of construction are descnbed ш Matenals and methods Coordinates 
refer to base pairs of DNA sequence relative to the mRNA cap site (CAP) at position +1 Promoter-CAT fusion sites are located between cap site and 
initiation codon of the desmin and vimentin genes, at +25 and +101 respectively Position of the TATA box homologies are indicated Abbreviations used 
are: E. EcoRl, B, BamHl. A. /(cd; S. SmI. Sm. Smal. M. Mbol (A) Desmin-CAT hybrids. 1 = p3.4DesCAT. 2 = pl.7DesCAT. 3 = p450DesCAT. 
4 = pl55DesCAT and 5 = p89DesCAT (B) Vimentm-CAT hybnds. a • 3 IVimCAT. b = p599VimCAT and с = pl76VimCAT 
myoblasts 
Τ 984 
myotubes 
^ w w w w w 9 Wf w 
· · · · 
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vim-CAÎ 
Fig. 3. Expression mediated by upstream regions of the desmin and vimentin genes in T984 myoblasts and T984 myotubes (A) Plasmid DNAs were 
transfected into T984 myoblasts and myotubes CAT activity was detemnned from equal volumes of cell extracts from myoblasts and myotubes. 
repespectively (B) Transfections of vimentin—CAT hybnds into hamster lens cells The assayed volumes of control extracts ( + . - ) were three times that of 
vimenlin-CAT transfected cells + . pSV2CAT. - . pSVOCAT. I. p3.4DesCAT. 2. pl.7DesCAT. 4. pl55DesCAT; 5. p89DesCAT. a. p3 IVimCAT; b, 
p599VimCAT; c. pl79VimCAT 
-599 relative to the transcription initiation site almost abolish-
ed vimentin-CAT expression, both in transfected myoblasts and 
myotubes (Figure ЗА). As a control, we transfected the 
vimentin—CAT hybrids into hamster lens cells, which express 
vimentin at high levels (Bloemendal et al., 1980). All three con­
structs were expressed at high levels in these cells, with 
рЗ.І ітСАТ expression 3-fold higher and p599VimCAT and 
pl76VimCAT 1.5- to 2-fold higher than pSV2CAT expression 
(Figure 3B). From these results it can be concluded that at least 
two upstream regions are involved in vimentin expression, of 
which the most distal region is required for high-level expres­
sion in T984 cells. 
Since CAT expression levels of muscle-specific promoter 
regions do not necessarily reflect the expression levels of the en­
dogenous gene (Seiler-Tuyns et al., 1984; Minty and Kedes, 
1986), T984 myoblasts and myotubes were assayed for the level 
of desmin and vimentin mRNA (Figure 4). No desmin mRNA 
was detected in T984 myoblasts, whereas T984 myotubes were 
shown to contain significant amounts of desmin transcripts. 
Vimentin mRNA was present in both myoblasts and myotubes, 
a b с d e f 
Fig. 4. Autoradiograms of Northern blots of RNA from T984 myoblasts and 
myotubes Ten micrograms of total RNA were hybndized to a desmin probe 
(lanes a—c) and a vimentin-specific probe (lanes d-f) The same blot was 
used for both probes. The autoradiograms were exposed for 2 weeks or 6 h 
at - 8 0 o C respectively RNA from vimentin- and desmin-expressing 
BHK-21 cells is shown as a marker Lanes a and f. proliferating BHK-21 
cells, lanes b and d. 8-day postfusion myotubes, lanes с and e. proliferating 
myoblasts 
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Fig. 5. Screening of C2C12 cells for desnun and vimentin expression during differentiation by the immunofluorescence microscopy assay and Western 
blotting, (A) Immunofluorescence staining of C2C12 myoblasts (top) and myotubes (bottom) The cells on the left were incubated with monoclonal desmin 
antibodies, and cells shown on the right with monoclonal vimentin antibodies. Incubations with polyclonal antibodies yielded identical results (not shown). 
(B) Western blotting of whole cell homogenates, prepared from subconfluent cultures of C2C12 myoblasts (lane c) and from C2CI2 myotubes (lane d) Equal 
amounts of protem were loaded onto lanes с and d. For comparison, a BHK cell extract was used (lanes a and b). Lane a was incubated with the desmin 
antibody only, lanes b-d were incubated with desmin antibody and thereafter with vimentin antibodies. 
although an ~ 2-fold reduction of transcripts was observed upon 
differentiation. Desmin-CAT expression apparently parallels the 
endogenous tissue-specific and developmentaily regulated expres­
sion pattern as determined by Western and Northern blotting. 
Desmin and vimentin expression in C2C12 myogenic celb 
Like T984 cells, myoblasts of the mouse muscle cell line C2C12 
can be induced to fuse and form multinucleated myotubes. Us­
ing monoclonal and polyclonal antibodies against desmin and 
vimentin, we screened these cells for interrnidiate filament ex­
pression by immunofluorescence and Western blotting during dif­
ferent stages of differentiation (Figure 5). Contrary to T984 cells, 
C2C12 cells were found to express desmin and vimentin during 
all stages of myogenesis. From immunofluorescence studies us­
ing desmin antibodies combined with Hoechst staining, it was 
clear that even in sparse cell cultures each individual C2C12 
myoblast expresses desmin. Therefore, the observed desmin ex­
pression is not due to premature differentiation of some of the 
myoblasts. Western blotting with polyclonal desmin and vimen­
tin antibodies confirmed that C2C12 myoblasts express both 
desmin and vimentin, as do C2C12 myotubes (Figure 5B). 
Transfection of desmin-CAT hybrids into proliferating C2C12 
myoblasts resulted in CAT expression levels of 25% of the level 
of pSV2CAT-transfected myoblasts (Figure 6A). In myotubes, 
however, desmin-CAT expression levels were similar to the 
pSV2CAT expression level, indicating a 4-fold increase in ex-
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Fig. 6. Expression mediated by upstream regions of the desmin and vimentin gene in proliferating C2C12 myoblasts and in C2C12 myotubes Plasmid DN As 
were transfectcd into C2C12 myoblasts and myotubes CAT activity was determined in equal volumes of cell extract from myoblasts and myotubes, 
respectively +, pSV2CAT. - , pSVOCAT, 1, p3.4DesCAT, 2. pl.7DesCAT, 4, pl55DesCAT, 5, p89DesCAT, b. p599VimCAT; c, pl76VimCAT (A) 
CAT activity in transfectcd myoblast and myotubes, assayed 40 h after transfection. (B) CAT activity in myoblasts, which were allowed to differentiate for 7 
days after transfection before CAT assays were performed, and in transfected myotubes, which were assayed for CAT activity after 40 h 
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Fig. 7. Autoradiograms of Northern blots of RNA from C2C12 myoblasts 
and myotubes. Ten micrograms of total RNA were first hybridized to a 
desmin-specific (lanes a—c) and then to a vimentin-specific probe (lanes 
d—h) The same blot was used for both probes and was not dehybndized 
after desmin probing. Autoradiograms were exposed for 4 days (desmin 
probe), 8 h (vimentin probe, lanes d and e) or 24 h (vimentin probe, lanes 
f and g) BHK-21 is shown as a marker Lanes a and h, proliferating 
BHK-21 cells, lanes b, d and f, proliferating myoblasts, lanes e, e and g, 
5-day postfusion myotubes. 
pression levels during C2C12 myogenesis (Figure 6A). The 
observed increase in desmin-CAT activity corresponds to the 
increase in desmin concentration, as determined by Western blot­
ting (Figure 5B). Northern blotting of RNA from C2C12 
myoblasts and myotubes clearly shows that the endogenous levels 
of desmin transcription follow the same expression pattern as 
the desmin-CAT constructs (Figure 7, lanes a-c). This indicates 
that the developmentally regulated expression of desmin synthesis 
is not controlled at the level of translation, but takes place at the 
transcriptional level, although an enhanced stability of desmin 
transcripts and desmin—CAT transcripts upon differentiation can­
not completely be excluded. 
When C2C12 myoblasts were transfected at low cell density 
and then allowed to differentiate into myotubes, the same increase 
in desmin-CAT activity was observed (Figure 6B). Since 
transfection of myotubes did not result in lower expression levels, 
the increase must be induced by a muscle-specific regulatory pro­
cess which is ftilly active in myotubes. 
myoblasts 
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Fig. 8. Transcriptional activity of upstream regions of the vimentin gene in 
proliferating C2C12 myoblasts and in myobtubes Vimentin-CAT hybrids 
were transfected into C2C12 myoblasts or myotubes Equal amounts of cell 
extract from transfected myotubes and transfected myoblasts were assayed 
respectively. + , pSV2CAT; - , pSVOCAT, a, p3 IVimCAT; b, 
p599VimCAT; c,pl76VimCAT 
Contrary to expression levels in T984 cells, p599VimCAT and 
pl76VimCAT expression amount to - 150% of pSV2CAT ex­
pression upon transfection into C2C12 myoblasts (Figure 6A). 
Obviously, sequences upstream from -599 in the vimentin flank­
ing sequence are not necessary for high level expression in C2C12 
myoblasts. Conversely, transfection of p599VimCAT and pl76-
VimCAT into C2C12 myotubes resulted in low CAT expression 
levels, hardly exceeding pSVOCAT expression (Figure 6). 
In order to compare p3. IVimCAT expression with p599Vim-
CAT and pl76VimCAT activity, the constructs were introduced 
into proliferating C2C12 myoblasts and into myotubes. In myo­
blasts p3. IVimCAT activity exceeded p599VimCAT and pl76-
VimCAT expression 2- to 3-fold, reaching values of 300-400% 
of pSV2CAT expression (Figure 8). After transfection of these 
constructs into myotubes, vimentin-CAT expression was very 
low, indicating that sequences upstream from -176 are not 
responsible for the observed drop in vimentin transcriptional ac­
tivity. Since it is very unlikely that a dramatic increase in 
pSV2CAT activity takes place upon differentiation (Grichnik et 
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al , 1986, Minty et al , 1986), a strong decrease in vimentin-
CAT expression levels must take place Vimcntin-CAT expres-
sion m C2C12 myotubes was 30-fold lower than in transfetted 
myoblasts 
An analysis of vimentin mRNA levels m C2C12 myoblasts 
and myotubes by Northern blotting shows a corresponding 
decrease of endogenous vimentin expression (Figure 7, lanes 
d-h) Likewise, Western blotting of C2C12 cells before and after 
differentiation not only shows an increase in desmin expression, 
but also a decrease in vimentm expression Again, regulation most 
probably is at the level of transcription 
From the dala obtained by immunofluorescence, immunoblot-
tmg, Northern blotting and CAT assays it may be concluded that 
C2C12 myotubes still express vimentin, although at much lower 
levels than prior to differentiation of myoblasts 
Discussion 
Transfecuon of desmin-CAT hybrid constructs into the mouse 
myogemc muscle cell lines T984 and C2C12, before and after 
differentiation, demonstrated that a region from -89 to +25 bp 
relative to the desmin transcription initiation site contains 
regulatory sequences that are involved in muscle-specific induc-
tion of desmin expression Immediately upstream from the region 
between -89 and +25 bp at least one (at -130) and perhaps 
two (-110) potential Spi protein binding sites are located (CG-
box, Kadonaga et al, 1986) This type of regulatory element 
occurs m several viral and eukaryoüc promoters CG-boxes have 
also been detected in the promoter regions of the IF genes for 
human cytokeratin 14 (Marchuk et al , 1985) and cytokeratm 19 
(Bader et al , 1986) Since we observed that deletion of these 
sequences did not influence desmin promoter activity m myogenic 
cells m a transient assay, it is unlikely that these GC boxes are 
involved in the regulation of desmin expression in these systems 
Cu-acting, developmcntally regulating elements which con-
trol tissue-specific expression are located within the 5' flanking 
regions of a number of muscle-specific genes The genes for 
skeletal o-actin (Melloul et al , 1984, Nudel et al , 1985, 
Bergsma et al , 1986, Sham, 1986), cardiac α-actin (Minty and 
Kedes, 1986, Minty et at , 1986, Mohun et al , 1986), muscle 
creatine kinase (Jaynes et al , 1986) and troponine I (Komeczny 
and Emerson, 1985) contain such muscle-spccifìc transcriptional 
control elements By comparing the regulatory sequences of these 
and other genes, α-actin-specific (Minty and Kedes, 1986) or 
even muscle-specific consensus sequences have been proposed 
(Jaynes et al, 1986) We compared the desmin promoter se­
quence from -89 to +25 bp with the 5' flanking sequence of 
published muscle-specific genes An 11-bp sequence from -82 
to -72 (CAGCTGTCAGG) has a perfect match at -440 in the 
mouse and human cardiac α-actin flanking region However, 
sequences homologous to the a actin or muscle-specific consensus 
sequences (Jaynes et al , 1986, Minty and Kedes, 1986) could 
nol be detected Deletion of a region from -443 to -395 of the 
human cardiac a-actin gene, including the 11-bp sequence, 
decreased transcriptional activity of the cardiac actm promoter 
2-fold, bul it was not essential for high-level, tissue specific ex­
pression We are currently investigating whether this 11 bp or 
other sequences in the desmin promoter region are responsible 
for tissue and stage-specific expression 
Other conserved, muscle specific sequences could not be 
detected in the 1 7-kbp 5' upstream region sequence of the desmin 
gene, when compared with the EMBL data base (version 9 0, 
EMBL, Heidelberg) 
In the mouse myogenic cell Ime T984, desmin expression was 
detected only after the cells had reached confluency This cor­
responds with the induction of desmin-CAT expression that oc­
curred upon myogenesis From the results obtained by Western 
blotting, Northern blotting, immunofluorescence tests and CAT 
assays it has become clear that desmin is already expressed in 
C2C12 myoblasts Upon differentiation, a 4-fold increase m the 
amount of desmin transenpts is observed, resulting m increased 
expression In both cell lines, regulation of desmin and vimen-
tin expression is probably not at the level of translation, but, most 
likely, at the level of transcription 
During in vitro myogenesis, C2C12 cell cultures express a 
number of genes in a muscle-specific, dcvclopmentally regulated 
manner (Blau et al, 1983, Bams et al , 1984, Seiler-Tuyns et 
al, 1984, Minty and Kedes, 1986, Silberstein et al, 1986) This 
involves induction as well as down-regulation of gene expres­
sion We show here that in C2C12 cells desmin expression does 
not follow the temporal expression pattern that is characteristic 
for other muscle-specific genes, its expression is initiated at an 
earlier stage In fact, desmin is the earliest known marker for 
cells in the myogenic lineage (Hill et al , 1986) Gene activation 
during myogemc development is a multistcp process, characteriz­
ed by an independent regulation of different classes of muscle-
specific proteins Most myofibrillar proteins are expressed in post­
mitotic myoblasts and myotubes, whereas desmin synthesis is 
initiated in replicating, presumptive myoblasts (Dlugosz et al, 
1983, Hill et al , 1986) Furthermore, it is possible to block the 
accumulation of muscle-specific proteins without repressing 
desmin synthesis (Dlugosz et al , 1983, Holtzer et al , 1985, 
Nelson and Lazandes, 1985) From these data and our results it 
may be concluded that C2C12 myoblasts represent a later stage 
in myogenic development, as compared with other myogemc cell 
lines, such as T984 and L8 (Yaffe and Saxel, 1977a), which do 
not express desmin at the myoblast stage and differentiate much 
more slowly This is in accordance with the findings of Minty 
et al (1986) who reported that C2C12 myoblasts contain muscle-
specific, transcription-modulating factors It is possible that these 
factors are sufficient for desmin expression The increase in 
transcriptional activity of the desmin promoter upon differentia­
tion may be caused by a higher concentration or different type 
of rraru-acting regulatory factor(s) in myotubes (Blau et al , 
1985) 
It is a matter of debate whether desmin and vimentin are co-
expressed in adult myotubes Bennett et al (1979), Osbom et 
al (1982) and Токиуамі et al (1984) reported that vimentm 
gradually disappears as myotubes mature, whereas others observ­
ed a continued co-expression (Granger and Lazandes, 1979, Gard 
and Lazandes, 1980, Hill et al, 1986) Zehner and Paterson 
(1985) observed an eightfold decrease m vimentm mRNA levels 
during m vivo myogenesis, whereas Ngai et al (1985) reported 
that during m vitro myogenesis vimentm mRNA levels did 
not change We observed only a slight decrease m vimentin ex­
pression in differentiating T984 cells In differentiating C2C12 
cells, however, vimentm expression decreased —30 fold, al­
though Western blotting and immunofluorescence tests show that 
C2C12 myotubes still contain vimentm At present we do not 
know whether the difference in regulation of vimentm expres­
sion between T984 and C2C12 cells is caused by insufficient 
maturation of the T984 myotubes (Blau et al , 1985, Silberstein 
et al , 1986), or if different control mechanisms exist in these 
cell types It was recently shown in studies on the expression 
of sequentially expressed myosin heavy chain (MHC) genes that 
m T984 myotubes the embryonic MHC gene is predominant and 
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only a small amount of adult MHC is expressed (Weydert et al.. 
1987) Therefore, insufficient maturation of T984 myotubes 
seems the most likely explanation 
Vimentin expression in T984, in C2C12 and in hamster lens 
cells is regulated by at least two separate regions One is located 
between -3100 and -599, the other between -176 and +101 
This second region contains a putative CAAT box at —90 bp, 
which is flanked by two potential Spi binding boxes at -120 
and -55 (Kadonaga et al, 1986, Jones et al, 1986), and a 
TATA box at -25 bp (Quax et al, 1983) The first region in-
creased transe optional activity in transient transfecuon assays, 
only low-level expression remained in T984 cells when this region 
was deleted In C2C12 myoblasts and hamster lens cells se-
quences upstream from —176 were neither required for high-
level expression, nor were they needed for the down-regulation 
of transcriptional activity in C2C12 cells We are presently invest-
igating the enhancing capacity of these sequences Preliminary 
results from experiments with further deleted vimentin promoter 
regions show that deletion of the CAAT box greatly diminishes 
vimentin—CAT exprebsion levels, both in hamster lens cells and 
in C2C12 cells Deletion of the potential Spi binding box at 
-120 bp has no effect on CAT expression (data not shown) 
It remains to be established whether desmin induction and 
vimentin repression are co-ordinated at the molecular level The 
data on the regulation of desmin and vimentin co-expression 
strongly suggest that their expression is not completely inter-
dependent 
Materials and methods 
Ceils and cell culture 
SV40-transformed hamster lens cells (Bloemendal eí al, 1980) were grown m 
Dulbecco s modified Eagle s medium (DMEM) supplemented with 10% fetal 
calf scrum The teratocarcmoma mouse muscle cell line T984 was originally 
isolated by Jakob et al (1976) T9B4 myoblasts were maintained m DMEM sup-
plemented with 15% fetal calf serum For differentiauon into mulunucleated 
myotubes, confluent cultures were switched to nutnent-dcficient medium (DMEM 
supplemented with 2% felal calf serum) The C2C12 cell Ime (Blau et al, 1983) 
was a subclone of the C2 Irne isolated by Yaffe and Saxel ( 1977b), and cultured 
as desenbed by Blau et al (1983) To induce myotube formadon confluent cultures 
were switched to low mitogen fusion medium (DMEM supplemented with 2% 
horae serum) C2C12 cells started to fuse after 2 4 - 3 6 h (Bains et al, 1984), 
whereas T984 myoblasts started to fuse after 48 h 
Construction of plasrmds and preparation of plasmid DNA 
In general the procedures suggested by Maniatis et al (1982) were followed 
for construction of plasrmds and preparation of plasmid DNA Five different 
desmin promoter—CAT hybrids were constructed (Figure 1A) A 114-bp 
BamUl-ΗραΏ fragment, containing sequences 89 bp upstream and 25 bp 
downstream from the CAP site including the TATA box of the desmin gene (Quax 
et al, 1985), was subcloned into die BamHl-Accl site of pSP65 From this 
plasmid, p89DesCAT was constructed by isolation and subclorung of the 
BomHI-MfldlU desmin fragment into superCAT, a derivative of pSVOCAT 
(Gorman et al, 1982) The 5' upstream 1 6-kbp BamHl fragment was ligated 
in front of the 114-bp BamHl-HpaU fragment in pSP65 From this plasmid, 
a 180-bpSfuI-Windin fragment, a 475 Ьр,4ссІ-/АшіШ fragment and a l 7 kbp 
Sacl-HindUl fragment were isolated and subcloned in superCAT, resulting in 
pl55DesCAT, p450DesCAT and pi 7DesCAT respectively The plasmid 
p89DesCAT was partially digested with £coRI, cutting only the EcoRl site m 
the polylinker, and completely with BamHl The 5' upstream 1 7-kbp 
EcoBl -BamHl desmin fragment was ligated into this plasmid This plasmid was 
subsequenüy linearized with BamHl and ligated to the 1 6-kbp BamHl upstream 
fragment resulting in p3 4DesCAT Three vimentm-CAT hybrids were con-
structed (Figure IB) A 1 2-кЪр ЕсоШ-Pstl fragment, containing sequences from 
-1100 to +101 relative to the CAP site, was isolated from the hamster vimen­
tin gene (Quax et al, 1983) This fragment was Mbol digested and the 277-bp 
Mbol-Psti fragment was ligated into superCAT, resulting in pl76VimCAT The 
1 2 kbp EcoRl-Pstl fragment was also digested with Smal, and the resulting 
700-bp Smal-Pst\ fragment was subcloned in superCAT, giving p599VimCAT 
p3 IVimCAT was constructed by ligating the 1 9-kbp 5' upstream Bamitl-EeoRI 
fragment and the 1 2-kbp EcoKL-Pstl fragment mto superCAT 
All DNA preparations to be used in transfecuon expenments were punfied 
on two successive CsCl gradients 
Cell transfecuon and CAT assays 
Cells were transfected by the calcium phosphate precipitation method, essential­
ly as desenbed by Wigler et al (1979) For hamster lens cells, T984 myoblasts 
and C2C12 myoblasts respectively, cells were plated at equal density in 100-rran2 
culture dishes the day before transfecuon Transfections were earned out on cell 
cultures which had reached - 2 0 % confluency To each culture dish 10 pg of 
plasmid DNA was added as a calcium phosphate precipitate, and 20 mm later 
5 ml rredium was added After 5 h of incubation, the cells were glycerol shocked 
for 2 5 mm, and incubated in normal growth medium for - 4 0 h Thereafter, 
CAT assays were performed or, m certain expenments with T984 and C2CI2 
myoblasts, the cells were incubated in fusion medium for 7 days and afterwards 
used in CAT assays Special care was taken to ensure that 40 h after transfecuon 
of myoblasts, when the cells were harvested for use in CAT assays, the cultures 
had not yet reached confluency This was done to minimize possible effects of 
differentiation and/or increasing cell density on desmin and vimentin expression 
For transfection of T984 or C2C12 myotubes, myoblasts were allowed to dif 
ferentiate for 7 days Transfections were earned out on the resulting confluent 
myotube cultures as desenbed, CAT assays were performed 40 h afterwards 
Cell extracts were prepared and used in CAT assays as desenbed by Gorman 
eial (1982) Transfections performed in parallel with pSVCAT (containing the 
SV40 early promoter) and with pSVOCAT (without promoter) were used to com­
pare expression levels Quantitation of CAT assays was performed by scmtdl-
ation counting of the appropriate areas of the chromatogram Experiments were 
earned out at least four times, using two different preparations of plasmid DNA 
¡mmunofluorescent staining and Western bloning 
In this study polyclonal rabbit antisera to chicken gizzard desmin (Ramaekers 
et al, 1983a, 1987) and to bovine lens vimentin (Ramaekers et al, 1983b) were 
used, both for Western blotting and іттшюЛиогеьсепі staining assays Monoclonal 
antibodies to desmin (RD301) and vimentin (RV202) (Broers et al, 1986, 
Ramaekers et al, 1987) were used in immunoftuorescence assays only, since 
they reacted very weakly in immunoblottmg assays The indirect im 
munofluorescence technique was performed as desenbed previously (Ramaekers 
et al, 1983a) Gel electrophoresis and immunoblottmg were earned out essen­
tially as desenbed by Broers et al (1986) 
RNA isolation and Northern blotting 
RNA from proliferating BHK-21 cells, T984 and C2C12 myoblasts and 5-day 
post fusion (C2C12) or 8-day post fusion (T9B4) myotubes was isolated by the 
LiCI-urea method (Auffray and Rougeon, 1980) Total RNA samples (10 /ig) 
were glyoxylated, fractionated on 1 % agarose gels and transferred to Highbond-
N (Amersham) As a desmin probe we used a 350-bp hamster desmin &шЗА 
fragment in M13, covering a region from 25 bp of exon 8 to 120 bp into the 
3' non-coding region (Quax et al, 1985) The vimentin probe was a 520-bp 
hamster vimentin ¿аиЭА fragment in M13, ranging from - 150 to +340 bprelabve 
to the transcription initiation site (Quax et al, 1983) Hybridization of Northern 
blots was performed as desenbed by Church and Gilbert (1984) 
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CHAPTER 3 
REGULATION OF VIMENTIN EXPRESSION IN 
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Most cell types start expressing vimentin when brought into tissue culture Using both vimentin-
expressing (HcLa) and vimentin-negative (MCF-7) epithelial cell lines, we have identified the as-
regulatory DNA elements involved in this process Sequences located 1 1 — 0 6 kb upstream of the 
vimentin transcription-initiation site strongly enhance expression in HeLa cells, but are silenced m 
MCF-7 cells Other regulatory elements in the vimentin promoter (an enhancer 3 2—26 kb upstream 
and a minimal promoter region including the CAAT-box) are potentially active in both cell types, 
but are silenced by the 0 5-kb fragment in MCF-7 cells Deletion of this fragment restores transcrip­
tional activity of a transfected vimentin promoter Our data indicate that a double AP 1/jun-binding 
site present in the 0 5-kb fragment mediates the induction of vimentin expression in cultured epithelial 
cells, while silencing sequences located within the same fragment are responsible for the absence of 
vimentin expression in MCF-7 cells 
In contrast to MCF-7 cells, a transfected vimentin promoter and gene are transcriptionally active 
in the vimentin negative epithelial cell line T24 TransfeUion studies show that type-III-intermcdiate-
filament expression is not impaired at any level in these cells 
Upon transfection and expression of a desmin construct in Г24 cells not only desmin, but also 
vimentin was detected Both proteins assembled into intermediate filaments This induction of 
vimentin expression appeared to be regulated at the post-transcnptional level 
Intermediate filaments (IF) represent a group of cyto-
skcletal structures of approximately 10 nm in diameter which, 
along with microtubules and microfilaments, occur in the 
cytoplasm of virtually all mammalian cells The IF proteins 
are encoded by a large multigene family and can be divided 
into six diflerent types on the basis of gene structure and 
homology [1—4] 
Apart from the lamins, the different types of IF subumts 
arc expressed in a developmentally regulated and tissue-
specific fashion This highly conserved specificity of ex­
pression suggests that each type or combination of subunits 
plays an important role in cellular differentiation [1 —6] 
The vimentin-expression pattern is more complex than 
that of the other IF subunits In adult tissues, vimentin is 
mainly expressed in cells of mesenchymal origin Moreover, 
during differentiation of a vanety of cell types vimentin ex­
pression is both positively and negatively regulated [1 — 3, 6] 
Depending on cell type, vimentin expression can precede the 
expression of the IF subunit specific for a particular tissue, it 
can be transiently coexpressed during development, or it can 
Correspondence to H Bloemendal, Department of Biochemistry, 
University ofNijmegen, Ρ О Box 9101, NL-6500 IIB Nijmegen, The 
Netherlands 
Abbreviation IF, intermediale Hlaments, AP-1, activator protein 
1, CAT chloramphenicol acetyltransferase, TK, thymidine kinase, 
IISV Herpes simplex virus 
remain present in the fully differentiated state [2, 3, 7] 
Coexpression of vimentin (a type-III-IF protein) and other 
type-III-IF proteins (desmin, glial fibrillary acidic protein and 
penpherm) or type-IV-IF proteins (neurofilaments) results in 
coassembly of these different types of IF subunits into the 
same filaments Coexpression of vimentin and cytokeratins 
(type-I and type-II-IF), however, results in the formation of 
separate IF networks [1 — 3] 
In the present study we focus on the regulation of a particu­
larly intriguing aspect of vimentin expression, ι с the induc­
tion of vimenlin-gcne expression and subsequent IF formation 
in cultured cells 
Regardless of their embryonic origin, most eukaryotic cells 
start synthesizing vimentin upon culturing This can be ac­
companied by the continued coexpression of the tissue-specific 
IF protein, but in other cases only vimentin expression remains 
[3,7-9] 
The function of vimentin filaments of cultured cells, and 
of cells in vivo, has remained obscure Vimentin expression is 
not essential for the cultured cell since some cell lines lack this 
type of IF or even all types of IF [3, 6] It has been suggested 
that vimentin expression in vitro is a sign of dedifferentiation 
[10,11] and, similarly, that its expression in neoplasms might 
be taken as evidence of reversion towards an embryonic 
phenotype [12] In many cells, vimentin expression is growth-
regulated Vimentin transcription can be induced by serum, 
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a variety of mitogens and also by certain inhibitors of cell 
proliferation, such as phorbol esters |13, 14] This complex 
regulation of expression takes place at the transcriptional level 
and is mediated by vanous positive and negative elements in 
the upstream region of the vimentin gene [13 — 18] 
We have demonstrated previously that 3 2 kb of the 
vimentin-gene 5 flanking region not only directs tissue-
specific expression in transgenic mice but also mediates tissue-
cullure-induced vimentin expression [19] The regulatory el­
ements in this region specifically involved in cell-type speci­
ficity of expression and/or induction of vimentin expression 
in cultured cells have not yet been identified Studies concern­
ing the regulation of vimentin expression, including deletion 
analysis of the vimentin promoter in transfection assays, have 
been performed on cultured, vimentin-producing cells, mak­
ing it impossible to distinguish between tissue-specific and 
tissue-culture induced vimentin expression 113 —18] 
Here we address this issue by using both vimentm-produc-
mg and vimentin-negative cell lines We identify elements 
which are specifically involved in the regulation of tissue-
culture induced vimentin expression as well as more general 
control elements In the vimentin-negative cell line MCF-7 
[20 — 23] these elements appear to be silenced The human 
bladder carcinoma cell line T24 [22, 24] also lacks vimentin 
IF, but transfection with vimentin-gene and vimentin-dcnved-
gene constructs showed that silencing of vimentin-gene ex­
pression does not occur in this cell line The effects of type-
III-IF expression on T24 cells are described 
MATERIALS AND METHODS 
Plasmid construction and isolation 
In general, plasmid construction and isolation procedures 
were as described by Sambrook et al [58] 
Deletion constructs 
Construction of 3 IVimCAT, 599VimCAT and 176Vim-
CAT has been described [15] These constructs are based on 
the vector pSuperCAI", a derivative of pSVOCAT [59] mio 
which the pUC18/19 polylinker has been inserted directly 5' 
of the chloramphenicol acetyltransferase (CAT) marker gene 
The constructs 2 6VimCAT, 2 IVimCAT, 1 9VimCAT, 
1 4VimCAT and 1 IVimCAT were generated from 
3 IVimCAT by using the tfmdIII, Pm\\, Pstl, Xho and EcoRI 
sites, respectively, in the vimentin-promoter region and the 
HmdUl (for 2 б ітСАТ) or Pstl site (all other constructs) at 
101 bp downstream of the transcnption-initiation site [15] 
Constructs 148VimCAT, 119VimCAT, 97VimCAT, 
SOVimCAT, 50VimCAT, 22VimCAT and +2VimCAT were 
generated from 176VimCAT using the exonuclease До/ЗІ 
under appropriate conditions [58] Briefly, 176VimCAT was 
linearized at the 5' end of the vimentin promoter with Sad, 
treated for different lengths of time with βα/ЗІ, subsequently 
blunt ended with T4 polymerase and digested with Bg/II, 
which cuts in the CAT sequence The resulting fragments of 
approximately 2 8 kb were hgated to the 1 4-kb Bgftl- Smal 
fragment from pSuperCAT, thereby regenerating the pSuper-
CAT vector 
The exact length of the Да/31-deletion constructs was de­
termined by sequence analysis using double-stranded DNA 
following standard procedures [60, 61] 
The only difference between the 15 CAT deletion con­
structs described above is the length of the vimentin-promoter 
region and the restriction site at the extreme 5' end All frag­
ments end at position +101 
The construct 2 SVimCAT was generated by isolating the 
2 5-kb BamHl -Smal fragment from 3 IVimCAT and sub-
cloning it in 5' to 3' orientation in pSuperCAT 
Enhancer-test constructs 
Plasmid 3 1 VimCATrev was generated by isolating the 2 5-
kb BamHl — Smal fragment as a Smal fragment, using the 
Smal polylinker site directly 5' of the АшіНІ site, and rc-
cloning this fragment in the reversed orientation in the Smal 
cut 3 IVimCAT vector 
The vector pBLCAT2 [62] contains the herpes-simplex-
virus (HSV) thymidine-kinase (TK) promoter fused to the 
CAT marker gene Both directly upstream of the TK promoter 
and downstream of the CAT gene lies a polylinker, containing 
unique restriction sites The plasmid pBLCAT3 is identical to 
this plasmid but does not contain the TK promoter 
The plasmids 2 5TKCAT5 and 2 5TKCAT5'rev were gen­
erated via isolation of the 2 5-kb BamHl — Smal fragment as 
a BamHl fragment This was done by subcloning the Smal 
fragment mentioned above (see constuction of 3 1 Vim­
CATrev) in a i'mal-cut pUC19 vector 5 of the BamHl site 
and reisolating the 2 5-kb fragment as a BamHl fragment 
This was inserted into the BamHl site of the 5' polylinker of 
pBLCAT2 in both onenlatiens This BamHl fragment was 
also inserted 5' of the CAT gene in pBLCAT3, yielding 
2 SCATS' 
The plasmids 2 5TKCAT3' and 2 5TKCAT3 rev were gen­
erated by isolating the 2 5-kb BamHl — Smal fragment as a 
Smal fragment (see above) and inserting it in the 3' polylinker 
of pBLCAT2 in both orientations 
The plasmid 2 0TKCAT5 was generated from 2 5TK-
CAT5' by removing the 5' 0 5-kb tfindlll fragment by partial 
fftndlll digestion followed by rehgation 
The plasmid 0 8TKCAT5 was generated from 
2 5TKCAT5' by deleting the most 5 1 8 kb of the vimentin 
promoter while leaving 0 8 kb from Xhol at 1 4 kb to Smal at 
0 6 kb This was done by SalljXhol digestion followed by 
rehgation The San site is located in the polylinker 5' of the 
vimentin promoter 
The plasmid 0 5TKCAT3'rev contains the 0 5-kb EcoRI -
Smal fragment inserted in the 3' polylinker of pBLCAT2 m 
the reversed orientation As a vector, a partial ¿coRI/Swal-
digcsted pBLCAT2 plasmid was prepared, since an £coRl site 
is also present in the CAT gene 
The plasmid AP-1TKCAT3' contains a 30-bp DNA frag-
ment, comprising the double activator-protein 1 (AP-l)/jun-
binding site located in the vimentin promoter at — 07 kb 
To obtain this sequence, the following oligomers were synthe-
sized 5 -AATTCCGTGAATCATCACCACTGACTCAGC-
3' (the 3 nucleotides at the 5 end of this 30-residue oligonu-
cleotide were introduced to generate an EcoVA site), 5'-GC-
TGAGTCAGTGGTGATGAT1CACGG-3' The double AP-
I-consensus sequence is underlined These oligomers were an-
nealed and inserted into the £coRI and Smal sites of the 3 
polylinker of pBLCAT2 in the normal orientation The 
plasmid AP-1TKCAT2 contains two of these fragments 
The plasmids 0 5 ГКСАТ5 and 0 STKCATS'rev were gen­
erated by isolating from 3 IVimCAI the most 5' part of the 
vimentin promoter region, running from 3 1 kb to 2 6 kb, as 
a 0 5-kb partial tfindlll fragment and inserting this fragment 
in two orientations in the 5' polylinker of pBLCAT2 
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The plasmids 2 5SV40CAT5' and 2 5SV40CAT5'rev were 
generated by inserting the 2 5-kb ДатНІ fragment into the 
bgfil site located 5' of the CAT gene of pAlOCAT, a denva-
tive of pSV2CAT containing the simian-virus 40 early pro­
moter but not the enhancer [59] The plasmids 2 5SV40CAI3' 
and 2 5SV40CAT3'rev were generated by inserting the 2 5-kb 
BamHl fragment into the BamHl site 3' of the CAT gene in 
both orientations 
Isolation and structure of the hamster vimentin gene used 
in this study has been described previously [27] Generation 
of the hybrid vimentin/dcsmin-gene constructs pVVim2 [28] 
and pVDes [19] has also been described previously 
The plasmids were Iransformcd into bacterial strains 
Escherichia colt HB101 or JM109 All DNA preparations to 
be used in transfection assays were purified on two successive 
CsCl gradients 
Cell culture and DNA transfections 
HeLa cells, T24 cells, MCF-7 cells, C2C12 cells and ham­
ster lens cells were cultured under standard conditions as 
described previously [15, 21, 22] 
Cells were Iransfected either transiently (CAT constructs) 
or stably (vimentin/desmin-gene constructs) using the cal­
cium-phosphate precipitation method, essentially as desenbed 
previously [15, 21] For each cell type, a glycerol shock was 
applied 
CAT activity was measured as described [15, 59] and, in 
most cases, normalized to the activity of a cotransfected 
RS VlacZ plasmid which served as control to monitor transfec­
tion efficiency [63] To each 100-mm2 culture dish 2 μg control 
plasmid (RSVlacZ) and 10 μg CAT plasmid were added as a 
coprecipitate For most transfections, one precipitate for each 
construct was simultaneously divided over the different cul­
ture dishes containing the different cell types Experiments 
were performed at least four limes with each construct, ш 
most cases using two different preparations of plasmid DNA 
Cell labeling and quantitative two-dimensional analysis 
of cell extracts 
MCF-7, HeLa and T24 cell-labeling with [35S]methionine 
was performed as described previously [21], except that 
500 μΟ [35S]methionine (> 1000 Ci/mmol specific activity, 
Amersham Nederland B V ) and 100-mm2 culture dishes were 
used 
Protein samples were prepared after the methods of 
Garrels [64, 65] as desenbed in Guide to Sample Labeling 
and Sample Preparation (Protein Databases Ine , New York) 
Briefly, proteins were harvested in sample buffer (0 3% SDS, 
5% 2-mercaploethanol, and 20 mM Tris, pH 8 0) and placed 
at 100°C for 2 min Cytoskeletal fractions were isolated as 
desenbed [21, 66] 
The samples were cooled on ice and treated with DNase 
and RNase to reduce viscosity Samples (both total cell extract 
and IF fractions) were shipped to Protein Databases Ine on 
dry ice, for further processing The samples were then analysed 
lor radioactivity and assayed by the Lowry method to deter­
mine specific activity and protein concentration, respectively 
The samples were dissolved in isoelectnc-focusing buffer 
(9 5 M urea, 2% Nomdet P40,100 mM dithiothratol and 2% 
basic ampholines) at 37 0 C for 30 mm 
The two-dimensional gel electrophoresis was performed 
after the methods of Garrels [64,65], and to achieve reproduc­
ible, standardized high resolution gels all procedures and oper­
ations were computer-controlled and computer-monitored 
Approximately 10—20 μΐ sample containing approximately 
400000 cpm and 20-30 μg protein were loaded onto the fo­
cusing tube which contained 2% pH 5 —7 ampholines The 
second dimension gel was 24 cm χ 24 cm χ 1 mm and con­
tained 12 5% acrylamide After electrophoresis at 60 W, the 
gels were processed for fluorography and multiple autoradio­
graphic exposures were made [64, 65, 67] 
Gel films were scanned and computer analyzed as de­
senbed [65,67] The threshold of detection and quantification 
for individual spots (cut-off value) was 3 cpm 
Antibodies, Western blotting 
and indirect immunofluorescence assay 
The following polyclonal and monoclonal antibodies were 
used in this study, a polyclonal rabbit antibody (poly-des) 
to chicken-gizzard muscle desmm [68], an affinity-punfied 
polyclonal antibody (poly-vim) to bovine lens vimentin [691, 
the monoclonal antibody RD301 to chicken desmin [70], the 
monoclonal antibody RV202 to bovine lens vimentin [71], the 
affinity-punfied polyclonal antibody (poly-ker) to human skin 
keratins [69] and the monoclonal antibodies RCK106 [71] and 
RCK.103 [72] to human keratins 
Western blotting was performed as reported earlier [21,73] 
using the monoclonal antibodies RV202 and RD301 Protein 
bands were visualized using '25I-labcled goal anti-mouse 
serum and autoradiography 
Single-label and double-label indirect immunofluores­
cence staining of cultured cells was performed as described 
previously [15, 29] 
Northern blot and run-on analysis 
RNA isolation, Northern blotting and hybridization were 
performed as described previously [15, 19] 
As a vimentin probe (E49), we used a 520-bp hamster-
vimentin SauJA fragment ranging from — 150 bp to f 370 bp 
relative to the transcription-initiation site [15, 19, 29] or the 
1 25-kb hamster vimentin cDNA pVim-2 [74] As a desmin 
probe (X54) a 350-bp hamster-desmin SaulA fragment was 
used, covenng the region from 25 bp of exon 8 to 120 bp into 
the 3' untranslated region [15, 19, 70] As an actin probe, we 
used a 1 25-kb hamster-actin-cDNA fragment [19, 75] 
Transcriptional run-on assays were performed as de­
senbed by Knapp et al [76] exept that nuclei were isolated 
from two 100-mm2 culture dishes containing exponentially 
growing HeLa, T24 or MCF-7 cells Incubation was carried 
out with 200 μΐ nuclear suspension, containing 2 — 8 χ IO7 nu­
clei Labeled RNA was extracted from the reaction mixture 
after 30 nun and hybndized to nitrocellulose filters containing 
hamster vimentin cDNA, hamster actin cDNA and pBR322 
DNA, at 42 °C for 24 h Hybridization conditions were as in 
Northern-blot analysis For binding to nitrocellulose, 5 μg 
plasmid DNA was linearized using appropriate restriction 
enzymes, denatured in 0 2 M NaOH for 30 mm at room tem­
perature, neutralized with 10 vol 6xNaCl/Cit (NaCl/Cit, 
1 M NaCl, 0 33 M citrate [58]) and applied to the nitrocellu­
lose using slot-blot equipment (Schleicher and Schuell) After 
hybndization, filters were RNase treated and washed, essen­
tially as desenbed [76] 
RESULTS 
Cell lines lacking vimentin expression 
Most cell-types initiate vimentin expression when brought 
into tissue-culture [3, 8, 19] However, the human bladder-
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Fig. 1. Vimentin expression in T24, HeLa and MCF-7 cells. (A) Indirect immunofluorescence staining of T24 cells using poly-vim. Only a small 
subset of cells (here focused on) contains positively staining, short, fibrillary structures. Bar indicates 10 μην (В) Autoradiographs of two-
dimensional gel electrophoresis of total (TOT; 1, 3, 5) and cytoskeletal cell extracts (CS; 2. 4, 6) of HeLa (1. 2), MCF-7 (3, 4) and T24 cells 
(5, 6) prepared after metabolic labeling with [35S]methioninc. Arrow indicates vimentin position. Note the absence of delectable vimentin in 
T24 and MCF-7 cells. Total cpm loaded were identical for each sample. Exposure times were for 4 and 6, 5 days; others, 2 days. (C) Nuclear 
run-on assays showing hybridization of nascent transcripts synthesized in isolated nuclei from HcLa, T24 and MCF-7 cells to vimentin cDNA 
(vim), control plasmid DNA (pUC) and actin cDNA (act). Note that vimentin transcription in T24 cells is very low relative to actin 
transcription. For T24 cells, 7 χ 107 nuclei were used, for HeLa and MCF-7 cells this was 2 χ IO7 and 4 χ IO7, respectively. (D) CAT expression 
mediated by the hamster-vimentin promoter in HeLa, T24 and MCF-7 cells. Plasmids used for transfection were pSV2CAT ( + ), pSVOCAT 
( —) and З.І ішСАТ (vim). CM, chloramphenicol; Ac, acetylated forms. 
carcinoma cell line RT4 and the human breast-adeno-
carcinoma cell line MCF-7 are completely devoid of vimentin. 
both at the mRNA and protein level [21-23]. Cells of the 
human bladder-carcinoma cell line T24 also do not contain 
vimentin-filament networks, but a small subpopulation 
(< 1%) contains short fibrillary structures which can be vis­
ualized in an immunofluorescence assay using antibodies di­
rected against vimentin ([22] and Fig la). In addition, trace 
amounts of vimentin mRNA can be detected in T24 cells ([22] 
and Fig. 7). Comparison of cytoskeletal and total-cell extracts 
of [35S]methionine-labeled HeLa, MCF-7 and T24 cells con­
firmed that no significant amounts of vimentin are present in 
the latter two cell types (Fig. lb). 
While vimentin expression is growth regulated and can be 
stimulated by some growth factors [13, 14]. we were unable to 
manipulate the number of vimentin-expressing T24 cells by 
changing growth conditions (such as composition of the cul­
ture medium; cell density; monolayer or suspension culture). 
To select for vimentin-positive and vimentin-negative T24 
cells, maximal dilution subcloning was applied. Even after 
several rounds of subcloning, the number of vimentin-expres­
sing cells did not change, indicating that the vimentin-contain-
ing cells do not represent a subpopulation. 
To examine the regulatory events underlying the different 
vimentin-expression patterns of these cultured epithelial cells, 
the rate of transcription of the vimentin gene in T24 cells 
compared to vimentin-expressing (HeLa cells) and non-ex­
pressing cells (MCF-7) was determined by nuclear run-on 
analyses. Only low rates of vimentin transcription could be 
detected in T24 cells (Fig. 1c). 
Transfecting MCF-7 cells with constructs containing the 
vimentin promoter linked to a marker gene did not result in 
significant expression. In contrast, this promoter is highly 
active in T24 cells and in HeLa cells (Fig. Id). 
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Fig 2. Functional assay of the hamster-vimenhn-promoter region by deletion analysis. (A) Schematic representation of the vimentin-promotcr 
deletion conslrucls containing varying lengths of the vimenlin 5 flanking region fused to Ihc CAT marker gene Arrows indicate 5 end of 
each construct Postions arc indicated relative to the transcnption-initiation site at +1 in kb (upper part) or in bp (lower part) Constructs 
are designated XVimCAT, where X (in kb or bp) is the position of 5 end of Ihe promoter region I he promoterless construct 2 SVimCAT 
(not shown) contains the 5 fiamHI — Smal fragment fused to the CAT gene CAAT-Ьох (at —90), TATA box and polenlial Spi box (at — 
122) are underlined B, ÄamHI restnction site, H, tfmdIII, Pv, Pvul, Ps, Psll, X.Xhol, E, EcoRl, S, Smal. M,Mbol Transcnption-initiation 
site is located at -I 1 (B — I)) Relative CAT activity of deletion constructs depicted in Fig 2a after transient transfection into HeLa cells (B), 
MCF-7 cells (C) and hamster-lens (HaLc) cells (D) Activity of 3 IVimCAT is arbitrarily set at 100% for HeLa and HaLe cells, for MCF-7 
cells pSV2CAT activity is taken as 100% Values are corrected for variations in transfection efficiency by normalizing against the activity of 
a cotransfected pRSVIacZ plasmid For each construct, the diagram shows the mean value and standard deviation calculated from at least 4 
independent experiments 
Transcriptional regulation of vimentin expression 
in cultured epithelial cells 
We demonstrated previously that 3 2 kb of the vunentm-
promoter region is sufficient to mediate tissue-culture-induced 
vimenlin expression [19] To more precisely identify the regu-
latory elements involved in this process, a series of plasmids 
was constructed in which decreasing lengths of 5' flanking 
region were fused to the bacterial CAT marker gene (Fig 2a) 
These constructs were tranifected in parallel into HeLa and 
MCF-7 cells 
In HeLa (Fig 2b) and T24 cells (data not shown), three 
different regions appeared to be involved in modulating the 
transcriptional activity of the vimentin promoter Deletion of 
a 0 6-kb region at the 5' end resulted in a twofold reduction 
of CAT expression Deletion of the region between — 1 1 kb 
and — 0 6 kb relative to the transcnption-initiation site de-
creased CAT expression 5 — 10-fold The region from — 2 6 kb 
to —1 1 kb could be deleted without affecting CAT-expression 
levels Deletions extending beyond the CAAT-box at - 9 0 bp 
completely abolished CAT expression (Fig 2b) Identical re-
sults were obtained when primary cultures (i e human 
hepatocytes) instead of epithelial cell lines were used These 
cells initiated vimentin expression after 1—2 days in culture 
[8, 19] and were transfectcd after 3 days (data not shown) 
Deletion of 5' flanking sequences up to — 1 1 kb had 
no effect on vimentin-promoter activity in MCF-7 cells 
(Fig 2c) However, deletion of the region between — 1 1 kb 
and — 0 6 kb resulted in increased CAT expression, indicating 
that t b s sequence has a negative effect on vimentin-promoter 
activity m MCF-7 cells The same senes of constructs was also 
transfected into transformed hamster lens cells (Fig 2d) and 
C2C12 cells (data not shown) These cell-types express 
vimentin instead of cytokeratins, not as a result of cultunng 
but because they express vimentin in their tissue of ongin 
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Fig. 3. Assay for enhancer activity in the S' flanking region of the 
vimentin gene. A schematic represcntalion of the enhancer-test con­
structs is given TK, HSV-TK promoter; SV40, simian-virus 40 early 
promoter, API, AP-1/jun-binding-site consensus sequence (see Ma­
terials and Methods) The black line represents vimentin 5' flanking 
region Note that plasmids Ì IVimCAT and 3 IVimCATrev contain 
the vimentin promoter. Arrow-heads indicate onenlalmn of the pro-
moter fragments relative to the CAT gene CAT activities of the 
enhancer-test constructs after transient transfection mio HeLa cells 
and MCF-7 cells are given relative lo pSV2CAT activity, which was 
set at 100%. CAT values were normalized lo pRSVLacZ activity of 
a cotransfecled plasmid. At least 4 transfections were performed with 
each construct Relative CAT activities represent ihe average values 
from these transfections Background aclivily of pBLCAl'I and 
pSuperCAT in MCF-7 cells varied between 2% and 5% For 
pAlOCAT (SV40CAT, not shown) and pBLCAT3 (not shown) back-
ground activity was on the threshold of detection В, ВшпШ, Η, 
WmdIII; Χ, ΑΆη, E, EcoKl, S, Smal 
[25, 26]. Deletion of the -1.1 kb to -0.6 kb region did not 
influence the high vimentm-promoter activity in these cells 
(Fig. 2d). The effects of deleting the -3.1 kb to -2.6 kb and 
CAAT-box regions were similar as observed for HeLa cells. 
These data indicate that the region from —1.1 kb to -0.6 kb 
in the 5' flanking region of the vimentin gene is involved 
in activation of the vimentin promoter under tissue-culture 
conditions in epithelial cells, while in cells which already ex­
press vimentin before being cultured this region is not needed 
for high-level promoter activity 
Reversing the orientation of the -3.1 kb to — 0.6 kb 
vimentm-promoter fragment resulted in a decrease of pro­
moter activity in HeLa cells of 65% (Fig 3) while deletion of 
V GTGAATCATCACCACTC,ACTCA(.C-3' 
AP-l/Jun consensus G 1C,A A TCA 
С С 
Fig. 4. Sequence located from —708 bp to —685 bp upstream of the 
transcription-initiation site in the hamstcr-vimentin promoter. AP-1/ 
jun-binding sites are underlined The AP-l/jun consensus sequence is 
shown. Note Ihe perfect match of both binding sites 
this region caused a 5 —10-fold decrease in activity (Fig. 2b). 
This indicates that the fragment has enhancing properties. 
When the —31 kb to — 0.6 kb fragment was tested in the 
promotcrless plasmids pSuperCAT (2 SVimCAT; see legend 
to Fig. 2) or pBLCAT3 (Fig. 3, 2.5CAT5'), no CAT activity 
was detected. 
To further characterize the nature of the various regulatory 
elements, different portions of the vimentin promoter were 
tested for enhancer activity by incorporating them into the 
plasmid pBLCAT2, which contains the HSV TK promoter 
fused to the CAT gene. Some DNA fragments were tested 
upstream and downstream of the CAT gene in pBLCAH, 
both in normal and inverted onentation (Fig 3) The region 
from —3.1 kbto —0.6 kb displayed strong enhancing activity 
in HeLa cells (Fig. 3). In contrast, this fragment did not func­
tion as an enhancer in MCF-7 cells 
Deletion of the 5' 0.5 kb or 1 8 kb from this fragment 
had no effect on activity (Fig. 3). The —3.1 kb to —2.6 kb 
fragment stimulated CAT expression in both cell types 
(Fig. 3), but the — 1.1 kb to — 0.6 kb fragment yielded similar 
results as the entire — 3 1 kb to —0.6 kb fragment in MCF-7 
cells, i.e no significant CAT activity was detected (Fig. 3). 
This indicates that the —1.1 kb to — 0.6 kb fragment can 
function as an enhancer in HeLa cells but not in MCF-7 cells. 
In addition, it inhibits the enhancing capabilities of more 5' 
sequences of the vimentin promoter in these cells. 
The —1.1 kb to —0 6kb vimentm-promoter fragment 
contains a double AP-1/jun-binding-site consensus sequence 
at —0.7 kb (Fig. 4). This sequence was synthesized, incorpor­
ated into pBLCAT2 and tested in HeLa and MCF-7 cells. 
In both cell types, the sequence displayed strong enhancing 
activity (Fig. 3), indicating that other sequences in the 
— 1.1 kb to — 0.6 kb fragment cause the silencing effect as 
observed in MCF-7 cells. In HeLa cells, the enhancer activity 
of the AP-1 element was similar to that of the 0.5-kb EcoRl — 
Smal fragment in which this element is located, suggesting 
that the enhancing capacities of thts fragment are mediated 
by the double AP-1 -consensus sequence at — 0 7 kb. 
When, instead of the HSV-TK promoter, the simian-virus 
40 early promoter was used to test for enhancing capacity of 
the —3.1 kbto —0.6 kb fragment, no CAT activity was detect­
ed (Fig 3), demonstrating that not all heterologous promoters 
can be stimulated by this DNA fragment. 
Expression of type-lll-IF-gene constructs in T24 cells 
Contrary to MCF-7 cells, the low rate of transcription of 
the endogenous vimentin gene of T24 cells is not reflected in 
the promoter activity of vimentin-promoter/CAT constructs 
transfected into these cells (Fig. 1 d). 
To examine possible dominant negative regulatory effects 
of elements located within or downstream of the vimentin 
gene, transfections with the hamster vimentin gene [27] were 
performed In addition, the vimentin/desmm hybnd genes 
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Fig. 5. Schematic representation of the IF-gene constructs stably trans­
fected into T24 cells. Vimentin. hamster vimentin gene containing 
3.2 kb of 5' and 2.6 kb of 3' flanking sequences. pVVim2. hybrid 
vimeniin-desmin gene construct, in which part of the vimentin gene 
(including exons 7 — 9) has been replaced with the corresponding 
region from the hamster-desmin gene. This allows detection of the 
pVVim2-encoded protein with the monoclonal antibody RD301. 
pVDes. hamster-desmin-gene construct containing the coding region 
of the desmin gene fused to the vimentin promoter. (D) Vimenlin 
exons. (•) Desmin exons. E49, vimentin probe; the 3' part of this 
probe (indicated by gray region) does not hybridize to pVDes. X54. 
desmin probe. L, fusion site between desmin-derived and vimentin-
derived sequences. 
pVVim2 [28, 29] and pVDes [19] were used (Fig. 5). We have 
previously demonstrated that in transgenic mice these con­
structs can be expressed with endogenous vimentin in a tissue-
specific fashion, while the pVVim2-derived and pVDes-de-
rived transcripts, proteins and IF can be readily discerned 
from their endogenous counterpart [19, 29]. Since the 
immunofluorescence and CAT assays might indicate that a 
deviant vimentin incapable of de novo IF formation is 
synthesized in T24 cells, expression of these IF constructs 
could rescue the endogenous vimentin by allowing the mutant 
vimentin to incorporate into a preformed type-III-IF network. 
Cytoskeletal extracts from stably transfected clones were 
analyzed by SDS/PAGE and Western blotting (Fig. 6). T24 
cells transfected with the intact vimentin gene expressed cor­
rectly sized vimentin at high levels. The pVVim2 protein was 
also expressed and was detected with a poyclonal antibody 
directed against vimentin (Fig. 6b) and a monoclonal anti­
body against desmin (data not shown). 
Surprisingly T24 cells transfected with pVDes not only 
expressed desmin, but also correctly sized vimentin (Fig. 6b). 
Southern-blot analysis of chromosomal DNA showed that 
these cells only contained the pVDes construct and not 
pVVim2 or the hamster vimentin gene (data not shown). 
Northern-blot analysis demonstrated that the transfected 
vimentin gene, pVVim2 and pVDes were all expressed at high 
levels. Vimentin-expression levels even exceeded those of 
transformed hamster-lens cells which express vimentin at high 
levels (Fig. 7). Both untransfected T24 cells and T24 cells 
only transfected with the neomycin plasmid, contained trace 
amounts of vimentin mRNA (Fig. 7b). The pVDes-expressing 
clones did not display elevated vimentin-transcript levels, in­
dicating that the increase in vimentin-protein expression ob­
served in these cells is not caused by induction or derepression 
at the transcriptional level. 
mOes 
Fig. 6. Cytoskeletal fractions of clones of T24 cells stably transfected 
with the constructs depicted in Fig. 5, analyzed by one-dimensional 
SDS/PAGE and immunoblotting. (A) Coomassie Brilliant Blue (CBB) 
staining of SDS/polyacrylamide gel. (->) Vimentin position. (B) 
Immunoblots. incubated with the monoclonal antibody to vimentin 
(RV202. mVim) and subsequenlly with the monoclonal antibody to 
desmin (RD301. mDcs) С untransfected T24 cells; vimDl. T24cell 
clone Dl. transfected with the vimentin gene; vimE4. clone E4, trans­
fected with the vimentin gene; neo, control clone, transfected with 
pSV2neo only; des. transfected with pVDes; vvim2. transfected with 
pVVim2. 
Influence of desmin expression on levels of other proteins 
For a more detailed and quantitative analysis of the newly 
synthesized vimentin in pVDes-expressing cells, cytoskeletal 
and total [35S]methionine-labeled cell fractions of pSV2neo-
transfected and pVDes-transfected cells were compared by 
automated, high-resolution two-dimensional gel electropho­
resis. Representative autoradtographs are shown in Fig. 8. 
For quantification, multiple exposures were subjected to 
computer-assisted analysis. Desmin was detected at the ex­
pected position in pVDes-transfected T24 cells, but not in T24 
cells transfected with pSV2neo only (Fig. 8). Desmin com­
prised 0.3% of total cellular protein and 0.8% of cytoskeletal 
proteins. Vimentin was detected at the correct position in the 
pVDes cell line. In these cells, the rate of vimentin synthesis 
was 100 —200-fold lower than desmin synthesis. 
In the pSV2neo-transfected control cell line, vimentin was 
detected at least once (Fig. 8). While the amount of vimentin 
was too low for quantification by computer or for detection 
in Western blotting, it was at least 20-fold lower than in pVDes 
cells, since otherwise it would have been above the threshold 
of detection (see Materials and Methods). 
Computer-assisted analysis of the quantitative similarities 
between identical proteins from pVDes-transfected and pNeo-
transfected cells showed that of 838 proteins matched in total 
cell extracts, 79% displayed no change in expression level. The 
same value was found for the cytoskeletal fraction (out of 
264 proteins matched). Desmin expression had no detectable 
impact on cell growth or morphology. 
Type-III-IF formation in T24 cells 
To examine whether in T24 cells type-III-IF expression is 
impaired at the level of IF assembly, indirect immunofluores-
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Fig. 7. Northern-blot analysis of 10 μς total RNA from exponentially 
growing stably transfected T24 cell clones, l'or each transfeclant, RNA 
was isolated from two independently cultured clones to allow detec­
tion of fluctuations in expression levels caused by differences in growth 
conditions. Blots were first hybridized to vimentin probe E49 (a), 
subsequently to a vimentin cDNA probe (b) and an actin probe (c). 
Lanes des" were also hybridized to a desmin probe (X54) HeLa. 
RNA from HeLa cells (2 μg); HaLc. hamster lens cells (10 μg)•, C, 
untransfected T24 cells; neo, pSV2neo-transfectcd cells; vvim2, 
pVVim2-transfected T24 cells; vimE4. vimentin-gene transfected T24 
cells; des and des". pVDes-transfected T24 cells. Note more sensitive 
detection of human vimentin transcripts with the hamster-cDNA 
probe than with vimentin probe R49, allowing detection of low levels 
of human vimentin RNA. This is caused by differences in sequence 
similarity and probe length (similarity between E49 and the corres­
ponding human vimentin region is 78%). 
cence assays using both polyclonal and monoclonal antibodies 
directed against vimentin, desmin and cytokeratin were 
performed on stable transfectants expressing vimentin, desmin 
or the pVVim2 hybrid protein. 
Normal type-III-IF networks were observed in each of 
these cell lines (Fig. 9). Staining of desmin-expressing cells 
with antibodies against vimentin revealed that the endogenous 
vimentin did participate in IF formation (Fig. 9e). These IF 
networks appeared more extensive when poly-vim was used in 
the assay, while using a monoclonal antibody against vimentin 
resulted in very weak staining, indicating that only small 
amounts of vimentin were present in these filaments. 
Double-label indirect immunofluorescence assays with 
polyclonal antibodies against vimentin or desmin and a mono­
clonal antibody against cytokeratin 18 showed that the type-
II1-IF networks colocalized to a large extent with the 
cytokeratin network (Fig. 9). In cells of the T24 clone D l , 
which expressed vimentin at very high levels (Fig. 6), vimentin 
not only assembled into IF but also accumulated in strongly 
fluorescent clumps. Similar clumps were observed upon single 
staining of these cells with a monoclonal antibody against 
keratin (Fig. 9. i —k), indicating that the cytokeratin network 
was affected by vimentin overexpression. 
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Fig. 8. Autoradiographs of two-dimensional gel electrophoresis of total 
(TOT; 1, 3) and cytoskeletal cell extracts (CS; 2,4) of T24 cell clones 
stably transfected with pVDes (Des; 1, 2) or pSV2neo (neo; 3, 4) 
prepared after metabolic labeling with |35S|methionine. Arrow pointed 
downwards indicates vimentin position (2), upward arrows indicates 
desmin position (1, 2). Total cpm loaded were identical for each 
sample. Exposure times for 1 and 3, 5 days; 2 and 4. 10 days. 
Effects on cell viability or morphology were not detected. 
DISCUSSION 
Transcriptional regulation of vimentin expression 
Induction of vimentin expression in cultured cells is regu­
lated at the level of transcription and can be mediated by 
3.2 kb of the hamster-vimentin promoter [19]. Here we show 
that at least three different regions in this promoter are in­
volved in the regulation of vimentin expression in cultured 
cells. An enhancer which is active both in vimentin-expressing 
and in vimentin-negative cells is located between — 3.2kb 
and —2.6 kb relative to the transcription initiation site. A 
CAAT-box sequence at — 90 bp is required for expression. 
The region from —1.1 kb to —0.6 kb functions as a strong 
enhancer in vimentin-expressing cultured epithelial cells but 
has the opposite effect in vimentin-negative MCF-7 cells. In 
cultured cells which are derived from vimentin-expressing cells 
which do not express cytokeratins, this region is not needed 
for high-level vimentin expression. The properties of this re­
gion seem to be related to the double AP-1/jun-binding site 
present in this fragment. The AP-1-binding site is a highly 
conserved enhancer-like element present in many viral and 
cellular genes that is recognized by the Fos and Jun family of 
oncoproteins [30 — 34]. Enhancer activity of the AP-1 site is 
dependent on cellular and promoter context ([35] and refer­
ences therein). We show here that the AP-1/jun-binding site 
can function as a strong enhancer in both HeLa and MCF-7 
cells. However, in MCF-7 cells D N A elements in the —1.1 kb 
to —0.6 kb promoter fragment are capable of silencing not 
only this AP-1 site but also of the entire —3.2 kb to —0.6 kb 
region, including the enhancer located between —3.2 kb and 
- 2 . 6 kb. 
These data indicate that the —1.1 kb to —0.6 kb region 
and the double AP-1-binding site located within it, are instru­
mental in inducing vimentin expression in cultured epithelial 
cells, while the silencing activity of this fragment explains the 
absence of vimentin expression in MCF-7 cells. The exact 
position and silencing characteristics of two negative-regulat­
ory elements within the —1.1 kb to — 0.6kb region will be 
described elsewhere [31a]. 
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Fig. 9. Double-label and single-label immunofluorescence staining of 
T24 cell clones stably transfected with pVDes (a, b, e), pVVim2 (c, d) 
the vimentin gene (g, h, i — k) or pSV2neo (f). (a, b), pVDes-transfected 
cells incubated with poly-des (a) and mono-ker (b)- (c, d), pVVim2-
transfected cells incubated with poly-des (c) and mono-ker (d). Ident-
ical results were obtained when poly-vim was used instead of poly-
des (not shown). Note (partial) colocalization of desmin and pVVim2 
filaments with keratin IF. (c) pVDes transfected cells incubated with 
poly-vim. Note vimentin IF staining in these cells transfected with 
pVDes. (0, pSV2neo-transfected cells incubated with poly-vim. Note 
absence of vimentin IF. (g, h). Vimentin-gene transfected cells (clone 
E4) incubated with poly-vim (g) and mono-ker (h). Note (partial) 
colocalization of vimentin and keratin IF. (i), Vimentin-gene trans-
fected cells (clone Dl) incubated with mono-vim. (j). As in k, incu-
bated with mono-ker. (k). As in i, at higher magnification. Cells from 
clone Dl expressed hamster vimentin at very high levels (Fig. 6). In 
these cells, most of the vimenlin appeared to be present in clumps 
instead of IF (i). This vimenlin overexpression led to disturbance of 
the keratin IF network 0, k). Bar indicates 10 pm. 
Both in HeLa cells and in T24 cells the simian-virus 40 
early promoter failed to be stimulated by the — 3.2kb to 
— 0.6 kb fragment, whereas vimentin-promoter and HSV-TK-
promoter activities were strongly enhanced by this fragment. 
This may be related to the fact that both the vimentin and TK 
promoter contain a CAAT-box, while the simian-virus 40 
(SV40) early promoter does not. 
The human vimentin promoter contains a double AP-1/ 
jun-binding site located at exactly the same position as in the 
hamster promoter. This sequence is involved in the increase 
of vimentin expression that occurs when serum is added to 
quiescent cells [14]. 
The AP-1 transcriptional complex is composed of serum-
inducible proteins such as c-fos and c-jun [31 — 34]. Hormones 
and growth factors present in serum have been shown to 
increase nuclear AP-1-binding activity via several signaling 
pathways [36]. 
Taken together, the data indicate that serum inducibilily 
of vimentin expression via enhanced activity of the AP-1 tran-
scriptional complex is, at least in part, responsible for the 
induction of vimentin expression in cultured cells. Since 
serum-starved cells do express vimentin, albeit at lower levels 
[13. 14], and since a construct containing 241 bp of the prox-
imal human-vimentin promoter but not the AP-1-binding site 
remained serum inducible [13], the possibility remains that 
additional regulatory elements are involved in the induction 
of vimentin expression in tissue culture. 
In contrast to MCF-7 cells, vimentin-negative T24 cells 
transcribed a transfected vimentin-promoter construct and 
intact vimentin gene at high rates, while endogenous vimenlin 
transcription and steady-state mRNA levels were low. This 
indicates that transcriptional factors needed for vimentin ex-
pression are present but do not activate the endogenous gene. 
Mutation or methylation of endogenous promoter sequences 
might cause this effect. 
Post-transcriptional regulation of vimentin expression 
Transfections of T24 cells with IF-gene constructs demon-
strated that type-Ill IF proteins can be expressed at high levels 
and assembled into IF. Surprisingly, expression of hamster 
desmin resulted in induction of endogenous vimentin ex-
pression at the post-transcriptional level. This protein ap-
peared to be correctly sized as judged by Western blotting 
and high-resolution two-dimensional gel electrophoresis. In 
addition, the human vimentin was incorporated into the des-
min IF. Even at the low expression levels observed in T24 cells, 
incorporation of vimentin subunits into desmin IF resulted in 
networks which were readily detectable in indirect immuno-
fluorescence assays using a polyclonal antibody directed 
against vimentin. Quantitative analysis revealed that vimentin 
levels in desmin-expressing cells were 100 —200-fold lower 
than desmin levels. More importantly, in control T24 cells, 
vimentin expression was mostly undetectable. 
Our results show that T24 cells normally express very 
low levels of vimentin, which are insufficient for de novo IF 
assembly. The minimal stable polymer for IF appears to be 
the tetramer (for reviews see [37 — 39]). Newly synthesized 
vimentin is found in a soluble pool of tetramers, from which 
it assembles into IF [39 — 41]. It has been demonstrated that 
IF are dynamic structures into which newly synthesized sub-
units are readily incorporated, even when expressed at rela-
tively low levels [39, 42 — 49]. When coexpressed, desmin and 
vimentin subunits form heterodimers which subsequently take 
part in IF formation [50]. IF subunits which cannot take part 
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in IF formation, e g because they contain a mutation or, in 
the case of keratins, because only type-I or type-II subumts 
are expressed, are subject to rapid degradation [49, 51, 52] 
Taken together, these data suggest that the post-transcnp-
tional induction of vimentin expression observed upon desnun 
expression in T24 cells might be caused by desmin-vimentm 
hcterodimer and tetramer formation As a result, vimentin 
subumts are protected against rapid turnover to which they 
would otherwise have been subjected due to their low cytoplas­
mic concentration, which may not allow efficient tetramer 
formation 
Alternatively, the observed induction of vimentin ex­
pression in the presence of a type-Ill (i e , desmin) IF network 
could result from changes at the translatie nal instead of the 
posl-translational level II has been demonstrated that in ad­
dition to the post-translational assembly of vimentin from the 
soluble pool of tetramers, a significant portion of nascent 
vimentin polypeptides directly (independent of ribosomes) as­
sociates with the IF cytoskeleton and incorporates into IF 
during translation [39, 53] This process is known as cotrans-
lational assembly The presence of desmin IF in T24 cells 
which normally do not contain a type-III-IF network could 
conceivably enhance translation at this level In addition, IF 
are involved in binding mRNA, polyribosomes, translation 
factors and other components of the translation complex [22, 
53 - 5 5 ] Stabilization of vimentin subumts (or increased 
vimentin translation) as observed here m vitro, ι e , in desmin-
expressing T24 cells, probably also occurs in vivo during cer­
tain stages of myogenesis The ratio of vimentin to desmin 
expressed and incorporated into the IF network of differen­
tiating muscle cells changes gradually, resulting in a total 
replacement of vimentin by desmin [50] 
Vimentin could be expressed at very high levels in T24 cells 
By SDS/PAGE analysis of different dilutions of cytoskeletal 
extracts of stably transfected cells it was determined that 
vimentin levels could exceed desmin levels at least 10-fold (e g 
Fig 6) and therefore represented at least 3 % of total cellular 
protein Immunofluorescence assays on these cells showed 
that part of this vimentin was present in strongly fluorescent 
clumps The same phenomenon was observed after staining 
the cy tokeratin IF, which were clearly affected by the vimentin 
overexpression Colocalization of type-III IF with intact 
cytokeratin IF was also observed m the cells expressing lower 
levels of type-III-IF protein In a previous study we demon­
strated that overexpression of amino-terminally deleted des­
min disturbed the endogenous cytokeratin network of HeLa 
cells [21] Our present results indicate that this disruption may, 
at least in part, have been caused by high levels of desmin 
expression 
The extremely high levels of vimentin expression and the 
concomitant disturbance of the cytokeratm-IF system did not 
appear to affect cell growth or viability This is in accordance 
with previous reports, describing the total disruption of 
cytokeratin-IF systems in cultured cells [56, 57] and suggests 
that IF do not fulfil an essential function in many cultured 
cell types As demonstrated here and in previous studies, cell 
lines can be useful in studying the various regulatory mechan­
isms that control vimentin expression However, to address 
the question of the function of these cytoskeletal structures 
studies must be undertaken at the level of the intact organism, 
ι e in transgenic animals 
This work was supported by the Netherlands Organization for 
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We have introduced a hybrid gene, pWim2, composed 
of the 5' region of the hamster vimentin gene encoding 
the head and rod domain of vimentin and the 3' region 
of the hamster desmin gene encoding the tail domain of 
desmin, into the germ line of mice by pronuclear injec­
tion. RNA and protein analysis of mice transgenic for 
this construct showed that the pVViml gene was express­
ed at high levels in a developmental and tissue-specific 
manner. This indicates that the vimentin-derived segment 
of the fusion gene contains all the regulatory elements 
required for vimentin-specific expression. Immunohisto-
chemical staining of fibroblast cultures derived from the 
transgenic mice with antibodies specific for vimentin and 
desmin demonstrated that the pWim2 protein is 
assembled into filaments that co-localize with the endo­
genous vimentin filaments. The expression of pWim2 
protein in mesenchymal cells does not interfere with the 
function of vimentin in these cells. 
Introduction 
The intermediate filaments (IFs) have been characterized as 
a unique set of cytoskeletal structures, composed of cell type-
specific proteins These proteins can be divided into five 
distinct classes, which arc expressed in a developmentally 
regulated and tissue-specific fashion (Franke el al , 1982, 
Osbom and Weber, 1982) For example, desmin is only ex­
pressed in muscle cells, while vimentin is almost exclusive­
ly found in cells of mesenchymal origin (Lazandes, 1982) 
In addition, vimentin is found in many cells cultured m vitro 
(Franke el al , 1979, Virtanen et al, 1981, Traub, 1985) 
The intermediate filament proteins are strongly related to 
the nuclear lamins and have been assigned to the same multi-
gene family (McKeon el al ,1986, Fisher el al, 1986) The 
IF subumts have a similar structural organization a central 
conserved a-hehcal domain (rod) of —320 amino acid 
residues is flanked by a non-helical amino-lerminal head 
domain and a carboxy-terminal tail domain of variable length 
(Geisler et al, 1982, Steinen el al, 1985) In vitro, the head 
and rod domains play a pivotal role in the polymerization 
of IF subumts (Kaufmann et al, 1985, Traub and Vorgias, 
1983) 
The close relationship between.the IFs is also reflected 
in their gene structure The exon-intron organization of 
vimentin, desmin and the glial fibrillary acidic protein is 
similar and coding sequences show up to 65% homology 
(in case ol vimentm and desmin, Quax el al , 1983, 1985, 
Roop and Steinert, 1986) For most IF genes little is known 
about the regulatory sequences controlling their develop­
mental and tissue-specific expression For hamster desmin 
we have shown that the region between -89 and +25 bp 
relative to the cap site is sufficient for cell type-specific tran­
sient expression The flanking 5' region of the vimentin gene 
contains several regulatory elements These elements are in­
strumental both in the downregulation of vimentin gene ex­
pression during myogenesis (Pieper el al , 1987, in press) 
and in the transcriptional modulation of vimentin gene ex­
pression in response to some growth factors (Rittling and 
Baserga, 1987) 
Determination of the cell type-specific function of vimenün 
and the characterization of the regulatory pathways controll-
ing vimentin gene expression is partly hampered by the tact 
that expression of vimentin is induced in most cells by m 
vjrro culture Therefore, we have introduced a 
vimentin-desmin hybrid gene construct into the germ line 
of mice to study the tissue-specific regulation of vimentm 
gene expression in vivo and to obtain insight in tissue-spcufic 
IF functions In this construct the last three exons of the 
hamster vimentm gene covering the complete tail domain 
were replaced by the last three exons of the hamster desmin 
gene This allows recognition of the gene product in the 
presence of endogenous vimentm, while retaining the struc-
tural features characteristic for intermediate filaments The 
expression of this fusion gene was analyzed in transgenic 
mice and in cell lines derived from these mice 
Results 
The pVVim2 construct 
For the construction of the vimentm-desmin hybrid gene, 
further referred to as pVVini2 gene, the hamster vimentm 
and hamster desmin genes served as starting materia] Figure 
1 shows a physical map of both genes Introns in both genes 
map at identical positions (Quax et al , 1983, 1985) In the 
pVVim2 construct a 9 2 kbp BamHl-Bglll fragment com-
prising the promoter region and the first six exons encoding 
head and rod domain of the vimentm gene were fused via 
the EcoRl site in the pUC19 polylmker to a 3 4 firoRI-S/u! 
fragment harboring the last three exons of the desmin gene 
encoding the tail domain In this construct 3 1 kbp of 5' 
flanking DNA is present No other constructs were examined 
for tissue-specific expression in transgenic mice in this study 
The pVVim2 gene construct is depicted in Figure la, and 
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Fig 1 (A) Physical map of the hamster vimcntin gene the hamster 
riesmm gene and the hybrid gene pVVim2 Bare represent exon 
sequences ДатНІ Bglll LcoRl and 5ml restnction sites are 
indicated as В Bg E and S respectively PL represents the polyhnker 
of the pUC19 vector (B) Schematic representation of the hybrid 
protein encoded by the pVVim2 gene 
the composition of the expected hybrid protein in Figure lb 
Amino acids 1 -408 comprise the head and rod domain of 
vimenün and amino acids 408—463 the tail domain of 
desmin Cotransfection of the pVVim2 plasmid with the 
pSV2-neo plasmid into tissue culture cells (HeLa and hamster 
lens) results in stable transformants expressing the pVVim2 
gene, as assayed with a polyclonal desmin antiserum (Van 
den Heuvel et al , 1987) The data show that the hybrid pro-
tein encoded by the pVVim2 construct is able to assemble 
into a cytoskeletal network with normal IF appearance 
Transgenic mice 
For the generation of transgenic mice the pVVim2 hybrid 
gene was excised from the vector and injected into the most 
accessible pronucleus of fertilized mouse eggs Three trans-
genic mice were obtained (Nos 32, 34 and 44) Southern 
blot analysis of tail DNA showed that the three transgenic 
founders had incorporated multiple copies of the gene in a 
head to-tail arrangement (Figure 2) None of the transgenic 
mice showed any abnormalities Two founders (Nos 32 and 
44) transmitted the pWim2 gene to their offspring Southern 
blot analysis mdicated that founder No 44 was mosaic for 
the р ітЗ gene, as its offspring showed a much stronger 
hybridization signal This was also confirmed by immuno­
fluorescence studies on tissues sections (see below) 
Tissue-specific expression 
The expression of the pV Vim2 protein was analyzed by the 
indirect immunofluorescence technique on tissue sections 
using polyclonal rabbit amisera directed against desmin 
(poly-Des), vimentin (poly Vim) and cytokeratm (poly Ker) 
(Ramaekers et al , 1983) The immunohistochemical analysis 
was performed on blood cells, sections from tail-skin ear-
shcll, liver, spleen and testis For blood cell analysis, blood 
was collected from the tail vem and smeared onto cover slips 
1 2 3 4 S 6 7 
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Fig 2 Southern blot analysis of tail DNA from transgenic mice β μ% 
of DNA was digested with Stul run on 0 6% agarose gel transferred 
to nitrocellulose and hybridized with the desmin specific probe AA85 
5ш] cleaves once in the pVVim2 fragment and in a head to-tail tandem 
array of pVVim2 copies it generates a single hybridizing fragment of 
unit size in all transgenic mouse lines multiple copies of pVVim2 
were integrated Lane t DNA from a control mouse lane 2 DNA 
from founder No 32 lane 3 DNA from offspring of founder No 
12 lane 4 DNA from founder No 34 lane 5 DNA from founder 
No 44 lanes 6 and 7 DNA from offspring of founder No 44 
Blood cells from transgenic mice displayed intensive stain­
ing after incubation with poly-Des antiserum, whereas cells 
from control mice were non reactive (Figure 3a—c) Stain 
mg of macrophages was most pronounced The staining pat­
terns often show a filamentous organization This suggests 
that the pVVim2 molecules are able to assemble into inter 
mediate filaments Sections of tail skin and ear shell from 
transgenic line 44 were used to analyze the tissue-specific 
expression of the pVVim2 gene A strong staining with the 
poly Des antiserum was observed in all tissues that normal 
ly express vimentin e g fibroblasts and cartilage (Figure 
3d-f) No reaction was seen, however, in epithelial tissues 
(epidermis and hair root sheath) that stained with the poly 
clonal keratin antiserum (data not shown) In frozen sections 
from transgenic spleen nearly all cells stain with poly Des, 
whereas in spleen from control mice only smooth muscle 
tissue of blood vessels are positive (data not shown) In testis 
of transgenic mice Leydig cells and Sertoli cells express the 
hybrid protein (Figure 3h) In liver of pVVim2 transgenic 
mice Kupffer cells which express vimentin stain strongly 
with the poly Des serum (Figure 3k) A comparison of liver 
sections from founder No 44 with liver sections from its 
positive offspring confirmed the mosaic character of trans 
gene integration in founder No 44, only Kupffer cells in 
distinct liver segments react with poly-Des antiserum in the 
founder (Figure 3m), whereas in positive offspring all Kupf 
fer cells stain with this antibody 
Identification of the pVVim2 mRNA and protein 
in vitro 
Ear shell fibroblasts from transgenic founder No 32 were 
immortalized by SV40 and the cells were cloned and used 
for RNA and protein analysis It appears that the hybrid 
pVVim2 protein is present in a filamentous network with 
normal IF appearance (Figure 4) Double tmmunofluor 
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Fig. 3, Indirect immunofluorescence studies Immunofluorescence was performed on blood smears ( a - c ) . frozen sections of tail skin (d-f)- testis 
(g-i) and liver ( j - m ) from control mice (a,d,gj). positive offspring of founder No 44 (b,c,e,f,hj,k,l) and of founder No 44 showing mosaic-
expression (m) Sections depicted m panels a-hj,k. and m are reacted with the poly Des antiserum. I and I are stained with the poly-Vim 
antiserum Note that incubation of the smears and tissues from control mice with a polyclonal desmin antiserum does not show any staining of blood 
celli (a) or epidermis and dermis (d) Staining is exclusively seen in cells known to express desmin. ι e smooth muscle cells of blood vessel walls 
(j) or myoid cells surrounding the seminiferous epithelium of the testis (g) In mice harboring the pVVim2 transgene, cells normally expressing only 
vimentin. ι e macrophages (b,c). fibroblasts (e,f). Leydig cells and Sertoli cells in testis (h). and Kupffer cells in liver (к,тп). now also express the 
pVVim2 protein, as visualized with poly-Des. For comparison the frozen sections were also incubated with poly-Vim (i,l) Mosaic expression can be 
seen m the liver section depicted in frame m Magnifications. a,b. 6 0 x . с 350x. d.c,f,y.h.i.j.k.l, 150x. m 200x. 
escence studies of the same cells with desmin and vimentin 
antibodies show that the hybrid protein is co-localized with 
the endogenous vimentin filaments (Figure 4c,d). 
RNA was isolated from these cell lines and analyzed by 
Northern blot (Figure 5). Clearly, only in fibroblastic cell 
lines derived from a pVVim2 transgenic mouse was an 
mRNA of the appropriate size (2.2 kb) observed with the 
desmin probe X54, whereas fibroblasts from control mice 
63 
P.J.Krimpenfort et at. 
Fig. 4. Double-label immunofluorescence staining of transformed fibroblasts from transgenic mouse No 32 Co-localization of pVVim2 protein and 
vimentin filaments is shown by staining with the polyclonal vimentin antibody poly Vim (c) and the monoclonal desmin antibody RD301 (d) 
Fibroblasts from control mice react with poly-Vim (a) and not with RD301 (b). a - d , x280 
were nonreactive. Hybridization with the vimentin-specific 
probe E49 showed the presence of the 2.0 kb long mouse 
vimentin mRNA in cell lines from both control and trans­
genic mice. 
The hybrid gene is expressed at a level similar to that of 
the endogenous vimentin. Comparison of mRNA levels in 
fibroblasts from transgenic and control mice (Figure 5, com­
pare lanes 1 and 2 to lane 3) clearly shows that the expres­
sion of the endogenous vimentin mRNA is not influenced 
by pVVim2 expression. 
Identification of the pVVim2 protein 
The immunohistochemical data were further substantiated 
by biochemical identification of the pVVim2 protein. Pro­
tein analysis by Western blotting was performed on the 
SV40-transformed fibroblastic pVVim2 positive cell clones 
which were also used for RNA analysis. In addition the in 
vivo synthesized pVVim2 protein was characterized. We 
chose lens cell tissue which normally expresses vimentin 
(Ramaekers el at., 1980). 
Western blots of SDS-polyacrylamide gels were reacted 
with a monoclonal antibody to desmin (RD301) and with 
a monoclonal antibody specific for vimentin (RV202). The 
epitope recognized by RD301 is located in the tail domain 
of desmin encoded by the last three exons of the hamster 
desmin gene (Van den Heuvel et ai, 1987). Lysates from 
BHK cells and a crude desmin preparation from mouse 
muscle were used as positive controls. SV40-transformed 
fibroblasts and lenses from control mice were used as 
negative controls. The results (Figure 6) clearly show the 
1 2 3 2 3 
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Fig. 5. Northern blot analysis of RNA from fibroblastic cell lines 
denved from pVVim2 transgenic mice 15 /xg total RNA was 
electrophoresed on a 1% agarose gel. transferred to nitrocellulose and 
hybridized with desmin-specific probe X54 (panel A), and with the 
vimentin specific probe E49 (panel B) Lanes 1 and 2, RNA isolated 
from two independent poly-Des positive cell lines denved from 
founder No 32, lane 3. RNA isolated from a poly-Des negative 
control cell line 
presence of the pVVim2 protein with an apparent mol. wt 
of 57 kd in the transgenic fibroblastic cell lines and lens cells. 
In skeletal muscle tissue no pVVim2 or vimentin protein was 
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Fig. 6. Biochemical charactenzauon of intermediate filament proteins 
from tissues of transgenic and control mice Western blots prepared 
from tissue proteins were incubated with the monoclonal desmin 
antibody RD301 (panel A) and subsequently with RV202 (panel B) 
Lane 1, transformed fibroblasts from control mouse. lane 2. 
transformed fibroblasts from transgenic mouse No. 32. lane 3. muscle. 
only positive for desmin. lane 4, BHK cells, positive control for 
desmin and vimentin. lane S. eye lens from transgenic mouse No. 32; 
lane 6. lens from control mouse, lane 7. BHK cells, additional protein 
bands below desmin represent characteristic IF breakdown products 
detected (Figure 6, lane 3). Since we used different anti-
bodies to detect the hybrid protein it seems unlikely that this 
negative reaction is caused by masking of epitopes due to 
conformational change during myogenesis. This was con-
firmed by immunohistochemical analyses of muscle tissue 
(data not shown). Both striated and smooth muscle cells from 
different organs were stained with mono- and polyclonal anti-
bodies against vimentin and desmin. In transgenic mice the 
desmin staining pattern was similar to that in control mice. 
No staining with the vimentin antibodies was observed in 
striated muscle cells indicating that both pWini2 and vimen-
tin are not expressed in these cells. Smooth muscle cells 
which do not express vimentin in control mice also do not 
express pVVim2 or vimentin in transgenic mice. 
The pVVim2 expression level 
In order to determine the expression level of pVVim2 cyto-
skeletal fractions of eye lenses from control and transgenic 
mice (founders No. 32 and No. 44) were analyzed by one-
dimensional SDS-PAGE (Figure 7a). In lenses of offspring 
from founder No. 44 high levels of IF expression were de-
tected clearly exceeding vimentin expression in lenses from 
control mice. Lenses of offspring from founder No. 32 also 
showed elevated, although much less, IF expression levels. 
Two-dimensional PAGE analysis of total lens extract from 
control and transgenic offspring from founder No. 44 con-
firmed these findings (Figure 7b). Immunoblotting of two-
dimensional gels positively identified the hybrid protein and 
vimentin which were not separated on these gels. Identical 
results were obtained with cytoskeletal preparations (data not 
shown). 
Discussion 
In this paper we describe the construction and transgenic 
expression of a hybrid gene between the genes of the cyto-
skeletal proteins vimentin and desmin. A DNA fragment 
containing 3.1 kb of 5' flanking DNA and the 5' part of 
the vimentin structural gene up to the 6th exon, encoding 
the head and rod of the vimentin, was fused to the three last 
exons of the desmin gene encoding the tail portion of desmin. 
This chimeric gene, pVVim2, was introduced into the germ 
line of mice and its expression was analyzed at the mRNA 
and protein level using specific DNA probes and immuno-
reagents. The data show that a properly sized mRNA is tran-
scribed from the pVVim2 gene. The pVVim2 mRNA is 
translated into a protein of the expected molecular weight. 
Immunohistochemical analysis of tissue sections indicates 
that the expression pattern of the transgenic pVVim2 gene 
is indistinguishable from that of the endogenous vimentin. 
The expression levels differ in the two transgenic mouse 
strains investigated. Offspring mice from founder No. 32 
expressed the hybrid gene at levels similar to the endogenous 
vimentin gene, whereas offspring from founder No. 44 ex-
pressed pVVim2 to a significantly higher level. RNA 
analysis shows that endogenous vimentin expression is not 
measurably influenced by transgenic pVViin2 expression. 
All the regulatory sequences required for the tissue-specific 
expression of vimentin are included in the 9.2 kb 
ВатНІ-BgHl fragment, starting 3.1 kb upstream from the 
transcriptional initiation site. The immunofluorescent stain­
ing pattern with poly-Des antiserum, especially of transform­
ed fibroblasts (Figure 4) demonstrates that the pVVim2 
protein under these circumstances can assemble into filamen­
tous structures. Double-label immunofluorescence studies 
which combine monoclonal antibodies RD301 and RV203 
with the poly-Vim and poly-Des antisera, respectively, show 
that the vimentin containing filaments match completely with 
the pVVim2 containing structures, strongly suggesting that 
pVVim2 protein copolymerizes with vimentin and becomes 
a part of the vimentin skeleton. This is in agreement with 
cross-linking studies in which copolymerization has been 
shown between vimentin and desmin (Quinlan and Franke, 
1982; Steinen el al., 1981). Since the pVVim2 protein con­
tains the vimentin α-helical domain and the desmin carboxy 
terminus, which is supposed to protrude from the skeletal 
backbone (Geisler and Weber, 1986), copolymerization bet­
ween pVVim2 and vimentin is not surprising. 
Intermediate filament proteins are expressed in a develop-
mentally regulated and tissue-specific fashion, and this pat­
tern of expression has been conserved among vertebrate 
species. However, some differences which may relate to a 
slight divergence in the developmental pattern of a distinct 
cell lineage, have been noted (Ngai et al., 1987). This sup­
ports the view that intermediate filaments fulfill an impor­
tant role in development. Furthermore, it suggests that 
alterations in highly conserved protein domains, which are 
supposed to be of crucial importance for proper functioning 
of IFs, are probably not tolerated. The amino acid sequence 
of the carboxy-terminal domain of vimentin is much more 
conserved among species than the sequence of the amino 
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Fig. 7. Biochemical characterization and analysis of expression levels of IF proteins from eye lenses of transgenic and control mice (A) Coomassie 
Bnlhant Blue (CBB) staining of one dimensional SDS gels of cytoskeletal preparations from control and transgenic mice Lane 1. lens extract from 
control mouse. lane 2. lens extract from transgenic mouse, derived from founder No 44. lane 3. lens extract from transgenic mouse derived from 
founder No. 32 Arrow indicates pVVim2 protein and vimentin position. C. crystallm polypeptide chains serve as standards for the amount of protein 
applied onto the gel (B) Total lens extracts of control (1-3) and transgenic mice (4-6) analyzed by two dimensional gel electrophoresis and stained 
with CBB or immunoblotled and stained with the monoclonal desmin antibody RD301 (2,5) and subsequently with the monoclonal vimentin antibody 
RV202 (3,6) Both mice were derived from founder No 44 Arrows indicate IF protein position Additional spots on the blots represent 
characteristic IF breakdown products 
terminal domain and approximates the conservation of the 
rod domain (Zehner et al., 1987). This is also observed for 
desmin (Quax et al.. 1984). However, the carboxy-terminal 
regions of different classes of IF subunits have significantly 
diverged. This is suggestive for the importance of the carb­
oxy terminal region in IP-specific function. Recently, it has 
been shown that the carboxy-terminal domain of both vimen­
tin and desmin can associate with lamin В at the nuclear 
envelope (Georgatos and Blobel, 1987; Georgatos et al., 
1987). Our results show that the presence of significant levels 
of pVVim2 protein in all vimentin-expressing cells does not 
interfere with normal mouse development. Preliminary 
results using transgenic mice in which desmin is expressed 
in a vimentin-specific fashion also indicate that the expres­
sion of desmin in mesenchymal cells does not interfere with 
normal development. This suggests that, if vimentin fulfills 
an essential function in development, this function is not 
hampered by the co-expression of pVVim2 or desmin. 
Materials and methods 
Plasmid construction 
Isolation and characterization of the hamster vimentin and desmin genes 
have been desenbed previously (Quax etol.. 1983. 1984. 1985, Quax Jeuken 
er ai . 1983) Intervening sequences map at similar positions in the gene 
The last three exons of the \ imcntin gene were replaced by the correspond­
ing exons of the desmin gene The 9 5 kb BamHl-Bgfll fragment harbor­
ing the first six exons of vimentin was subcloned into the SamHI site of 
the pOC 19 A 3 4kb EcoRi-Siul fragment containing the last three exons 
of desmin was tused to the 3' end of the vimentin fragment via the EcoRl 
site in the poiylinker region The complete pVVim2 hybrid gene is present 
on a 13 kb в я т Ш fragment As hybridization probe specific for hamster 
vimentin M13 phage E49 was used, which contained a Sau3A fragment 
covering the region between 150 nucleotides upstream to 370 nucleotides 
downstream from the cap site (Quax el al.. 1983) For hamster desmin the 
M13 phages X54 (a SÜU3A insert, containing the last 25 nucleotides of ex-
on 8. mtron 8 and the first 350 nucleotides ofexon 9) and АА85 [aPstl-Taql 
insert corresponding to nucleotides 165 to 357 downstream from the stop 
codon (Quax et al., 1985)] were used. 
Cell culture 
Cell cultures from ear fibroblasts were established as described (Bloemen­
dal ei al . 1980) 
Transgenic mice 
Fertilized mouse eggs were recovered in cumulus from oviducts of super-
ovulated (CBA x C57Bl/LiA) Fl females that had mated with Fl males 
several hours earlier Approximately 200 copies of the pWim2 hybnd gene 
construct (without plasmid sequences) were micromjected in the most access­
ible pronucleus Micromjected eggs were implanted into oviducts of 1-day 
pseudopregnant MA or Fl foster mothers and earned to term Total genomic 
DNA was prepared from tail biopsies 3 - 4 weeks after birth For Southern 
blot analysis. 8 /xg of total genomic DNA was digested with ßomHI or Stul. 
run on a 0 6% agarose gel and transferred to nitrocellulose The filter was 
hybridized to i:P-labeled probes as described (Cuypers ÍV al.. 1984), 
Northern blot analysis 
Fifteen/ig of total cellular RNA. prepared by the LiCl-urea method (Auffray 
and Rougeon. 1980) was separated on a 1% agarose gel in lormaldehyde 
and transferred to nitrocellulose 
Immunohistochemical analysis 
The intermediate filament protein expression of tissues and cell lines was 
assayed by indirect immunofluorescence and Western blot analysis The 
antisera used for this purpose include (ι) an affinity purified polyclonal 
antibody directed against human skin keratins (poly-Ker). this andbody reacts 
with virtually all epithelial tissues but not with non-epithelial cells (Ramaekers 
el al . 1983a). (n) an affinity purified polyclonal antibody to bovine lens 
vimentin (poly Vim) (Ramaekers et al . 1983a); (m) a rabbit antibody to 
chicken gizzard muscle desmin (poly Des) (Ramaekers el al. 1983b); 
(iv) monoclonal antibodies RV202 and RV203 directed against bovine lens 
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vimentin (Broers et al, 1986) and (ν) a mouse monotlonal antibody RD30t 
to desmin raised against chicken gizzard desmin (Broers et al, 1986) As 
second antibodies for indirect immunolluorescence either fluorescein iso-
thiocyanale (FITQ-conjugalcd gnat anti-rabbit IgG or FTTC-conjugatcd rabbit 
anti-mouse IgG were used at a dilution of 1 25 (Nordic, Tilburg. The 
Netherlands) For double-label immunofluorescence FITC-conjugated goat 
anli-rabbit IgG was combined with Texas Red-conjugated sheep (Fab')2 
anti-mouse Ig (New England Nuclear, Boston. MA, USA) In control ex-
penments PBS was subsututed for the pnmary antibody Cells on coverslips 
and 5 μπι thick frozen sections of mouse tissues were fixed in methanol 
for S s (—20eC) and acetone ( 3 x 5 s), air dried and incubated with the 
primary antibody for 30-45 mm al room temperature Further processing 
for indirect immunofluorescence was performed as desenbed (Broers et al, 
1986) 
Ge/ electrophoresis end Immunoblotting essays 
Cytoskeletal preparations of eye lens were made as follows lenses were 
suspended in PBS containing 1% Γπιοη XlOO 1 mM phenylmcüiyl-
sulphonyllluondc (PMSF Merck.Dannsladt) and I mM EDTA for 10 mm 
at 0oC After ccntnfugation (3000 g for 10 mm) and washing (PBS) the 
pellet was dissolved by boiling during 5 mm in SUS sample buffer For 
the crude desmin preparation from mouse skeletal muscle, frozen 5 μπι thick 
sections were first extracted with 1 5 M KCl, 0 5% Triton X100, 5 mM 
EDTA. 0 4 mM PMSF. and І0 mM Tris-HCI. pH 7 2 and processed 
as described above One- and two-dimensional SDS gel electrophoresis and 
immunoblotting was perforrned as desenbed (Broers et al . 1986) 
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CHAPTER 5 
TRANSGENIC EXPRESSION OF THE MUSCLE-SPECIFIC 
INTERMEDIATE FILAMENT PROTEIN DESMIN 
IN NONMUSCLE CELLS 
The Journal of CeU Biology (1989) 108,1009-1024. 
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Transgenic Expression of the Muscle-specific 
Intermediate Filament Protein Desmin in Nonmuscle Cells 
Frank R. Pieper,* Gert Schaart,* Paul J. Krimpenfort,§ Jos B. Henderik,* Han J. Moshage.U 
Annemiete van de Kemp,* Frans С. Ramaekers,* Anton Berns,S and Hans Bloemendal* 
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Abstract. The coding region of the hamster desmin 
gene was fused to the 5' flanking sequences of the 
hamster vimentin gene and introduced into the germ 
line of mice The expression of this intermediate fila­
ment gene construct (pVDes) was analyzed at the 
RNA and protein level in transgenic mice as well as in 
fibroblast cell lines and primary hepatocyte cultures 
denved from these mice In all transgenic mice, the 
pVDes encoded protem was coexpressed with mouse 
vimentin m a tissue-specific fashion and was indistin­
guishable from normal hamster desmin Cultunng of 
transgenic hepatocytes induced desmin expression indi­
cating that 3 2 kbp of the vimentin gene 5' region 
regulates both tissue-specific and tissue culture-in­
duced intermediate filament protein expression Im-
munohistochemical staining and double label iramuno-
electron microscopy of cultured transgenic fibroblasts 
showed that the pVDes protein assembled into inter­
mediate filaments which colocahzed with the mouse 
vimentin filaments Endogenous vimentin RNA levels 
were not influenced by high-level pVDes expression 
The coexpression of desmin and vimentin in nonmus­
cle cells did not result in detectable developmental, 
morphological, or physiological abnormalities 
INTERMEDIATE filaments (IFs)' represent a unique group of cytoskeletal structures that occur in the cytoplasm of virtually all mammalian cells The expression of the 
different classes of IF subunits is regulated in a tissue-
specific and developmentally regulated fashion Generally, 
cytokeratins are expressed in cells of epithelial origin while 
neurofilaments are expressed in neuronal cells, glial fibril­
lary acidic protein in astrocytes, desmin almost exclusively 
in striated and most smooth muscle cells, and vimentin 
mainly in cells of mesenchymal origin (58, 59, 64) The ex­
pression of the nuclear lamins, which are part of the IF mul-
bgene family, is also cell type specific and developmentally 
regulated (12,29,61) The highly conserved specificity of IF 
subumt expression during development suggests that each 
type of subunit plays an important role in cellular differenti­
ation 
On the basis of gene structure and sequence data, the IF 
subunits have been divided into four subfamilies Vimentin 
(47), desmin (48), glial fibrillary acidic protein (40), and 
possibly a recently described neurofilament protein (39) dis­
play a high degree ofhomology and constitute one subfamily 
of proteins (type III subunits) Like the other IF proteins, 
1 АЬЬк шпол used in this paper IF, intermediale filament 
they have a conserved central α-helical domain of ~310 
amino acid residues, flanked by nonhehcal ammo-terminal 
and carboxy-terminal domains of variable length and se­
quence (12, 22, 58, 59, 64) In view of the highly specific 
expression pattern of each IF subunit, it may be assumed that 
their variable terminal regions at least partly determine the 
specific properties that are needed m different cell types dur­
ing vanous stages of development (23, 38, 58) 
The vimentin expression pattern is relatively complex 
During embryogenesis, vimentin is the first of the nonepithe-
lial subunits to be expressed (18, 30) The appearance of the 
cell type-specific IF subunits is often preceded by vimentin 
expression, and in certain cases coexpression with the other 
types of IF is observed (9, 19,37,56, 57, 64,65) When non­
mesenchymal cells are dissociated from tissues and brought 
into culture, induction of vimentin synthesis often occurs (15, 
64) This is mostly accompanied by the continued coexpres­
sion of the tissue-specific IF protein, but in some cases only 
vimentin expression remains (6, 17) The level of vimentin 
expression is growth regulated and can be stimulated by 
some growth factors (11, 54) This complex expression is 
mediated by multiple regulatory elements in the 5' flanking 
sequence of the vimentin gene (46, 54) 
In cultured cells, the study of cell type-specific regulation 
and function of IF expression is necessarily limited The 
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FÎ^M/Ï /. (A) Schematic representation of the IF gene construct pVDes (not drawn to scale). The line on the left represents the vimentin 
gene 5' flanking region (from -3,100 to +101 relative to vimentin cap site). Bar represents the desmin gene with black regions indicating 
the desmin 5'- and 3' untranslated sequences, hatched regions indicating exons, and open regions indicating the introns. Positions of the 
vimentin-specific (E49) and desmin-specific (X54) probes are indicated. E, Eco RI restriction site; 5, Bam HI restriction site. (B) Southern 
blot analysis of tail DNA from mice transgenic for pVDes. ±10 /ig of DNA was digested with Eco RI. Hybridization was performed with 
the vimentin probe E49. Asterisk indicates position of the 8.5-kbp Eco RI fragment from the single copy mouse vimentin gene. Arrow 
indicates position of the 5.15-kbpEcoRI fragment from pVDes. (Lane /) DNA from offspring of founder 430; (lane 2) DNA from founder 
430; (lanes 3 and 7) DNA from control mice; (lanes 4 and 5) DNA from offspring of founder 426; (lane 6) DNA from founder 426; 
(lanes 8 and 9) DNA from offspring of founder 429; and (lane 10) DNA from founder 429. 
phenomenon of tissue culture-induced vimentin expression 
is not understood. The observations, that some cell lines do 
not express IFs (27, 41, 64) and that disruption of IFs does 
not affect growth or morphology of cultured cells (21, 34, 
42), indicate that IFs-at least in vitro-do not fulfill an es-
sential cellular function (13). 
Transgenic mice, which have proven to be useful in the 
study of tissue-specific gene expression (for review, see ref-
erence 44), provide a better system to study IF gene regula-
tion and function. Our approach was to change the normal 
IF expression pattern by introducing an IF gene construct 
into the germ line of mice composed of the 5' flanking region 
of the vimentin gene and the complete coding region of the 
desmin gene. Transgenic mice, primary cell cultures, and 
cell lines derived from these mice were analyzed for the pat-
tern and levels of desmin and vimentin expression. 
Materials and Methods 
Plasmid Construction 
For construction of the fiVDes gene, the 0.7-kpb Hpa II-Bam HI fragment 
from the hamster desmin gene (from +25 bp to +700 bp relative to the cap 
site; reference 4S) was subcloned into an Ace I-Bam HI-digested pUCI9 
plasmid. The 3.2-kbp Bam HI-Eco RI (from +700 to +3,900) and the 3.4-
kbp Eco RI-Stu I (from +3,900 to +7,300) desmin fragments were hgated 
immediately 3' to this fragment, thereby generating a complete desmin gene 
(pDes) without 5' sequences upstream of the Hpa II site at +25. In this con-
struct, 60 bp of 5'- and 775 bp of 3' untranslated sequences (including the 
"poly A" signal) are present. The 3.2-kbp vimentm promoter region (ranging 
from -3,100 to +101 relative to the vimentin cap site) was isolated as a 
Hind III fragment by ligaling the 3.45-kbp Bam HI-Eco RI fragment Irom 
рЗ.І ітСАТ (46) into an Eco RI-Bam HI-digested pUC19 plasmid, and 
subsequent partial Hind III digestion of this clone. This vimentin 5' region 
was ligated into the Hind III site of the pUC19 polyhnker of pDes in the 
5'-3Orientation. The resulting construct (pVDes) contains some additional 
base pairs from the pUC19 polylinker between the Hind III and the Ace I 
site. To facilitate removal of plasmid sequences before microinjection, the 
Bam HI site in the first Intron of desmin was removed by tilling in and subse­
quent blunt end ligation after partial Bam HI digestion. 
Generation and Identification of Transgenic Mice 
Transgenic mice were generated by pronuclear microinjection as described 
previously (36). Plasmid sequences were removed by Bam HI (5'. complete) 
and Eco RI (3', partial) digestion, leaving a I0.5-kbp IF hybrid gene. This 
was isolated and purified by preparative gel electrophoresis and electroelu-
tion, dissolved in ultrapure water, and dialyzed against 10 mM Tris-HCI, 
0.1 M EDTA (pH 7.4). The DNA concentration was adjusted to 4 μ^/πύ, 
and ±200 pVDes copies were injected. Several weeks after birth of animals 
that had developed from microinjected eggs, tail DNA was isolated and ana­
lyzed by Southern blotting. Briefly, equal amounts (I0μg) of total genomic 
DNA of each mouse was digested with the appropriate restriction enzyme(s), 
run on a 0.6% agarose gel, and transferred to nitrocellulose. The filter was 
hybridized to 32P-labeled probes (see below) and washed as described (5). 
The number of integrated f^Des copies was determined by Southern blot 
analysis of serial dilutions of tail DNA. using the vimentin-specific probe 
E49, and subsequent densitometnc scanning of the au to radiographs. pVDes 
hybridization signals were compared to those of the single copy mouse 
vimentin gene and of serial dilutions of the pVDes plasmid. 
Northern Blot Analysis and Hybridization Probes 
Total cellular RNA was isolated from tissues and cultured cells by the LiCl-
urea method of Auffray and Rougeon (1). Primer extension analysis on total 
cellular RNA from ear fibroblast cell lines was performed as described (24, 
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procedure 2), using a 21-mer 5' desmin pnmer (S'-GGAGGCAGCGGG-
CAGGCAGCCC-3'; ftom +25 to +4é relative to the transcnption initiation 
site). For Northern blotting, 10-, IS-, or 20^g RNA samples were glyox-
ylated, ГгасйолаЫ on a 1 2% agarose gel, and transferred to Highbond-N 
(Amersham International, Amersham, UK) Hybridization was performed 
as described by Church and Gilbert (S) A 350-bp hamster desmin Sau3A 
fragment in М1Э (X54), covenng a region from 25 bp of exon β to 120 bp 
into the Э' untranslated region, was used as a desmin probe (46, 48) A 
S20-bp hamster vimenun Sau3A fragment in M13, ranging from -150 to 
+770 bp relative to the cap site, was used as a vimentm probe (46,47) As 
an actm probe, we used a 1.25-kbp Pstl hamster actin cDNA fragment (8), 
which hybridizes to α-, β-, and 7-actin. Densitometnc scanning was per­
formed on autoradiographs exposed for different times. 
Cell Culture 
Ear fibroblast cell lines were established and cultured as described (3). 
Mouse hepatocytes were isolated and cultured using the hepatic portal 
perfusion method as desenbed by Klaunig et al (32, 33), with die following 
modifications Instead of Hanks' solution, Williams E medium (Flow Lab­
oratories, Ine , McLean, VA) supplemented with 2 5 mM EGTA was used. 
Hepatocytes were cultured in Williams E medium supplemented with 10% 
FCS, 2 mM L-glutamine, 20 mU/ml bovine insulin, Ι μΜ dexamelhasone, 
and antibiotics (25 μg/ml fungizone, 100 μg/mi vancomycin. 50 μ^πιΙ gen-
tamycin). 
Gel Electrophoresis and ¡mmunoblotting 
Cytoskeletal preparatrans of eye lens and cultured cells were obtained as de-
scribed (35) One- and two-dimensional SDS gel electrophoresis and immu-
noblotting procedures have also been desenbed previously (4). 
Immunohistochemical Analysis 
Single- and double-label indirect immunofluorescence analyses of frozen 
tissue sections and cultured cells were performed as described previously 
(36) In the underlying study, however, muscle tissue sections were pie-
trcated with 0 5 % Tnton X-100 in PBS before incubation with the first anti-
bodies. The following polyclonal and monoclonal antibodies were used (a) 
an affimiy-punfied polyclonal rabbit antibody (poly-kcr) raised against hu-
man skin keratins, which reads with virtually aJI epithelial tissues (51), (b) 
an affinity-punfied polyclonal rabbit antibody (poly-vim) to vimentm (51), 
(c) a polyclonal rabbit antibody (poly-dcs) to desmin (52), {d) the monoclo-
nal antibody RV202 to vimentm (4). (?) the monoclonal antibody RD301 
to desmin (4), and (ƒ) the monoclonal antibody RCK 102 to human cytoker-
atins 5 and 8 (53). 
Immunoelectron Microscopy 
Transformed fibroblasts from control and transgenic mice were grown on 
Thermanox coverslips (Lux, Lab-Тек Div., Miles Laboratones Ine , Naper-
ville, IL), coaled with fibronectin by а ЗО-тт incubation wilh a crude prep­
aration from human serum. Cells at ^75% сопЛікпсу were washed with 
double Hanks' bufiêr and cooveilcd to cytoskeletons by extraction for 2.5 
mm at room temperature with a buffer (pH 7.2) containing 0.5% Tnton 
X-100 as desenbed by Tolle et al. (63), and fixed in buffered 0.5 % parafor-
maldehyde containing 0.3% Triton X-100 (pH 7.2) The cells were pro-
cessed for immunogold labeling and electron microscopy essentially as de-
scribed by De Mey (7) and as in AuroProbe EM product information 
(Janssen Phannaccuuca, Beene. Belgium), l b reduce background staining 
the coverslips чете preuicubaied for 20 mm with a TBS solution (pH 8.2) 
containing 10% normal goat serum and 0.1% BSA. The monoclonal аші 
polyclonal antibodies were diluted in a similar buffer containing 1% nor­
mal goat scrum and Q.1% Twccn-2Q. Vfashing buflbrs also contained 0.1% 
l>veen-20. Furthemiore, the 5-nm and lO-tun antibody-coated colloidal 
gold prepaiaüoiis (Janssen Pharmaccutica) were preabsorbed extensively 
on fibroblast cytoskeletons and diluted m Tns buffer, pH 8 2, containing 1% 
BSA. 
Results 
Generation of Transgenic Mice 
We have demonstrated previously that the structural gene for 
hamster desmin and modifications thereof can be expressed 
after gene transfer into different types of cultured nonmuscle 
cells resulting in assembly of the newly synthesized protein 
into intermediate filaments (28, 48). Regulatory sequences 
which control desmin expression are located in a region be-
tween -89 and +25 relative to the transcription initiation 
site (46). We removed these regulatory elements by deleting 
the complete 5' flanking region of the desmin gene up to the 
Hpall site at position +25, and replaced it by 3.2 kbp of 5' 
flanking sequences (-3,100-+101) from the hamster vimen-
tin gene (Fig. 1 A). This upstream region contains regulatory 
elements that confer high levels of vimentin expression in 
cultured cells and are instrumental in the down-regulation of 
vimentm expression during myogenesis (46). The resulting 
IF gene construct pVDes (10.5 kbp without plasmid se-
quences) consists of the complete coding region of the des-
min gene and additional 5' and 3' untranslated regions, fused 
to 3.2 kbp of vimentin upstream sequences (Fig. 1 A; see 
Materials and Methods). 
After removal of plasmid sequences the pVDes gene was 
injected into the most accessible pronucleus of fertilized 
mouse eggs. Southern blot analysis of tail DNA of mice born 
from these manipulated eggs showed that 5 of 32 mice had 
incorporated multiple copies of the construct into their ge-
nome in a head-lo-tail tandem array. Three of these (strains 
426, 429, and 430) produced offspring, all of which inherited 
the (iVDes transgene (Fig. 1 fl). Southern blot analysis re-
vealed no detectable rearrangements in the pVDes sequences 
(data not shown). Offspring from founders 426 and 429 con-
tained Aj25 and 30 copies, respectively, whereas 430 and ils 
offspring had incorporated only 3 pVDes copies. F, and F2 
analysis showed that integration had taken place into single 
loci. 
Tissue-specific pVDes Expression 
The desmin expression pattern in tissue sections from trans-
genic mouse strains 426,429, and 430 and from control mice 
was analyzed by the indirect immunofluorescence technique, 
using polyclonal rabbit antisera directed against desmin (poly-
des), vimentin (poly-vim), and cytokeratins (poly-ker) (51, 
52). From transgenic mice 427 and 428 only tail sections 
were examined. From mouse strains 426, 429, and 430 a 
number of tissues was analyzed and for each of these strains 
at least two male and female mice were used. 
Cells expressing vimentin but not desmin in tissues from 
control mice (e.g., fibroblasts, endothelial cells, cartilage, 
Kupfler cells, macrophages, Schwann cells) displayed inten-
sive staining in transgenic tissues after incubation with poly-
des and with poly-vim (Fig. 2). Occasionally, a filamentous 
staining pattern was observed, suggesting that the pVDes-
encoded desmin had assembled into IFs (Fig. 2, g and /1). 
Epithelial tissues stained with poly-ker but not with poly-
dcs. In transgenic striated muscle tissue, connective tissue 
fibroblasts not only expressed vimentin (Fig.2 t) but also 
desmin, both in skeletal (Fig. 2 k) and heart muscle (not 
shown). All five transgenic mice and their oftspring (from 
426, 429, and 430) expressed pVDes in a vimentin-specific 
fashion. Surprisingly, in testis from the three transgenic 
mouse strains Sertoli and Leydig cells, although expressing 
vimentin, deviated from all other tissues tested (listed in leg-
end to Fig. 2) in that they did not contain detectable amounts 
of desmin (Fig. 2, l-o). 
We did not observe any morphological effects of pVDes cx-
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Figure 2. Expression of desmin and vimentin in tissues from control and transgenic mice as detected with the indirect immunofluorescence 
assay using poly-des and poly-vim. (a-c) Tail skin from control (a and b) and transgenic (c) mice incubated with poly-vim (a) and poly-des 
{b and c). E, epidermis; H, hair follicle, {d-f) Esophagus from control {d and e) and transgenic (ƒ) mice incubated with poly-vim {d) 
and poly-des {e and/). Arrow indicates desmin-positive Langerhans cells. A/, muscle tissue; £, epithelial tissue, {g and h) Cells from 
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blood smears of transgenic mice showing a filamentous staining pattern añer incubation with poly-des. (i-k) striated muscle tissue of control 
0 andy) and transgenic (k) mice incubated with poly-vim (0 and poly-des (7 and it). Note staining of transgenic muscle and nonmuscle 
cells with poly-des. (/-o) Testis tissue from control (/ and m) and transgenic (n and o) mice incubated with poly-vim (/ and n) and poly-des 
(m and 0). Note presence of desmin only in myoid cells and blood vessel smooth muscle cells in both control and transgenic testis tissues. 
Other tissues investigated include kidney, liver, spleen, heart, brain, tongue, bladder, uterus, and prostate. Bars, 4 ц т . 
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ñgMre 3. Characterization of pVDes protein from eye lens. (A) Coomassie Brilliant Blue (CBB)-stained SDS-polyacrylamide gels with 
equal amounts of total lens extracts from control (C) and transgenic mice (strains 426,429, and 430). (B) Immunoblots of total lens extracts 
from control (C) and transgenic mice (strains 426, 429, and 430) incubated with the monoclonal antibody to desmin (RD301; mDes) and 
then with the monoclonal antibody to vimentin (RV202; mVim). Cytoskeletal proteins from BHK-21 cells were used as markers. (C) Total 
lens extracts of control (/ and 4) and transgenic mice from strains 429 (2 and 5) and 430 (5 and 6) analyzed by two dimensional PAGE 
and immunoblotting. Blots were incubated with RD30I (mDes) and then with RV202 (mVim). 
76 
pression, nor did the transgenic mice show detectable de­
velopmental or physiological abnormalities 
Characterization of In Vivo-synthesized 
pVDes Protein 
lb identify biochemically and charactenze the in vivo-syn-
thesized pVDes protein, we analyzed eye lens extracts from 
transgenic mouse strains 426, 429, and 430 Eye lens tissue 
has the advantage of expressing high levels of vimentin in the 
absence of desmin (50) One-dimensional SDS-PAGE analy 
sis of total lens extracts (Fig 3 Λ) and cytoskeletal fractions 
(not shown), followed by immunoblotting with monoclonal 
antibodies to desmin (RD301, 4) and vimentin (RV202, 4), 
showed that the pVDes protein is expressed in transgenic 
lenses (Fig 3, A and B) Immunoblotting of two-dimen­
sional gels from total lens extracts (Fig 3 C) confirmed the 
identity of the pVDes protein, which coimgrated with desmin 
from BHK-21 hamster cells (not shown) Eye lenses from 
strains 426 and 429 contain comparable amounts of desmin 
A relatively low concentration of hamster desmin was de­
tected in strain 430 lenses (Fig 3) As judged from Coomas-
sie Brilliant Blue-stained gels and immunoblots of both total 
lens extracts and cytoskeletal fractions, lens vimentin expres­
sion levels were not influenced by pVDes expression 
In Vivo Expression Levels offlYDes 
To determine the pVDes mRNA expression levels in different 
tissues and its influence on endogenous vimentin and desmin 
expression, RNA from transgenic and control tissues was 
analyzed by Northern blotting We also included RNA from 
transgenic mice which express the vimentin-desmin hybrid 
gene pVVim2 (36) In this construct, the last three exons of 
the vimentin gene have been replaced by the last three exons 
of the desmin gene, allowing the detection of the pVVim2 
transcript with a desmin-specific probe Blots were first 
hybridized to a vimentin-specific probe (E49, Fig 1 A), 
which recognizes both endogenous vimentin, pVDes and 
pVVim2 transenpts, and subsequently to a desmin-specific 
probe (X54, Fig 1 A) In control tissues only a 2 0-kb mRNA 
band was detected, representing the mouse vimentin mes­
senger (e g , Fig 4/4, lane 4) In transgenic tissues an addi­
tional 2 4- or 2 3-kb band was observed that corresponds to 
the correctly sized pVDes transcript (e g , Fig 4 A, lanes 
1-3) or the pVVim2 transcript, respectively (e g , Fig 4 A, 
lanes 5 and 6) Primer extension analysis showed that tran­
scription started at the authentic initiation site (data not 
shown) Expression levels were determined by densitometnc 
scanning of autoradiographs from blots containing equal 
amounts of RNA Actin mRNA levels served as a standard 
The levels of vimentin mRNA did not differ between control 
and transgenic tissues (Fig 4) Relative to mouse vimentin 
mRNA, the amount of pVDes transenpts vaned between 
different tissues In skeletal muscle tissue, pVDes expression 
was relatively high, exceeding mouse vimentin transcript 
levels (Fig 4 A) Both pVDes and pVVim2 mRNA levels 
were identical for skeletal muscle tissue from different parts 
of the body (Fig 4Λ, lanes 1,2,5, and 6) The lowest pVDes 
expression levels were detected in heart tissue (Fig 4 B) 
Again, no pVDes expression was observed in testis from 
different transgenic strains (Fig 4 C) indicating that the lack 
of expression in Sertoli and Leydig cells is caused at the level 
of transcription or as a result of mRNA instability In con­
trast, pVVim2 was expressed at high levels in testis of trans­
genic mice (Fig 4 C, lane 4) Generally, pVDes expression 
levels were higher in tissues from strain 429 than in corre­
sponding tissues from strain 426 (data not shown) An excep­
tion is skeletal muscle tissue, which in strain 426 contained 
almost twice the amount of pVDes mRNA found in strain 
429 (Fig 4 C) The relative levels of pVVim2 expression 
also vaned between different tissues and were highest in 
skeletal muscle 
In Vitro Expression ofpVDes 
Transgenic cell lines were established by immortalization of 
ear-shell fibroblasts from offspring of strains 426, 429, and 
430 with SV40 Double-label immunofluorescence assays 
showed that in each of these cell lines both desmin and 
vimentin are expressed and assembled into filamentous struc­
tures (Fig S A) In assays where the polyclonal vimentin an­
tiserum and the monoclonal antibody to desmin were com­
bined, vimentin and desmin staining intensities were about 
equal for cell lines 426 and 429, whereas cells from line 430 
showed a much weaker desmin staining intensity Upon incu­
bation of line 430 fibroblasts with poly-des, this difference 
was not observed Generally, there was a complete match of 
desmin and vunentin filaments (Fig 5 А, с and d) Double-
immunogold labeling of control and transgenic fibroblasts 
revealed that the pVDes protein coassembled into bona fide 
IFs together with endogenous vimentin (Fig 5 B, a-e) 
The pVDes and vimentin expression levels of the trans­
genic cell lines were analyzed by Northern blot analysis 
using desmin- and vimentin-specific probes (Fig 6, A and 
B) The pVDes transcript was of the expected size (2 4 kb) 
and was detected in all three cell lines (Fig 6 A ) For cell 
line 430, the pVDes mRNA level was 20-fold lower than that 
of mouse vimentin mRNA In contrast, cell lines 426 and 
429 showed pVDes mRNA levels that were similar to those 
of the endogenous vimentin The amount of vimentin mRNA 
(2 0 kb) was not influenced by pVDes expression (Fig 6 B) 
This was also observed for a pVVim2 expressing ear-shell 
fibroblast cell line (strain 32, 36), which was cultured in par­
allel (Fig ЬВ) As in transgenic tissues, pVDes mRNA was 
less abundant than pVVim2 mRNA 
To identify the pVDes protein in the fibroblast cell lines 
and determine the correlation between transcript and protein 
levels in vitro, the relative amounts of IF protein in cytoskele­
tal fractions of the transgenic cell lines were analyzed by one-
dimensional SDS-PAGE (Fig 7) Desmin and vimentin were 
identified by immunoblotting with monoclonal antibodies to 
desmin (RD301) and vimentin (RV202), subsequently (Fig 
7 B) The pVDes protein has an apparent molecular mass of 
54 kD and cannot be distinguished from hamster desmin of 
BHK-21 cells Coomassie Brilliant Blue-stained gels re­
flected the levels of IF mRNA (Fig 6) at the protein level 
(Fig 7 A) 
Induction ofpVDes Expression in Tissue Culture 
In liver tissue, hepatocytes express specific cytokeratins and 
completely lack vunentin (16) Cultunng of rat hepatocytes 
induces vunentin expression (17) Indirect immunofluores­
cence assays with poly-vim, poly-des, and poly-ker on frozen 
sections of liver from control and transgeme mice confirmed 
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Figure 4. Northern blot analysis of 15 μg of 
total RNA from skeletal muscle (A), heart 
(fi), and testis (C) from control and transgenic 
mice Blots were hybridized to a vimentin-
(E49; Vim) and then to a desmin-specific probe 
(X54; Des). The minor additional band above 
the desmin mRNA position was observed in all 
tissues and probably represents a splicing inter­
mediate or is derived from a cryptic initiation 
site. After dehybridization the blots were hy­
bridized to an actin probe [Act) that recognizes 
both a-actin (1.8 kbp) and /3/7-actin transcripts 
(2.1 kbp). A similar analysis was performed on 
RNA from kidney, liver, spleen, brain, and 
lens (results not shown). (A) RNA from skele­
tal muscle of abdomen (lanes /, 3,4, and 5) and 
thigh (lanes 2 and 6). (Lanes 1, 2, and 8) 
pVDes strain 426; (lanes 3) 429; (lanes 4) con­
trol; (lanes 5-7) pVVira2 strain 44. To illustrate 
the difference in length between pVVim2 and 
pVDes transcripts (2.3 and 2.4 kbp, respec­
tively) RNA from strains 44 and 426 was run 
on a longer gel and hybridized to E49 (lanes 7 
and 8). (S) RNA from heart tissue. (Lanes 1 ) 
pVDes strain 426; (lanes 2) 429; (lanes 3) con­
trol; (lanes 4) pVVim2 strain 44. To identify positively pVdes and endogenous desmin mRNA, longer exposure times, low stringency 
washes, and longer gels were used (lanes 2' and 3'). (Lane 2') As for lane 2, hybridized to E49; (lane 2") as for lane 2', hybridized to E49 
and X54, subsequently; (larte 3') as for lane 3 hybridized to E49 and X54, subsequently, (lanes 1-4) Exposure time and gel length as 
in Fig. 4, a and с. (С) RNA from testis. (Lanes I ) pVDes strain 426; (lanes 2) 429; (lanes 3) control; and (lanes 4) pVVim2 strain 44. 
After hybridization to X54 and long exposure times, a faint 2.3-kbp band was observed in lanes 1-3, representing endogenous desmin 
(not shown). 
Act 
that hepatocytes express only cytokeratins, whereas KupfTer 
cells express vimentin in control mice and also desmin in 
transgenic mice. 
Hepatocytes from control and transgenic mice (strains 426 
and 429) were isolated, cultured as a monolayer, and ana­
lyzed for IF expression by the indirect immunofluorescence 
assay during 4 dof culture. Inali cases, the onset of vimentin 
synthesis was observed after 12-14 h (Fig. 8). At this point, 
vimentin expression occurred in only few cells and staining 
intensities were low. In addition, the filaments were not dis­
tributed uniformly throughout the cell but were located at the 
periphery (Fig. 8). Within the next 30-40 h, the number of 
vimentin-containing cells and the amount of vimentin in 
each cell increased until amost every cell was vimentin posi­
tive. Cytokeratins were expressed continuously and did not 
colocalize with vimentin filaments (Fig. 8,/and g). About 
25 h after the earliest detection of vimentin in the immu­
nofluorescence assays, hepatocytes from transgenic mice of 
strain 429 initiated expression of desmin (Fig. 9, a and b). 
Again, a gradual increase in expression over a 40-h period 
was observed until most cells were desmin positive. In con­
trol hepatocytes, desmin expression was never observed. 
Eventually, desmin and vimentin staining patterns were iden­
tical, suggesting copolymerization of these proteins. In cul­
tured hepatocytes from four different transgenic mice of 
strain 426, desmin expression could not be detected (Fig. 9, 
e and/). Each of these mice, however, showed the tissue-
specific expression pattern that is characteristic of all pVDes 
transgenic mice and, as described, pVDes levels in strain 426 
were generally comparable to those of strain 429, both in tis­
sues and in the fibroblast cell lines. To extend our analysis, 
hepatocytes of the two different pVVim2 transgenic mouse 
strains (Nos. 32 and 44; reference 36) were also brought into 
culture. Hepatocytes from these mice displayed vimentin and 
cytokeratin expression patterns, which did not differ from 
those of control and pVDes hepatocytes. Initiation of pVVim2 
expression was observed 1 d later than vimentin expression. 
In summary, tissue culture-induced IF gene construct ex­
pression occurred in three out of four transgenic strains. 
Discussion 
Expression of desmin in adult mammalian tissues occurs al­
most exclusively in muscle cells. We have changed the tissue-
specific distribution of this IF protein by creating transgenic 
mice, which express the IF gene construct pVDes, composed 
of the coding region of the hamster desmin gene and the 5' 
flanking region of the vimentin gene, in a vimentin-specific 
fashion. The pVDes protein was indistinguishable from ham­
ster desmin. The levels of pVDes protein recovered in cyto-
skeletal fractions from transgenic cell lines correlated with 
the pVDes mRNA levels, supporting the notion that IF syn­
thesis is determined primarily by the amount of mRNA pres­
ent (43, 46, 54, 58). Double-label immunofluorescence as­
says and double-immunogold labeling of cultured transgenic 
ear fibroblast cells showed that the pVDes protein assembled 
into IFs that colocalized with the endogenous vimentin fila­
ments. This is in agreement with previous reports concern­
ing coexpression of desmin and vimentin in different types 
of muscle cells (49, 62). Taken together, the data indicate that 
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the pVDes-encoded desmin subunits are incorporated into 
the endogenous vimentin filaments. 
The in vivo expression pattern of the pVDes protein was 
determined by immunohistochemical analysis of tissue sec­
tions from different transgenic strains. Each transgenic mouse 
and all offspring expressed hamster desmin in a vimentin-
specific fashion. pVDes expression did not detectably affect 
cellular morphology or differentiation. Desmin synthesis in 
vimentin-negative cells was never observed. Surprisingly, no 
pVDes expression was detected in Sertoli and Leydig cells of 
all three lines of transgenic mice although these cells do ex­
press vimentin (12, 66, 67; Fig. 2). This lack of expression 
is either caused at the transcriptional level or by pVDes 
mRNA instability since no pVDes transcripts were detected 
in transgenic testis (Fig. 4 C). In contrast, an IF gene con­
struct (pVVim2), consisting of the 5' flanking region and first 
six exons plus introns of the vimentin gene, fused to the last 
three exons and introns of the desmin gene is expressed in 
these testicular cells. Since regulatory elements have been 
identified within introns of some genes (2, 26, 35, 45, 55, 
60), it is possible that such elements are located within the 
first six introns of the vimentin gene. 
An important aspect of gene regulation in general is the 
establishment of the appropriate level of expression. For 
vimentin, questions concerning the mechanisms of this as­
pect of regulation cannot be addressed by the use of cultured 
cells only, since it is unclear whether or not expression levels 
are elevated upon culturing of vimentin-expressing cells, 
overruling regulatory mechanisms active in vivo. We show 
here that endogenous vimentin mRNA and protein levels 
were not influenced by pVDes expression. Obviously, the 
amounts of IF protein are not strictly regulated and can be 
elevated without deleterious effects. 
The highest pVDes transcript levels were detected in skele­
tal muscle tissue (Fig. 4). Immunohistochemical staining of 
striated muscle tissue sections showed that nonmuscle cells, 
which are included in this tissue, express both vimentin and 
pVDes (Fig. 2). Transgenic myoblasts presumably also ex­
press these proteins. Since the pVDes encoded hamster des­
min is indistinguishable from endogenous mouse desmin in 
these stainings, we cannot exclude the possibility that pVDes 
is also expressed in muscle cells of transgenic mice; e.g., as 
a result of the presence of muscle-specific regulatory se­
quences within the introns of the desmin gene in addition to 
those present in the desmin gene 5' region (46). However, 
pVVim2 mRNA levels were also highest in skeletal muscle 
tissue (Fig. 4), but it has been shown that the pVVim2 protein 
is not expressed in transgenic striated muscle cells (36). Fur­
thermore, in transgenic heart tissue pVDes mRNA levels 
were low although endogenous desmin is expressed at high 
levels (Fig. 4 B). 
Our studies on cultured hepatocytes establish that se­
quences in the 3.2 kbp of 5' flanking region of the vimentin 
gene confer tissue culture-induced vimentin expression. In 
hepatocytes from pVDes strain 429, desmin protein expres­
sion was first observed after 40-50 h of culture, and lagged 
~25 h behind the initiation of vimentin synthesis. A similar 
time lag was observed in hepatocytes from pVVim2-express­
ing mice. pVDes and pVVim2 transcripts also were detected 
M d later than vimentin mRNA (data not shown). This lapse 
may result from differences in mRNA stabilities. On the 
other hand, species differences in cis regulatory sequences 
of the hamster and mouse vimentin genes could explain the 
observed delay in desmin synthesis. Reports on vimentin ex­
pression during avian and mammalian hematopoiesis have 
shown that divergence of m-linked sequences can result in 
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Figure 5. (A) Double-label immunofluorescence staining of control (a and b) and transgenic (c and d) transformed ear-shell fibroblasts 
incubated with poly-vim (a and c) and the monoclonal antibody to desmin RD30I (6 and d). Note colocalization of filaments stained by 
both antibodies in transgenic fibroblasts. Bars, 4 μιη. (В) Colocalization of desmin and vimentin in IFs of transgenic cultured fibroblasts 
as seen at the ultrastructural level after double-immunogold labeling. All preparations were incubated with a mixture of secondary antibody-
coated colloidal gold probes in the detection step, (a) IFs from transgenic fibroblasts incubated with PBS instead of primary antibodies. 
(b and c) IFs from control (fc) and transgenic (c) fibroblasts, incubated with poly-vim and RD301, detected with 5- and 10-nm gold particles, 
respectively, (d and e) IFs from transgenic fibroblasts, incubated with poly-des and RV202, detected with 5- and 10-nm gold particles, 
respectively. Bar, 200 nm. 
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Figure 6. Northern blot analysis of 10 /ig of total RNA from exponentially growing control (C) and transgenic transformed ear fibroblast 
cell lines (pVDes strains 426,429, and 430; pV Vim2 strain 32). To exclude clonal variation and influences of growth conditions on expression 
levels, RNA was isolated from two independent cell lines for each pVDes strain. Blots were hybridized to a desmin-(/4, X54, Des) and 
subsequently to a vimentin-specific probe (В, E49, Vim). After dehybridization the blots were hybridized to an actin-specific probe (Act). 
Fibroblasts from strain 430 contained relatively little pVDes transcripts, which were readily detected, however, after longer exposure times 
(lanes 43σ). 
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Figure 7. Cytoskeletal fractions of control (lanes 
/) and transgenic (lanes 2-4) transformed 
fibroblast cell lines, analyzed by one-dimen-
ional SDS-PAGE and immunoblotting. (A) 
Coomassie Brilliant Blue (CBB) staining of 
SDS-polyacrylamide gel. (B) Immunoblots, 
incubated with the monoclonal antibody to des-
min (RD301, mDes) and subsequently with 
the monoclonal antibody to vimentin (RV202, 
mVim). (Lane I) Control fibroblasts; (lane 2) 
strain 426; (lane 3) strain 429; (lane 4) strain 
430. 
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species-specific regulation of expression (43). Timing of hu-
man neurofilament (NF-L) gene expression in transgenic 
mice also differed from endogenous NF-L expression (31). 
Cultured hepatocytes from pVDes strain 426 expressed 
vimentin, but no pVDes expression could be detected by in-
direct immunofluorescence (Fig. 9) and Northern blotting 
(data not shown). However, mice from this strain displayed 
tissue-specific pVDes expression at similar levels as strain 
429. The site of integration of the pVDes copies in strain 426 
might not allow transcriptional activation under in vitro con-
ditions. At the same time, regulatory processes in control of 
tissue-specific and tissue culture-induced vimentin expres-
sion may not be identical. We did not detect major rearrange-
ments in the vimentin promoter region of the pVDes copies 
of strain 426. It remains to be established exactly which S' 
sequences mediate induction of vimentin synthesis in cul-
tured cells. 
The reasons for the existence of the highly specific expres-
sion patterns of desmin and vimentin are unknown. Although 
the functional differences between these proteins are ob-
scure, some different properties have been noted. Compari-
son of hamster vimentin and desmin in vivo phosphorylation 
patterns have shown that desmin contains an additional, 
subunit-specifìc phosphorylation site in the COOH-terminal 
"tail" region (10,20). This might allow a differential response 
to exogenous stimuli and may reflect subunit-specific func-
tions. In addition, it has been described that the "іаіГ do­
mains of desmin and vimentin both associate with lamin В 
at the nuclear envelope but with different affinities (25). In 
double immunofluorescence assays on transgenic ear-shell 
fibroblast cells and cultured hepatocytes we observed a small 
percentage of cells that displayed large differences in desmin 
and vimentin staining intensities, suggesting that some fila­
ments contained predominantly desmin or vimentin subuniti. 
The same observation has been made for pVVim2-expressing 
cultured fibroblasts (36). This might reflect differences in as­
sembly characteristics. 
The coexpression of desmin and vimentin in tissues and 
cultured cells from transgenic mice did not result in detect­
able abnormalities. Future experiments, aimed at interfering 
with IF expression in vivo will hopefully shed some light on 
the function of these cytoskeletal structures. 
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Intermediate filaments - vimentm — desmm — eye lens — transgenic 
mice 
Immunocytochenlstry of eye lens cells from transgenic mice соек· 
pressiBg desmin aad vlmentln reveals that the transgenic desmin ex­
pression Is not uniform In the same lens, some epithelial and fiber 
cells overexpress desmin, while in others desmin is not expressed 
Conversely, the endogenous vlmentln is always expressed The 
concomitant expression of vimentln and desmin results in the assem­
bly of hybrid intermediate filaments (IFs) Moreover, the overexpres-
Sion of the transgene generates pleomorphic IF assembly and leads to 
intermingled filamentous whorls and to accumulation of amorphous 
desmin The abnormalities of IF assembly Induced by desmin over-
expression are correlated with perturbation of the enucleation pro­
cess in the lens fibers, changes In cell shape, fiber fusion and exten­
sive interaallzatioa of the general plasma membrane and Junctional 
domains The alterations of lens cells described In this study were 
observed in all transgenic mice examined The level of expression of 
the transgene was paralleled by the degree of damage Our results 
Indicate that proper expression, assembly and membrane interaction 
of IFs play an important role in the terminal differentiation of the 
lentlcnlar epithelium into fiber cells. We anticipate that alterations 
during these processes may Initiate cataract formation 
Introduction 
The ultrastructural features and molecular interaction of 
lens fiber plasma membranes and cytoskeletal constituents 
are of particular interest with respect to eye lens cell shape 
and to the formation of specialized membrane domains 
Although the presence of intermediate filaments (IFs) as 
cytoskeleton constituents of epithelial and lens fiber cells 
has been reported, very little is known regarding the func­
tional role and the mode of assembly of IFs [1, 3, 7, 8, 36, 
42, 43] In the eye lens, IFs are made up of vimentm, a 
protein commonly expressed in cells of mesenchymal on-
n
 Dr Irène Duma, Institut Jacques Monod, Tour 43, 2 Place Jus 
sieu, F 75251 Pans Cedex 05/France 
gin [1, 7, 8, 33, 36, 43,44] Upon terminal differentiation of 
the epithelium into fiber cells, vimentm IFs are still pres-
ent in elongating and deep cortical fibers [1, 17,42] in close 
association with the inner cytoplasmic surface of the 
ріпыпа membranes [1, 2, 17] 
It is well established that tissue specific expression and 
assembly of IF proteins are tightly controlled during devel­
opment and differentiation [4, 7, 8, 11, 33, 40, 41, 47, 52] 
In previous studies, the normal tissue specific distribu­
tion of IF proteins has been changed by creating trans­
genic mice which express the muscle specific desmin gene 
under the direction of the vimentm promoter (pVDes) 
Electron microscopic and immunocvtochemical observa­
tions showed that in fibroblast cell lines and primary hepa-
tocyle cultures derived from these mice, the desmin assem­
bled into normal IFs which colocalized with endogenous 
vimentm IFs Moreover, pVDes expression did not detect-
ably affect cellular morphology or differentiation [ 41] 
Recently, it has been reported that in lens of transgenic 
mice bearing multiple copies of the chicken vimentm gene, 
inhibition of the normal fiber cell enucleation [16] and 
elongation processes occurred, as a consequence of the 
overexpression of the transgene leading to cataract forma­
tion However, the structural features of IFs were reported 
to be normal [12-14] 
Incidentally, on keeping the offspring from transgenic 
mice expressing desmin for several months, we observed 
the development of cataract Hence, we wondered whether 
in the lens the expression of the muscle specific desmin 
gene leads to abnormal lens development. 
In the present study we addressed this question by elec­
tron microscopy and immunocytochemtstry to the struc­
tural organization of epithelial cells and fibers, in the eye 
lens of transgenic mice expressing desmin, before any 
macroscopical alteration was noticed We demonstrated 
that in individual lens cells coexpresstng vimentm and des 
min, changes of both IF cytoskeleton and membrane as­
sembly occur 
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Materials and methods 
Transgenic mice 
The production of the transgenic mice strains 426,429 and 430 has 
been described previously [41] Control mice have been used from 
the same litter as the transgenic offspring and also from the wild 
type of the same strain 
Lens preparation 
Lenses were carefully dissected immediately after killing the ani-
mals and were fixed by immersion in 3% paraformaldehyde in 
phosphate buffered saline (PBS),/JH 7 4, for 1 h at room tempera-
ture Subsequently, the antenor, elongating and nuclear regions 
were separated and impregnated overnight at 4°C in 2 M sucrose-
PBS for cryosectionmg The samples were then frozen in liquid 
nitrogen and transferred to the cryochamber cooled to — 100oC 
Cryosectionmg was performed according to Tokuyasu 155], using 
the Reichert-Jung Ultracut E equipped with an FC4D cryoattach-
ment 
Plasma membrane-cytoskeïeton complex 
The plasma membrane cytoskeleton complex was prepared ac-
cording to the isolation procedure described previously [1] Decap-
sulated lenses of control and transgenic mice were homogenized in 
40 т м KCl, 5mM MgCl2 and 50 mM Tns-HCl, pH 7 5 (TKM), 
containing 1 mM phenylmethylsulfonyl fluoride Following 2 
washes in TKM, the plasma membrane cytoskeleton complex was 
obtained by centnfugalion at 3000^ Supematants were also col­
lected, día I у zed against bidistilled water and concentrated in a 
speed Vac concentrator (Savant Instruments, Ine, Farmingdale, 
NY/USA) 
Antibodies 
The following polyclonal and monoclonal antibodies were used a) 
an affinity-pu π Π ed rabbit polyclonal andbody (polyvim КЗ 4) di­
rected against vimentin [45] (1 50-1 500 dilution), b) a polyclonal 
rabbit antibody (polydes K5) to desmin [46] (1 50-1 500 dilution), 
c) the monoclonal antibody RV202 to vimentin [10] (I 200 dilu­
tion), d) the monoclonal antibody RD301 to desmin [10] (1 500 
dilution), e) a polyclonal rabbit antibody to the major intrinsic 
membrane protein (MP26) of the lens fibers [IB] (1 2000 dilution), 
and f) human antibodies directed against lamm В (serum F) ob­
tained from a patient with systemic lupus erythematosus [27] 
(1 200 dilution) 
immunofluorescence 
[mmunofluorescence experiments were performed on Ι-μιη cryo-
sections layed onto poly L lysme-coated coverslips Sections were 
initially fixed mildly with 3% paraformaldehyde PBS for 10 mm 
and incubated m a quenching solution (50 mM NH4CI-PBS, 
30 mm) and in a blocking buffer (0 2% gelatm-PBS, 30 mm) Im 
munolabeling was performed by incubating the sections for 45 mm 
with the primary antibodies After washing in gelatin-PBS, sections 
were incubated with the second antibodies conjugated to rhoda-
mine (Kirkegaard and Perry Lab , Gaithersburg, MD/USA) Sec 
lions were mounted using Moviol and examined with a Leitz Ans-
toplan microscope equipped with epifluorescence illumination 
and with X63 na 1 4 and X100 na I 32 immersion optics 
Electron microscopy 
For electron microscopy, the lens pieces were fixed in 2% glutaral-
dehyde in cacodylate buffer 0 2 M, pH 7 4, for 1 h, washed in the 
same buffer and, subsequently, fixed in a mixture of 1% osmium 
tctroxide-0 8% potassium ferrocyanate in the same buffer for 
40 mm After washing, the samples were dehydrated in senes of 
graded ethanol solution and embedded in Epon Araldtte 
Immunogold labeling was performed on 1 μτη cryosections of 
3% paraformaldehyde-fixed intact tissue or on fresh preparations 
of plasma membrane cytoskeleton complex (TKM ghosts), resus-
pended in PBS and spread on glass coverslips coated with poly-
1 lysine Single immunolabclmg was performed after a mild fixa­
tion as desenbed above and followed by incubation with a second 
antibody conjugated to 5-nm gold particles for polyclonal antibod 
íes, or with protein A conjugated to 10 nm gold particles for hu-
man serum (Janssen Pharmaceutica, Beerse/Belgium) Double im-
munogold labeling was performed on cryosections incubated four 
times a)2h\t\ the first antibody directed against vimentin (poly-
vim), b)2 h or overnight at 40C in goat anti rabbit IgG conjugated 
with 5-nm gold particles, c) 2 h in the monoclonal antibody di 
reeled against desmin (RD301), and d)2 h in goal and mouse IgG 
conjugated to 10-nm gold particles 
The immunogold labeled cryosections were postfix ed in 2% glu 
taraldehyde-O 1% tannic acid m 0 2 м cacodylate buffer for 30 mm 
and in 1% osmium tetroxide m the same buffer for 45 mm and then 
processed for thin sections as desenbed before 
Thin sections were stained with uranyl acetate and lead citrate 
and examined in a Philips Ε M 400 operating at 80 kV 
Electrophoresis and immunoblotting 
Sodium dodecyl sulfate Polyacrylamide gel electrophoresis (SDS-
PAGb) was earned out in 10% Polyacrylamide slab gels according 
to l^emmli [34] using a Bio-Rad miniprotean II slab cell operating 
at 200 V for 1 h Aliquots of the different samples were solubilized 
in sample buffer (2% SDS, 5% 2-ß-mercaptoethanol) and heated at 
37 "C for several minutes After electrophoresis, the gels were 
stained with Coomassie Blue and/or counterstamed with silver to 
reveal the presence of minor bands Proteins separated by SDS-
PAGE were electrophoretically transferred onto nitrocellulose pa-
per and incubated with the primary antibodies as desenbed else-
where [18] Alkaline phosphatase conjugated goat anti-mouse or 
anti rabbit IgG were used as secondary antibodies (Promega, Ma-
dison, WI/USA) and the color reaction developed with 5 bromo-
4-chloro 3 indolyl phosphate/Nitroblue tetrazohum (BCIP/ 
NBT) 
Unless otherwise indicated, all chemicals used for this work 
were purchased from Sigma Chemicals Co (St Louis, MO/ 
USA) 
Results 
Transgenic mice 
The transgenic mouse strains 426, 429 and 430 contain 
multiple copies of the construct pVDes (10 5 kbp without 
plasmid sequences) that consists of the complete coding 
region of the desmin gene as well as additional 5' and 3* 
untranslated regions fused to 3 2 kbp of vimentin upstream 
sequences 
Offspring from founders 
426 and 429 displayed pVDes expression at levels compa-
rable to endogenous vimentin expression (high expressioh 
strains) PVDes expression levels of offspring from found-
er 430 was approximative I y 10-fold lower than endogenous 
vimentin expression (low expression strain) both at the 
mRNA and protein level [41] 
In the present study we examined at least four different 
lenses from offspring of each transgenic mouse strain 
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ranging from 6 to 24 months old. None of the lenses used 
for this study showed alterations which could be identified 
macroscopically as cataract formation. 
Patterns of desmin and vimentin expression 
Desmin expression was studied by indirect immunofluo­
rescence in cryosections of the transgenic mouse lenses 
and by comparison with control lenses. Polyclonal and 
monoclonal antibodies directed against desmin and vimen-
tin were used (Figs. 1, 2). 
In Figure la, the epithelium of a pVDes high expression 
lens is shown. This layer comprises either single cells 
Fig. 1. Cryosections of transgenic mice lens incubated first with 
a polyclonal antibody against desmin and then with rhodamine-
labeled antibodies.— a. The epithelium consists of several layers 
of cells. The cytoplasm is filled with desmin. Elongating fibers un­
derneath the epithelial cells display uneven distribution of desmin 
(strain 429). — b. Elongation zone (EZ). The elongating epithelial 
cells and fibers in the strain 430 of low desmin expression are also 
characterized by a non-uniform distribution of desmin. — c. Corti­
cal region where the fibers have still nuclei (n). The desmin content 
is distributed in a mosaic fashion. Note the presence of highly flu­
orescent fibers interspaced with others devoid of desmin. — DC 
Deep cortex (strain 426). - Bars 25 цт (a), 16 pm (b), 10 pm (c). 
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closely associated or a multilayered accumulation of cells, 
never found in control lenses The expression of desmin in 
the epithelial cells, as revealed by the immunofluorescence 
intensity, is not uniform Some cells appear completely 
loaded with desmin, whereas others in close proximity are 
faintly fluorescent The heterogeneity of expression ap­
pears even more evident in the elongating fibers located 
underneath the epithelial layer (Figs la-c) In this region, 
the desmin antibodies occupy cortical fibers which still 
have nuclei and are charactenzed by extensive cytoplasmic 
fusion (Fig 1c) At the border line between cortical and 
nuclear fibers the desmin expression is abruptly reduced 
(Fig 1c) This "mosaic mode" of desmin accumulation in 
individual epithelial or elongating cortical fiber cells is 
also observed in lenses denved from pVDes strain 430 of 
low desmin expression (Fig lb) In contrast, the expres­
sion pattern of vimentin appears quite similar in lenses 
from both transgenic (not shown) and control mice (Fig 
2a) Vimentin, as usual, appears to be more abundant in 
the epithelial layer than in the fiber cells where fluores­
cence is weak but homogeneous 
Ultrastruclural features of the terminal differentiation of 
lens cells 
Eye lens fibers are formed through the process of terminal 
differentiation of cells from the epithelial monolayer cov­
ering the antenor surface of the organ Near the so-called 
equator these cells elongate and differentiate into fibers 
Concomitantly division ceases, and the fibers become anu-
cleated In transgenic mice the pattern of cell elongation is 
disorganized In the elongation zone the disruption of the 
fiber architecture is well demonstrated on thin sections of 
intact transgenic mouse lenses (Figs 3a, b) In contrast to 
control lenses, the maintenance of the cell nuclei charac­
tenzed the elongating fibers migrating toward the deeper 
lens cortex (Fig 3a) Vacuoles of different sizes and con­
tent an· wrapped by membrane profiles In the fiber cyto­
plasm, clusters of nbosomes and nuclear debns are ob­
served, and interconnected cytoplasmic areas are occupied 
by low electron density matenal of rather homogeneous 
appearance (Fig 3b) The persistence of the internalization 
of junctional domains which occurs normally to remove 
epithelial gap junctions dunng terminal differentiation 
characterizes the transgenic mice lens fibers In addition, 
small areas of fiber fusion are frequently found (Figs 4a, 
b) 
The organization of the lens fibers m normal and 
transgenic lenses 
The typical organization of control lens fibers as observed 
by indirect immunofluorescence, using a monospecific an­
tibody against MP26, is shown in Figure Sa This polypep­
tide is a general fiber plasma membrane protein which ac­
cumulates into specialized membrane domains of junc­
tional nature [18] The immunolabeling outlines the fibers 
and shows that they have uniform thickness and only few 
internalization of membrane profiles In contrast, in the 
lenses of transgenic mice, the fiber architecture is damaged 
(Figs Sb, c) The great vanety in shape, thickness and fiber 
orientation is outlined by the intense fluorescence of the 
membrane profiles Abrupt membrane interruptions corre­
spond to large areas of fiber fusion and the membrane and 
junction internalization process is enhanced (Figs Sb, c) 
In each individual lens examined, using MP26 and des­
min antibodies, we have observed that the alterations of 
the fiber architecture are paralleled by the level of desmin 
expression (compare Figs lb and c, Figs 4 and Sb, c) 
Desmin and vimenttn organization 
In control epithelial cells, the IFs form bundles onented in 
different directions within the cytoplasm (Fig 2b) In lens 
from transgenic mice, the epithelial cell shows a pleomor­
phic organization of IFs The IF organization is primarily 
represented by areas of the cytoplasm occupied by inter­
mingled and coiled filamentous structures (Fig 6) In addi­
tion, immunogold labeling on cryosections of intact lens 
shows accumulation of amorphous desmin, close to the 
plasma membrane profiles (Figs 4a, b) and a dense net­
work of intermingled and coiled filamentous structures 
comprising desmin, localized in the perinuclear region 
(Fig 7a) The preponderance of curvilinear forms of IFs in 
transgenic mice epithelium is particularly evident around 
inclusion bodies of high electron density (Figs 6, 7b) In 
some epithelial cells spiral motifs and whorls resembling 
fingerprints of concentncally accumulated IFs, strongly 
reacting with anti-desmin antibodies, are found (Fig 7c) 
When intact lenses are processed for electron microsco­
py, the organization of the cytoskeleton and in particular 
of IFs, is not easily apparent because the cytoplasm is 
loaded by crystallins Therefore, the plasma membrane-cy-
toskeleton complex of elongating and cortical fibers can be 
better visualized by using ghost preparations as described 
in Materials and methods (Figs 2c, 7b, c, 8,9) In elongat­
ing and cortical fibers of control lenses, gently extracted 
with TKM, IFs appear as a loose network, and the smooth 
appearance of each individual filament is evident (Fig 2c) 
When the plane of the section is tangential to the plasma 
membrane, end-on attachment of IFs is visualized (Fig 
2c) In transgenic mice lens, the ghost preparation provides 
a better visualization of the pleomorphic organization of 
IFs The IFs form conchoidal whorls resembling finger-
pnnts (Figs 7b, c, 8a) The central core of these IF assem­
blies is often occupied by a rather homogeneous and com­
pact area of high electron density (Fig 7b) 
In contrast to the control, the transgenic mice lens 
ghosts contain many nuclei The conchoidal whorls of IFs, 
clearly visualized in this type of preparation, are fre­
quently found near the nuclear envelope (Fig 8a) Immu­
nogold labeling with anti-lamm В antibodies shows an in­
tense staining of the nuclear envelope, where the intermin­
gled IFs corresponding to the peripheral zone of the whorl, 
are attached (Fig 8c) In the same preparation IF bundles 
are associated to the plasma membrane Immunogold 
staining shows that the inner cytoplasmic surface of the 
plasma membrane is labeled by antibodies directed against 
lamín В (Fig 8b) 
Another type of desmin-containing structure observed in 
the transgenic lens ghost preparation, both by fluorescent 
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Fig. 2. Different aspects of the vimentin organization in control 
lens.—a. Cryosection processed for immunofluorescence using a 
polyclonal antibody against vimentin. Note the homogeneous dis 
tnbution of vimentin which appears more abundant in the epithe­
lial layer than in the fiber cells. С Capsule. — E Epithelium. — b. 
Thin section of an intact control lens showing the cytoplasm of an 
epithelial cell. The IF bundles, occupying the cytoplasm, run in 
difTerent directions. — с Thin sections of TKM fiber ghosts. Note 
the IF end-on attachment to the plasma membrane (arrows). —й. 
Same material as (c) but immunogold labeled with polyclonal an­
tibody against vimentin. The gold particles are unevenly distrib­
uted along the IFs. - Bars 10 μπι (a), 100 nm (b» d), 200 nm (c). 
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Fig. 4. Ultrathin section made on cryosection of transgenic 
mouse lens, showing the fiber cortical region immunolabeled with 
anti-desmin antibodies. Note that membrane profiles have irregu­
lar features with multiple internalizations of the general plasma 
membranes and intercellular junctions. The arrows point to inter­
ruptions of the plasma membrane of adjacent fibers connected by 
a cytoplasmic bridge. The gold particles are associated with amor­
phous desmin accumulation. — Bars 110 nm (a), 60 nm (b). 
and immunogold labeling, corresponds to cross-linked 
branches or large trabeculae of 60 to 70 nm average size, 
displaying either amorphous or tiny filamentous appear­
ance (Figs. 9a-c). This desmin-comprising material re­
mains associated both to the plasma membrane and to the 
nuclear envelope in elongating cortical fibers (Figs. 9a, c). 
Double immunogold labeling of ghosts with antibodies 
raised against desmin and vimentin, respectively, shows 
that the intermediate filamentous or amorphous accumula­
tion comprises these two IF polypeptides (Fig. 9d). 
Soluble desmin and vimentin in transgenic mouse lens 
In a previous paper [41], we have shown by electrophoresis 
and immunoblotting, the presence of desmin in the water-
insoluble fraction of transgenic lens. In this study, immu­
noblotting of both the lenticular plasma membrane-cyto-
skeleton complex (TKM ghosts) and the water-soluble 
fractions with antibodies against vimentin and desmin re­
vealed the presence of a soluble form of vimentin and des­
min in transgenic mice lens (Figs. 10a, b). Roughly, the 
amount of desmin was similar in the ghost and water-sol­
uble fractions. 
Fig. 3. Thin sections of intact transgenic lens stained with uranyl 
acetate and lead citrate. — a, b. The fibers have a great diversity in 
shape and form. Indentations and projections of the plasma mem­
brane are visible. The cytoplasm is occupied by remnants of endo­
plasmic reticulum and vacuoles (V) of different sizes wrapped by 
membrane profiles. Note the irregular framework comprising ho­
mogeneous material of low electron density (LED). Amorphous 
desmin? Compare Figures 4a and 9a, с — N Nucleus. — Bars 
350 nm. 
Discussion 
Expression of the transgenic desmin 
Previous studies revealed that in transgenic mice the pro­
tein encoded by a gene construct comprising the hamster 
vimentin promoter and the desmin coding sequences 
(pVDes) is coexpressed with mouse vimentin in a tissue-
specific fashion and is indistinguishable from normal des-
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Fig. 5. Cryosections processed for immunofluorescence using 
polyclonal antibody against MP26. — a. Typical aspect and regular 
pattern of the cortical fiber membrane profiles, in a control lens. — 
b. pVDes low expression (strain 430).— c. pVDes high expression 
(strain 426). Note the great variety in shape and orientation of the 
fibers outlined by the intense fluorescence of the membrane pro­
files. Arrows point to regions of abrupt interruption of membranes 
and multiple fusion of the fibers. — Bars 8 μιη. 
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Fig. 6. Thin section of intact transgenic mouse lens showing the 
perinuclear cytoplasmic area of an epithelial cell, occupied by IF 
bundles, running in different directions. Electron-dense bodies are 
wrapped by accumulations of curled IFs (arrows). 
Bar 150 nm. 
N Nucleus. 
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Legend Fig. 7 see page 70. 
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Legend Fig. 8 see page 70. 
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mm [41] One might expect that in the lens the transgene 
encoded des mm would display the same uniform expression 
pattern as the endogenous vimcnlin However, wc found 
that the level of expression of the uansgenc, monitored by 
immunofluorcscent inlensily, was high in some individual 
lens cells while in others no desmin could be detected This 
mosaic expression pattern and the excessive accumulation 
of desmin in individual cells was also evident in lenses 
from the strain with low levels of desmin expression 
Conversely, vimenlin was uniformly expressed in all 
epithelial cells as well in cortical elongating fibers of both 
control and transgenic mouse lenses The reasons for the 
heterogeneity of desmin expression remain to be clarified 
A similar finding was reported by В reuman el al [9], who 
showed that a portion of the lens cells escaped cell lineage 
ablation upon expression of a diphiena toxin A gene 
driven by an eye lens specific promoter although a second 
transgene controlled by the same promoter was active in 
those cells 
Lens fibers originate from two disünct morphogcnclic 
groups Primary fibers elongate form the posterior cells of 
the primary lens vesicle to form the lens nucleus, whereas 
secondary fiber cells differentiate from the cquttonal 
region of the lens epithelium and arc deposited in layers 
around the lens nucleus [36, 37, 58, 59] Transgene 
rearrangements in cither one of these cell types could 
explain the observed expression pattern Alternatively, 
since the lens is characterized by regional subpopulations 
of cells having diverging features , regulation of transgene 
expression may vary between lens cell types 
Figs 7 and 8 sec pages 68 and 69 
big 7 Ultralhin sections of transgenic mice lens of high desmin 
expression —a Immunogold Ubeling with antibody against des 
mm made on a cryosection showing the perinuclear region of an 
epithelial cell The filamentous network close to the nuclear enve 
lope is heavily labeled hy (he antibody (S nm gold particles) — b 
Isolated plasma membrane cyloskeleton complex (TKM ghost) of 
transgenic mice lens, showing irregular loops and whorls of com 
pact IF bundles wrapping electron dense material — с Similar 
sample as (b) processed for double immunogold labeling using an 
tibodies against vimentin (5 nm gold particles) and desmin (10 nm 
gold particles) The filamentous conchoidal whorl with exception 
of the central core is heavil) labeled only by the desmin anti 
body —Bars 150 nm (a) 90 nm (b, c) 
Fig 8 Thin sections of transgenic mice lens ghost preparation 
immunolabeled with antibody against lamín В (10 nm gold par 
tides) — a A giant conchoidal whorl of collapsed lbs remains as 
sociated to the nuclear envelope (N) — b Another area of the 
same preparation showing a discrete distribution of the immunola 
beling associated to the plasma membranes (arrows) Note the IF 
end on attachment to the membranes — с High magnification of a 
region оГ(а) showing that the immunolabehng with the antibodies 
directed against lamm В is, in this region, strictly localized at the 
nuclear envelope (NE) The curled meshwork of IFs is in close 
association with the labeled nuclear envelope — Bars 800 nm (•), 
150nm(b) 80 nm (c) 
Aïsembt\ and miraceUular organization of the transgeme 
desmin 
An interesting feature revealed by the present study 
concerns the pleomorphic aspect of desmin assembly We 
found intermingled 10 nm lbs and filamentous conchoidal 
whorls This desmin containing meshwork has features 
similar to perinuclear coalcscent bundles of IFs which 
have been described during mitosis, in neoplastic transfor-
mation and has been induced experimentally by anti-IF 
antibody [28] or by drugs affecting aclin filaments and mi-
crotubules [5, 20, 29, 30, 50, 52] It has also been reported 
that microinjection of keratin mRNA [32] into cultured calf 
lens epithelial cells induced the formation of bundles of 
collapsed non oriented keratin IFs and the accumulation 
of non-filamentous keratin in the perinuclear areas, where 
as vimentin IFs appeared normal [32] 
The question remains why the IFs made by transgenic 
desmin, although they contain endogenous vimentm, arc 
not organized normally In this respect one has to keep in 
mind that assembly and disassembly of IFs, including hy-
brid desmin vimentin filaments [53], involves more than 
one regulatory event [7, 19, 20] Unlike actin microfila-
ments and microtubules, which are polar structures, both 
ends of IFs have identical polymerization dynamics [31, 
56] and IF polymerization takes place by rapid self-assem-
bly from soluble tetrameri с homo or heterooligomers at 
the two ends of the filament [31] One molecular model 
conceives that growth of IFs occurs by subunit addition 
into the vimentm filament network at numerous and dis­
crete sites throughout the cell necessitating a transient dis­
ruption of filament integrity [39, 51] Experimental evi­
dence shows that the intracellular organization of vimentin 
and desmin IFs is determined by interaction with initiation 
sites at both the nuclear envelope and the plasma mem-
Flg 9 Thin section of plasma membrane cytoskelcton complex 
(TKM ghost) from transgenic mice lens with high desmin expres 
sion —а, с Isolated fiber ghosts processed for immunogold label 
ing with antibody against desmin An amorphous deposit and a 
trabecular meshwork of desmin are associated to the plasma mem 
brane and to the nuclear envelope (NE arrows) — b Similar mate 
rial as in (a) and (c) processed for immunofluorescence using an 
tibody against desmin The polymerized desmin forms a trabecular 
meshwork — d Double immunogold labeling on a similar prepa 
ration using polyclonal antibody against vimentin (arrows) (5 nm 
gold particles) and the monoclonal antibody against desmin (10 
nm gold particles) The heteropolymers of vimentin desmin form a 
filamentous network and amorphous accumulation —Ban 
120 nm (ι, c), 700 nm (b), 60 nm (d) 
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Flg. 10. Immunoblotling of plasma membrane cytoskeleton com-
plex (a) and supernatant fractions (b) from control (lane* C) and 
transgenic mice lens of high desmin expression {lanes T) incubated 
first with the monoclonal antibody against desmin (d, аггон) and 
then with the monoclonal antibody against vimentm (v, аггон) 
Note the considerable amount of desmin in (he supernatant Trac­
tion (b) (lane T) comparable to the amount of desmm comprised 
in the plasma membrane-cyloskelelon complex (a) of transgenic 
mice lens (lane T) 
brane [21-26] This model proposes that the amphitropic 
protein ankynn [11] constitutes the major attachment site 
for vimentin to the inner surface of the plasma membrane 
In nucleated cells studied so far, it is believed that vimen­
tm and desmin subunits are initiated to polymerize by co­
operative interaction of their carboxy terminal segments 
with lamm В [l i, 21, 27] The role of the C-termmal tail of 
IF proteins in the assembly of IFs is also demonstrated by 
expenments showing that expression of C-termmally 
truncated IFs can lead to a disrupted IF system 
[31] It is interesting to note that desmin binds to lamín В 
with lower affinity than vimenlin [25] Its binding site is 
not located at the very end of the molecule, 
but within the 21 amino acid residues following its he­
lical domain [48] Our present results of immunolabelmg, 
using antibodies against lamín B, indicate that in trans-
genic mice lens this protein is present in the plasma mem-
brane and in the nuclear envelope where IFs have end-on 
attachment In bovine lens fibers, lacking nuclei, we dem-
onstrated the presence of ankynn and a polypeptide which 
reacts with antibodies against lamm В in the plasma mem­
brane, where vimentin IFs have end-on attachment [3] 
Recent studies in the electrocyte of Torpedo have shown 
the existence of a lamm В like protein localized at the in­
nervated membrane, whereas ankynn is at the non-mner-
valed side IFs were shown to be inserted into the plasma 
membrane at both sides [15] We may then hypothesize 
that incorrect organization of IFs in transgenic mice lens 
cells overexpressing desmin, could be explained by the fact 
that, since the number of nuclear and plasma membrane 
binding sites is limited, they cannot mediate the correct IF 
assembly in view of the high concentration of the mono-
menc desmin (and vimentm) This situation troubles the 
normal enucleation process and consequently the terminal 
differentiation of the lens fibers 
We observed that cellular overexpression of desmin is 
followed by alterations of the plasma membrane architec­
ture Internalization of specialized membrane domains, 
swelling and fusion of lens fibers has been demonstrated 
These effects on Ihe integrity of the plasma membrane may 
be a consequence of the impairment of IF-membrane at­
tachment sites by excess of desmin Our findings would 
then indicate that the correct vectorial association of IFs 
with the plasma membrane lb receptors (ι e , lamm В and 
ankynn) is stnngent for membrane assembly and the for­
mation of specialized membrane domains In support to 
this hypothesis, several experiments demonstrated the exis­
tence of a complex correlation between plasma membrane 
assembly, cell shape modulation, anchorage and cell con­
tact with different levels of \Y protein subunit expression 
И] 
It is noteworthly that the changes of the plasma mem­
brane architecture that we have observed in transgenic 
mice, where cataract is not macroscopically detectable, are 
similar to those reported in early stages of congenital cata­
ract In these precataractous stages [35, 38, 49, 54] the fi­
bers show changes in shape and orientation, and a process 
of swelling characterizes individual cell damage Major 
changes include internalization ofpentalammar structures 
and the conversion of gap junctions into collapsed slack­
ing of membranes [54] Again, during these precataractous 
stages the alterations involve individual cells and defined 
areas of the lens cells, and also cell to cell communication 
and transport are impaired [35, 38, 49, 54] 
Concluding remarks 
The ability to manipulate the mammalian genome by the 
generation of transgenic animals provides an experimental 
approach for altering development and differentiation 
One method to ablate selectively specific cell types during 
development involves the targeted expression of lethal 
proteins by appropriate transcriptional regulatory ele­
ments That is the case of the genetic ablation of primary 
lens fiber cells generated in transgenic mice and resulting 
in cataract formation (9| 
Another experimental model for perturbing develop­
ment and cell differentiation is based on the overexpres­
sion of a transgene in individual cells which normally ex­
press the same or a homologous gene [12-14, 33, 41] In 
our experiments, the overexpression of muscle-
specific desmin in eye lens, where the endogenous vimen­
tm is normally expressed, involves impairment of the enu­
cleation process [16] and incorrect assembly of the cyto-
skelctal structures which in turn perturbes the process of 
terminal differentiation of the lens cellular elements and 
eventually lead to cataract 
So lar, clear evidence for a function of IFs has not been 
provided We believe that the findings presented here, 
combined with our recent data on the existence of vecto­
rial IF attachment to the plasma membrane in enucleated 
fiber cells, indicate an important function for IFs, namely 
the maintenance ol the correct membrane architecture in 
the lens cells 
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Jos M. H. Raats,* Frank R. Pieper,* Wilma T. M. Vree Egberts,* 
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Abstract. To study the role of the amino-terminal do­
main of the desmin subunit m intermediate filament 
(IF) formation, several deletions in the sequence en­
coding this domain were made The deleted hamster 
desmin genes were fused to the RSV promoter Ex­
pression of such constructs in vimentin-free MCF-7 
cells as well as in vunentin-containmg HeLa cells, 
resulted in the synthesis of mutant protems of the ex­
pected size Single- and double-label immunofluores­
cence assays of transfected cells showed that in the ab­
sence of vimentin, desmin subunits missing amino 
acids 4-13 are still capable of filament formation, al­
though in addition to filaments large numbers of des­
min dots are present Mutant desmm subunits missing 
larger portions of their ammo terminus cannot form 
filaments on their own It may be concluded that the 
amino-terminal region comprising ammo acids 7-17 
contains residues indispensable for desmin fila-
I NTERMEDiATE filaments (IFs),' along with microtubules and microfilaments, are part of the cytoskeleton of most eukaryotic cells The different classes of IF subunits aie 
expressed in a more or less tissue-specific manner in the 
adult organ (9, 70, 71, 74) Sequence data revealed that IFS 
can be subdivided into six types including the lamins (type 
V) (21, 70) and nestin (type VI) (48) 
All IF proteins share an α-helical "rod" domain of con­
served secondary structure and size This central rod, which 
is flanked by nonhehcal end domains of variable size, se­
quence, and chemical characteristics (9, 21, 23, 24, 48, 70, 
72, 74, 77), comprises ~310 amino acid residues for type 
I to IV as well as type VI, and 356 amino acids for lamins 
The of-hehcal rod plays an important role in filament forma­
tion Albeit several proposals have been made to explain IF 
Dr Ramaekere present address is Deparnnent of Molecular Cell Biology 
Umveisiry of Lunbuig, Maastricht The Netherlands Addiess correspon 
dencetoJ M H Raats, Department of Biochenuslry University of Nijme­
gen, Ρ О Boi 9101 6300 HB Nijmegen, The Netherlands 
1 Abbrwiatums used in this paper IF, intermedíale filament 
ment formation in vivo Furthermore it was shown that 
the endogenous vimentin IF network in HeLa cells 
masks the effects of mutant desmin on IF assembly 
Intact and mutant desmin colocalized completely with 
endogenous vunentin in HeLa cells Surprisingly, in 
these cells endogenous keratm also seemed to colocal-
ize with endogenous vunentin, even if the endogenous 
vimentin filaments were disturbed after expression of 
some of the mutant desmin protems In MCF-7 cells 
some overlap between endogenous keratm and intact 
exogenous desmm filaments was also observed, but 
mutant desmin proteins did not affect the keratin IF 
structures In the absence of vunentin networks 
(MCF-7 cells), the initiation of desmin filament forma-
tion seems to start on the preexisting keratin fila-
ments However, in the presence of vunentin (HeLa 
cells) a gradual integration of desmm in the preexist-
ing vunentin filaments apparently takes place 
assembly (1,9,70,72), the exact mechanism of filament for-
mation is not yet fully understood 
The IF end domains are the major sites of postsynthetic 
modifications such as phosphorylation and limited proteoly-
sis (9, 22, 26,42, 55, 74) Reassembly experiments with in-
tact and proteolytically digested IF subunits revealed that the 
amino-terminal domains of desmin and vunentin are in-
volved in in vitro filament formation (30, 41, 75) Next to 
limited proteolysis of the amino-terminal parts of desmin and 
vunentin, phosphorylation of these domains might be an-
other mechanism involved in the regulation of filament rear-
rangement (4, 13, 15, 17-19, 25, 26, 39,40,42,47, 69) Fur-
thermore, it has been suggested that the amino-terminal 
domain is involved in binding of IFs to the plasma membrane 
(29, 31) 
Removal of the last 27 carboxy-termmal amino acids did 
not affect the in vitro filament-forming capacity of the des-
mm subunits (41) The existence of a tailless keratin 
(cytokeratin 19) (6) as well as transfection studies with mu-
tant keratm cDNAs (2, 3) and modified desmm genes (37) 
allow the assumption that the tail domain is not an indispens-
able part of IF proteins On the other hand, the carboxy-
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terminal domain has also been suggested to be involved in 
binding of IFs to the nuclear lamina (29-31). Since it dis­
plays the highest variability in both length and sequence 
(74), it might also have some subunit-specific function. 
To study expression, assembly, and possible function of 
IFs inside the living cell various approaches have already 
been undertaken. For instance IF subunits were expressed 
in tissue culture cells by means of IF mRNA injection (20), 
by transfection with IF cDNAs or genes (2, 3, 16, 32, 33, 37, 
46, 54, 60), and by expressing IF genes in transgenic mice 
(11, 12, 45, 57). Because modifications can easily be 
achieved at the DNA level, transfection of modified cDNAs 
or genes into tissue culture cells is an excellent tool to study 
the role of the different IF protein domains in vivo. A number 
of such studies has already been published (2, 3, 37,46,51). 
However, we assume that in the transfection expenments de­
scribed previously (2, 3, 37), the effects on filament forma­
tion caused by deletions in the IF subunits were masked by 
the presence of intact endogenous IFs. To avoid this we es­
tablished a vimentin-firee in vivo test system for the expres­
sion of intact and mutant desmin genes. In this expression 
system, the mutant desmin subunits form homopolymeric 
IFs. No copolymerization can occur with endogenous IF 
subunits. Our in vivo assembly study with normal and 
anuno-temunally deleted desmin subunits shows a number 
of differences with the previous in vivo IF assembly study 
in cells containing intact IFs (3). The use of a vimentin-free 
expression system also allowed us to study the initiation of 
(type Ш) IF assembly in the absence of preexisting IFs into 
which the newly synthesized subunits can be incorporated. 
Materials and Methods 
Plasmid Construction 
In general, the procedures suggested by Maraatis et al (52) were followed 
for construction of plasmids and preparation of plasmid DNA 
The complete hamster desmin gene without 5' regulatory sequences, 
pDes (57) was used for expressing the complete desmin protein in MCF-7 
and HeLa cells and for preparation of the anuno-temunaJ deletion con-
stmcis of the hamster desmin gene In this construct 57 bp of 5' and 775 
bp of Э' untranslated sequences, including the poly A signal, are present 
For the preparation of the amino-terminal deletion constructs of the ham­
ster desmin gene (NAXpRSVDes) listed in Table I, the 07-kbp Hpa II-Bam 
HI fragment of the hamster desmin gene (60) (from +25 to +737 bp relative 
to the CAP site) was subcloned into an Ace I-Bam HI-digested pUC19 plas­
mid Excision of DNA fragments with Stu I (+91) and Bal I (+385), or with 
Stu I (+91) and Sma I (+526) resulted, after religation of the remaining 
plasmid, in a deletion of 294 (Stu I-Bal I) and 435 bp (Stu I-Sma I) m the 
first едоп of the desmin gene Both plasmids were cleaved with Bam HI 
(+737) and Hind ID (pUC19 poly I inker) The deletion-containing frag­
ments were hgated in pDes from which the 07-kbp Bam HI (+737)-Hind 
UI (pUC19 polyl inker) fragment was removed This resulted in the plasmids 
NA98pRSVDes and NA145pRSVDes For the other ami no-terminal dele­
tion constructs, a pUCI9 plasmid, containing the Hpa Π (+25)-Bam HI 
(+737) fragment, was cleaved at the unique Stu I site at position +91 ВаІЭІ 
exonuclcase was used to generate deletions of various length in the DNA 
sequence The plasmids were treated with T4 DNA polymerase lo create 
blunt ended DNA cleaved at the unique Bam HI site at position +737 A 
pUC19 plasmid containing the Hpa II (+25)-Bam HI (+737) desmin frag­
ment was cleaved with Stu I (+91)-Bam HI (+737) The Bam HI blunt des­
min fragments were hgated in this plasmid The resulting plasmids were 
cleaved with Bam HI (+737) and Hind Ш (pUC19 polyl inker) and the 
deletion-containing fragments were hgated in the pDes plasmid from which 
the 07-kbp Hind Ш (pUCI9 polylinker)-Bam HI (+737) fragment was re-
nroved 
The RSV promoter was isolated by linearizing the pRSV-CAT plasmid 
(34) by cleaving и at the unique Nde I site T4 polymerase was used to create 
blunt-ended DNA Hind ІП linkers were hgated to this plasmid The RSV 
promoter was excised with Hind HI This resulted m a 0 58-kbp Hind 
III-Hmd Ш fragment which was hgated in the 5-3' orientation in die Hind 
III (pUC19 polyl inker) site of all desmin deletion constructs The resulting 
constructs contain some additional base pairs from the pUC19 polylinker 
between the Hind Ш and Ace I sites The DNA constructs were transformed 
into bacterial strain Escherichia coti HB101 or JM109 
All DNA preparations to be used in transfection expenments were 
punned on two successive CsCl gradients 
To determine which deletion constructs were in the proper reading frame 
for desmin protein expression, plasmid DNA from each deletion clone was 
isolated and sequenced using the double-stranded sequencing protocol de­
scribed by Chen and Seeberg (14, 35) 
Cell Culture 
MCF-7 cells (50, 53, 67) were maintained in Eagle's modified MEM 
(EMEM, Flow Laboratories, Maclean, VA) supplemented with 10% FCS 
(Gibco Laboratories, Grand Island, NY) and 6 ng/ml insulin (bovine) 
HeLa cells were cultivated in DMEM (Gibco Laboratories) supplemented 
with 10% FCS Stably transfected cell lines of MCF-7 and HeLa cells were 
maintained in EMEM supplemented with 10% FCS, 6 ng/ml insulin, and 
300 μg/ml Geneticin (G418, Gibco Laboratories), and in DMEM sup­
plemented with 10% FCS and 300 Mg/ml 0418, respectively 
DNA Transfections 
Cells were transfected by the calcium phosphate precipitation method, es­
sentially as desenbed by Wigler el al. (78) Cells were plates in 100- or 35-
mm culture dishes (Costar Corp , Boston, MA) 24-48 h before transfection 
and grown in DMEM supplemented with 10% FCS Transfections were ear­
ned out on cell cultures that had reached ~40% confluency 20 ^g/100 mm 
or 5 μg/35 mm plasmid DNA was added to each culture dish as a calcium 
phosphate precipitate, 20 min later 5 ml/100 mm or 2 mJ/35 mm culture 
medium containing 5 μg/mI chloroqume (Sigma Chemical Co , St Louis, 
MO) was added After 5 h of incubation the cells were glycerol shocked 
for 2 5 mm, and incubated in normal growth medium for 48 h Thereafter 
immunofluorescence assays, immunoprecipitation, and Western blotting 
procedures were performed For preparation of stably transfected cell lines, 
cells were plated in 100-mm dishes and cotransfected with 1 μg pSV-neo 
(68) and 19 μg of a construct 24 h after transfection the cells were brought 
under G418 selection (300 Mg/ml) After ±14 d, colonies of stable transfor­
mants were transferred to 96-microwell dishes with a stenle pipette tip Af­
ter wells reached confluency, these cells were analyzed for desmin expres­
sion by indirect immunosiaimng and Western blotting 
Antibodies and Indirect Immunofluorescence Assay 
Single- and double-label indirect immunofluorescence staining procedures 
were performed on cultured cells as desenbed previously (45) We used the 
Table /. Deletion Mutants of Hamster Desmin 
Constnict 
pRSVDes 
ΝΔ3 
ΝΔ10 
ΝΔ13 
ΝΔ60 
ΝΔ91 
ΝΔ94 
ΝΔ98 
ΝΔ125 
ΝΔ145 
Size of 
deletion 
None 
3 AA 
10 AA 
13 AA 
60 AA 
91 AA 
94 AA 
98 AA 
125 AA 
145 AA 
Number of 
amino acids 
deleted 
None 
A A 5 - 7 · 
A A 4 - 1 3 
A A 5-17* 
АА4-6Э 
A A 4 - 9 4 
AA 4-97 
AA 4-101 
AA 4-128 
AA 4-148 
The deletion constructions are named NAXpRSVDes (ΝΔΧ) where N stands 
for amino terminal deletion, whereas ΔΧ indicates the number of amino acids 
removed as a result of the deletions made in the hamster desmin gene AA, 
amino acids 
* After ligation AA 5 of desmin is restored 
t Ammo acid substitutions caused by ligation 
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following polyclonal and monoclonal antibodies: (a) A polyclonal rabbit an-
tibody (polyndes) to chicken gizzard muscle desmin (65); (b) the mAb 
RD301 to chicken desmin (60); (c) the affimty-punfìed polyclonal antibody 
(poly-vim) to bovine lens vimentin (64); (d) the mAb RV202 to bovine lens 
vimentin (66); (e) the affinity-purified polyclonal antibody (poly-ker) to hu-
man skin keratins (64), and if) the mAbs RCK102 to human keratins S and 
8 (10), RCK106 (66), CK 18-2 (10), and RGE 53 (63), all three to keratin 
18, and RCKIOS to keratin 7 (66). 
One-dimensional PAGE and Western Blotting 
The preparation of cytoskeletal extracts of cultured cells as well as one-
dimensional SDS-gel electrophoresis and immunoblotting procedures have 
been described previously (10). Western blots were incubated either with 
the mAb RD30I to desmin, followed by l25I-labeled goat anti-mouse anti-
body, or with the polyclonal rabbit antibody (poly-des) to desmin, followed 
by a swine anti-rabbit antibody, and subsequently with 125I-labeled Staphy-
lococcus aureus protein A, The radiolabeled bands were visualized by auto-
radiography. 
Cell Labeling, Extraction, and Immunoprecipitation 
of IF Proteins 
For cell labeling, tissue culture cells were grown in IOC-nun dishes in 6 ml 
of methionine-free EMEM for 2 h Thereafter, 200 (iCi [35S]methionine 
(>1,000 Ci/mmol sp act, Amereham Corp., Arlington Heights, IL) and 0.36 
ml dialyzed PCS (final concentration 6%) was added. After a 24-h incuba-
tion at 370C the cells were rinsed three times with PBS. Cells were har-
vested by scraping with a cell lifter (Costar Corp.) in PBS and pelleting. 
IF proteins were isolated as described previously (8). In all solutions 
1 mM of the protease inhibitor PMSF was included. 
Radiolabeled IF proteins were obtained selectively by immunoprecipita-
tion with specific monoclonal and polyclonal antibodies as described (8). 
An aliquot containing 5 χ 106 cpm of the [35S]methionine-labeled cell ex­
tract was used for each precipitation. A volume containing 2,000 cpm of 
the precipitate was used for gel analysis. After separation the gels were 
fluorographed, dned, and exposed to Kodak X-Omat AR-5 film (Eastman 
Kodak Co , Rochester, NY). 
Results 
Selection of the Desmin Expression System 
The hamster desmin gene and modifications thereof can be 
expressed after transfer into different types of nonmuscle 
cells (37, 57, 60). To study desmin filament formation in 
vivo, vimentin-containing cells have previously been trans-
fected with different types of desmin deletion constructs 
(37). Since desmin and vimentin can form heteropolymers 
in vivo (62, 73), it could not be excluded that the endogenous 
vimentin compensates for the effects caused by deletions in 
the desmin gene. To avoid this, desmin filament formation 
was studied in cells lacking vimentin. The human breast ade­
nocarcinoma epithelial cell line MCF-7 we used for our 
transfection studies does express keratins 7, 8, and 18, but 
neither desmin nor vimentin (38, 53). The effect of endoge­
nous vimentin on mutant desmin assembly was determined 
by transfection of mutant desmin genes into HeLa cells, a hu­
man epithelial cell line expressing both vimentin and kera­
tins 7, 8, 17, and 18 but no desmin (53). 
Both the hamster desmin promoter (unpublished results) 
as well as the hamster vimentin promoter (38) show little or 
no activity in MCF-7 cells. For this reason we replaced the 
5' upstream region of the hamster desmin gene by the 0.58-
kbp promoter fragment (34), yielding the pRSVDes plasmid 
(Fig. 1 A). The RSV promoter is capable of directing high 
level expression of different types of constructs in both MCF-7 
and HeLa cells (unpublished results). To test whether ex-
pRSVDes 
pUC19 RSV DESMIN 
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TATA-boxi 
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Figure 1. {Α ) Schematic representation of the expression vectors for 
hamster desmin (pRSVDes) and mutations thereof (NAXpRSVDes 
[ΝΔΧ]). N indicates amino terminal deletion, whereas ΔΧ indi­
cates the number of amino acids (AA) deleted as a result of the 
modifications made in the hamster desmin gene RSV indicates that 
the desmin gene and mutations thereof are under control of the RSV 
promoter, в м . pUC19, a . RSV sequence, D, noncoding area 
RSV promoter; B, deleted area of desmin exon 1; —, noncoding 
sequences; a. desmin exons. H, Hind Ш; 5, Stu I; B, Bal I; 5m, 
Sma I; Ba, Bam HI; £, Eco RI. 1, relative to the CAP-site of RSV; 
2, relative to the CAP-site of the desmin gene. (S) Schematic rep-
resentation of deleted desmin subumts. All deletion constructs con-
lain AA 1-4. The size of each deletion is indicated by vertical 
arrows. 
pression of pRSVDes resulted in desmin filament formation 
in MCF-7 and HeLa cells, both cell types were transfected 
with this construct. In a typical transient transfection assay 
± 3 0 % of the HeLa cells and ±15% of the MCF-7 cells 
reacted positively with desmin antibodies 48 h after transfec-
tion. The desmin filament network in MCF-7 cells showed 
no morphological abnormalities and was similar to that of 
HeLa cells transfected with pRSVdes (compare Figs. 3 a and 
4 a) or with the complete hamster desmin gene (not shown) 
(37, 60). 
Construction of Mutant Desmin Genes 
Various mutant genes were constructed by removing se-
quences of the hamster desmin gene encoding the amino-
terminal region of the protein (Materials and Methods, Fig. 
1, and Table I). In all deletion constructs the original desmin 
ATG start codon, as well as the surrounding region starting 
from +25 up to +91 bp relative to the CAP site were re-
tained. Therefore, in all amino-terminal deletion constructs 
the first three amino acids of desmin are maintained. 
Expression of the deletion constructs NAXpRSVDes 
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Figure 2. (A ) Immunoprecipitation of mutant desmin proteins ex-
pressed in MCF-7 cells with a polyclonal antibody against desmin 
(pDes) revealed that all mutant desmin genes were expressed 
properly and of the expected size Bands corresponding to the mu-
tant desmins are pointed out by an arrowhead. Mutant genes trans-
fected are indicated as ΝΔΧ (see Fig. 1 and Table I). Immunopre­
cipitation of cytoskeletal proteins from BHK-21 cells with 
polyclonal antibodies against desmin (pDes) and vimentin (рУіт) 
were used as markers for vimentin (Vim) and desmin (Des). Immu­
noprecipitation of nontransfected MCF-7 cells with a polyclonal an­
tibody against keratin (pKer) (A and B, lane C; pKer) indicated that 
additional proteins precipitated with poly-des might be keratins. 
(B) Immunoprccipnations of cell extracts of transfected and non­
transfected MCF-7 cells with polyclonal antibodies against vimen-
tin (pVim), showed that in both transfected as well as nontransfected 
cells, vimentin could not be demonstrated. 
should result in amino-terminally deleted desmin subunits nom 
which 3-145 amino-terminal residues are missing (Fig. IB). 
Expression of Mutant Desmin 
MCF-7 cells were transfected with the different deletion con­
structs, labeled with [35S]methionine, and analyzed for mu­
tant desmin protein expression 48 h after transfection. IF 
proteins were isolated and immunoprecipitated with poly­
clonal antibodies directed against desmin (poly-des), vimentin 
(poly-vim), and keratins (poly-ker). Immunoprecipitation of 
the mutant desmin proteins with poly-des demonstrated that 
all mutant genes were expressed properly and that the mu­
tant IF proteins were of the expected size (Fig. 2 A). In addi­
tion to the mutant desmin bands four other protein bands 
were observed in each sample. These bands were also de-
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Table II Indirect Immunofluorescence 
Desnun Staining Patterns Observed in 
Transiently Transfected Vimenttn-free MCF-7and 
Vimentin-containmg HeLa Cells 
Tmufected 
COTSlniCtS 
pRSVDes 
ΝΔ3 
ΝΔ10 
ΝΔ13 
ΝΔ60 
ΝΔ9Ι 
ΝΔ94 
ΝΔ98 
ΝΔ125 
ΝΔ145 
in tmurfected MCF 7 
F 
F 
F, Do 
Do, Di 
Dl 
Dl 
Dl 
Di 
Di 
Dl 
Imiminofluorescciice patten 
in transfeci«) HeLa* 
F 
F 
F, Do 
F. Do, Di 
F, Di 
F, Di 
F, Di 
F. Di 
F, Di 
F . D i 
F filamentous staining pattern, Do, dotted staining pattern. Di, diffuse staining 
pattern 
a
 Staining paflem depends on expression level of mutant desnun If expression 
level was low most cells showed intact desnun filaments if the expression lev 
el was high, most cells showed staining patterns identical to those seen in 
MCF 7 cells 
tected ш nontransfected MCF-7 cells (Fig 2 B, lane C, 
pDes) Immunoprecipitation of transfected and nontrans­
fected MCF-7 cells with poly-ker indicated that these bands 
probably represent endogenous keratins (Fig 2 B, compare 
lanes C.pVim, pDes, andpKer) MCF-7 cells are completely 
devoid of vimentin, as demonstrated by the absence of vi-
mentin after immunoprecipitation with poly-vim, both be­
fore and after transfection (Fig 2 fi) 
The mutant desnun genes were also expressed properly af­
ter transfection into HeLa cells, as demonstrated by Western 
blotting with polyclonal antibodies against vimentin and des­
nun (results not shown) 
The Effect ofAmino-Terminal Deletions on the 
Filament-farming Capacity of Desmin in MCF-7 Cells 
Transient transfection of the amino-terminal desmin deletion 
constructs into MCF-7 cells resulted in four, morphologi­
cally distinct immunofluorescence patterns after staining 
with poly-des fibbie Π and Fig 3) Expression of pRSVDes 
and the deletion construct ΝΔ3 yielded normal filamentous 
desnun staining patterns (Fig 3 a) Expression of the dele­
tion construct ΝΔ10 resulted in a deviating picture In addi­
tion to desmin filaments, in nearly all transfected cells small 
fluorescent desnun dots were seen (Fig 3 b) While in some 
cells the dotted pattern was most pronounced, others showed 
a predominantly filamentous feature The filaments were 
mainly observed in the nuclear area, whereas the dots 
seemed to be situated more closely to the plasma membrane 
Upon transfection of the deletion construct ΝΔ13 no normal 
desnun filaments were observed The transfected cells dis­
played a diffuse cytoplasmic staining together with strongly 
fluorescent dots (Fig 3 c) These dots were not seen in close 
proximity of the nucleus In few transfected cells, hazy 
filamentous structures were observed together with the 
diffuse cytoplasmic and dotted staining pattern Although af­
ter transfection of ΝΔ10 and ΝΔ13, the observed desmin dots 
did not show any particular interaction with the nuclear 
envelope, very large dots often clustered around the nucleus 
lb ensure that these dots were not caused by overexpression 
of the mutant desmin proteins, MCF-7 cells were transfected 
with smaller quantities of the respective constructs (2-200 
times less than descnbed in Materials and Methods) The to­
tal amount of DNA used to transfect cells was kept constant 
by adding pUC plasmid DNA These experiments showed 
that the dots were not caused by overexpression, since they 
remained at each concentration, although they became very 
small when lower amounts of the construct were transfected 
Expression of the deletion constructs ΝΔ60 to ΝΔ145 did 
not result in the formation of desmin filaments Only a 
diffuse cytoplasmic staining reaction was seen in these 
MCF-7 cells (Fig 3 d) 
The Effect ofAmino-Terminal Deletions on the 
Filament-forming Capacity of Desmin in HeLa Cells 
The effects of amino-terminal deletions on filament forma­
tion in HeLa cells were much less pronounced as compared 
with the effect seen in MCF-7 cells (ТШе Π and Fig 4) 
Transfection of the mutant desmin genes generally yielded 
normal filaments (not shown) However, for each construct, 
at least some transfected HeLa cells displayed desmin pat­
terns, similar to those observed in MCF-7 cells (Fig 4, 
α-d) Transfection of smaller quantities of construct DNA 
into HeLa cells (200 times less than descnbed in Materials 
and Methods), resulted in intact desmin filaments only Pre­
sumably, only when mutant desimns are expressed at high 
levels, IF formation is disturbed and the staining patterns are 
similar to those observed in transfected MCF-7 cells 
Interaction of Intact and Mutant Desmin with the 
Endogenous Keratin Network in MCF-? Cells 
Double immunofluorescence labeling of transiently trans­
fected MCF-7 cells revealed that the endogenous keratin fila­
ments are morphologically different from the exogenous des­
min networks formed by intact desnun subumts (Fig S, a and 
b), although in some areas of the cell colocalization of both 
filament systems could be observed 
Transfection of all deletion constructs on MCF-7 cells 
resulted in desmin staining patterns as descnbed above 
Double and single labeling with keratin antibodies revealed 
that the keratin filament organization was never affected by 
the mutant desmin proteins (Fig 5, b, d,f, and A) The des­
min dots, seen after transfection of ΝΔ10 and ΝΔ13 were 
situated in the darn of the keratin network (Fig S, c-f) 
Interaction of Intact and Mutant Desmin with 
Endogenous Keratin and Vimentin Filaments in 
HeLa Cells 
After expression of mtact desmin subumts double im­
munofluorescence staining showed that the newly synthe­
sized desmin did colocalize completely with the endogenous 
vimentin filaments (see also references 37, 57, 60) More­
over, after expression of the different desmin constructs, 
vimentin staining patterns were identical to those of desmin, 
even if desmin filament formation was disturbed (Fig 6, c, 
d, g, h, к, and /) These results strongly suggest that in HeLa 
cells vimentin and desnun form heteropolymers 
Unexpectedly in HeLa cells the exogenous desnun fila­
ments, formed by intact desnun subumts, colocalized nearly 
completely with the pre-existing endogenous keratin filaments 
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Figure 3. Single-label indirect immunofluorescence assay of MCF-7 cells transfected with (a) pRSVDes, (b) ΝΔ10, (c) ΝΔ13, (d) ΝΔ145, 
and incubated with a polyclonal antibody against desmin (poly-des). Abnormal desmin staining patterns already occur after deletion of 
10 amino-terminal residues. Bars, 10 μιη. 
(Fig. 6, a and b). In contrast to MCF-7 cells, a certain num­
ber of cells transfected with ΝΔ10 or ΝΔ13 and displaying 
the desmin dots as described above, showed the same pattern 
after staining with five different keratin antibodies (Fig. 6, e 
and/). Expression of the other deletion constructs did not 
affect endogenous keratin filament networks (Fig. 6, l'andy). 
Initiation of Desmin Filament Formation in 
MCF-7 Cells 
To study the initiation site of intact desmin subunits in the 
absence of vimentin filaments, MCF-7 cells were transfected 
with pRSVDes. At subsequent time intervals after transfec-
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ñgure 4. Single-label indirect immunofluorescence assay of HeLa cells transfected with (a) pRSVDes, φ) ΝΔ10, (с) ΝΔ13, (d) ΝΔ124, 
and incubated with a polyclonal antibody against desmin (poly-des). Staining patterns identical to those observed in MCF-7 cells are present 
in HeLa cells expressing high levels of mutant desmin. Bars, 10 μπι. 
tion (7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 18, 24, 48, 72, and 
173 h) cells were analyzed by the indirect immunofluores­
cence assay with the polyclonal desmin antiserum. In con­
trast to previous "testtube" observations (29), desmin fila­
ment formation in MCF-7 cells did not start at the nuclear 
envelope. Desmin filament formation appeared to initiate in 
the cytoplasmic area. Some transfected cells displayed a dot­
ted staining pattern at the beginning of the time course (Fig. 
7 a). The dots developed into short tiny desmin filaments 
randomly situated throughout the cytoplasm (Fig. 7, b and 
c). These rodlike structures then elongated and formed an 
extensive IF structure (Fig. 7 rf). To study this phenomenon 
in more detail, MCF-7 cells were stably transfected with 
pRSVDes and lines expressing low levels of desmin were 
selected. Double labeling immunofluorescence with keratin 
and desmin antibodies suggested that the scarce desmin fila­
ment structures partially colocalized with the endogenous 
keratin filament network (Fig. 8). Therefore, at least in 
MCF-7 cells, desmin filament formation seems to start on 
the endogenous keratin filament network rather than on initi­
ation sites at the nuclear or plasma membrane. In MCF-7 
cells the initial process following transfection was reversed 
late (173 h) after transfection. Intact filaments were reduced 
to tiny, short, rodlike structures spread throughout the 
cytoplasm (Fig. 9, a and c). Remarkably, in some cells the 
rodlike structures appeared to cluster at the cell membrane 
(Fig. 9, a and b). 
Discussion 
A variety of studies has already been devoted to the elucida­
tion of the role of the nonhelical IF end domains in filament 
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Figure 5. Double-label indirect immunofluorescence assay of MCF-7 
cells transfected with (a and b) pRSVDes, (c and d) ΝΔ10, (e and 
ƒ) ΝΔ13, (g and Α) ΝΔ98, and incubated with a polyclonal antibody 
against desmin (poly-des). (a, c, e, and g) and a monoclonal anti-
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formation. For instance amino-terminally deleted keratin 
subunits incorporated into the preexisting keratin network 
without disturbing it (3). On the other hand, previous in vitro 
reassembly studies with desmin subunits missing 67 amino-
terminal residues showed that these subunits, incapable of 
filament formation on their own, could form normal desmin 
filaments when mixed with wild-type desmin subunit (41). 
The mechanism of IF assembly might be different for keratin 
and type ΙΠ IF subunit. However, we do suspect that in the 
in vivo reassociation study with mutant keratin cDNAs, the 
presence of intact endogenous keratin subunits may mask the 
effects of deletions in the nonhelical end domains on filament 
formation. Our vimentin-free expression system eliminates 
this problem. No IF subunits, capable of copolymerization 
with mutant desmin subunits, are present in the MCF-7 cells. 
As the amino-terminal part of the IF subunit seems to be of 
major importance in regulating filament rearrangements (9, 
13, 15, 17-19, 22, 26, 30, 40-42, 47, 55, 69, 74, 75), we 
chose to study the effects of deletions in this domain on fila­
ment formation. All our desmin constructs were expressed 
properly in MCF-7 and HeLa cells after transient transfec-
tion. Since IFs are expressed in a tissue-specific manner, it 
might be possible that control mechanisms for desmin as­
sembly operative in muscle cells are not present in epithelial 
MCF-7 cells. However, considering the impossibility of study­
ing homopolymeric desmin assembly in vimentin-containing 
muscle cells together with the feet that normal desmin fila­
ments were formed when the nonmodified gene (pRSVDes) 
was expressed in MCF-7 and HeLa cells, we believe that our 
study contributes to the understanding of type ΠΙ IF assem­
bly in vivo. 
The Amino-Terminal Domain of Desmin 
Is Indispensable for Filament Formation 
In Vivo 
In both vimentin and desmin a highly conserved nonapeptide 
SSYRRXFGG (X being isoleucine or methionine in vimen-
tin, and threonine in desmin) is present closely behind the 
initiation methionine (position 1) (36,49,58,60). This nona­
peptide contains a phosphorylation site for protein kinase С 
at position 13 of desmin (42). In construct ΝΔ10 amino acid 
residues 4-13 are removed, including the two serine residues 
at positions 12 and 13, the tyrosine at position 14 is sub­
stituted for aspartic acid. Transfection of this construct in 
MCF-7 cells resulted already in abnormal desmin organiza­
tion. The observed staining pattern suggests that these mu­
tant subunits are still capable of assembling into filaments 
but probably lost the capability to bind to the plasma mem­
brane, presumably via interaction with ankyrin which is sup­
posed to serve as a natural capping factor (27, 28, 31). The 
lack of capping, which probably blocks IF elongation, might 
cause curling of the desmin filaments at their amino-terminal 
ends resulting in the dotted staining pattern. Whether the 
disturbed staining pattern is caused by removal of the phos-
body against keratin (RCKlOó) (b, d,f, and A). Weak immunofluo-
rescent dots visible in d and ƒ are caused by the very strong fluores-
cent desmin dots. Single labeling with mono-ker never showed 
dotted keratin staining patterns similar to those observed for desmin. 
Note intact keratin filaments in all transfected cells. Bars, 10 μπ\. 
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Figure 6. Double-label indirect immunofluorescence assay of HeLa cells transfected with pRSVDes (α-d), ΝΔ10 (e-h), ΝΔ145 (i-l), and 
incubated with a polyclonal antibody against desmin (poly-des) (a, c, e, g, i, and k), an mAb against keratin (RCK102) (b, f, andy) and 
an mAb against vimentin (RV202) (d. A, and /). Note complete colocalization of desmin and vimentin staining Large colocalizing areas 
are also present for desmin and keratin staining in cells transfected with pRSVDes and ΝΔ10. In cells transfected with ΝΔ145, no colocaliza­
tion of desmin and keratin patterns is observed. Bars, 10 μχη 
phorylation site or merely by disturbance of the conserved 
sequence is not yet clear. Removal of amino acids 5-17 
(ΝΔ13) including the residues SSYRRT from the nonapep-
tide causes the loss of filament forming capacity of the mu­
tant subunit. These data indicate that this conserved se­
quence is involved in filament formation in vivo. The 
presence of desmin dots after expression of ΝΔ13 revealed 
that the mutant subunits retain the possibility to interact with 
other cellular components (probably the endogenous keratin 
filaments). Whether the remaining residues of the nonapep-
tide (FGG) are involved in this interaction or other residues 
situated between position 17 and 63 is not yet understood. 
Expression of desmin constructs containing larger deletions 
than ΝΔ13 (ΝΔ60-ΝΔ145, Table I) resulted in desmin 
subunits incapable of forming desmin filaments or dots. The 
diffuse cytoplasmic staining observed, indicates that these 
mutant subunits remained in the soluble phase. 
Intact Vimentin Subunits Capable of 
Copolymetization with Mutant Desmin Subunits 
Mask the Effect of Mutations on IF Formation 
All cells transfected with the mutant desmin constructs, dis-
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Figure 7 Single-label indirect immunofluorescence assay of MCF-7 cells transfected with pRSVDes. and incubated with a polyclonal anti­
body against desmin (poly-des). Cells were fixed (a) 16, φ and c) 48, and (d) 72 h after transfection. Note that initiation of desmin filament 
formation starts in the cytoplasmic area Bars. 10 /im 
Figure 8. Double-label indirect immunofluorescence assay of MCF-7 cells stably transfected with pRSVDes and expressing only low levels 
of desmin. Cells are stained with a polyclonal antibody against desmin (poly-des) (a, c, and e) and a monoclonal antibody against keratin 
(RCK102) (b, d, and/) Note large colocalizing areas of desmin and keratin staining, especially when desmin filaments are scarce. Bars, 
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Figure 9. Single- and double-label indirect immunofluorescence assay of MCF-7 cells transfected with pRSVDes. Cells were fixed and 
stained with a polyclonal antibody against desmin ipoly-des) (a-c) and an mAb against keratin {RCKI06) {d) 173 h after transfection. 
Note short, cytoplasmic filamentous desmin structures which show large areas of colocalization with keratin filaments. Some transfected 
cells showed a clustering of the rodlike desmin structures near the plasma membrane at late times after transfection. Bars, 10 μτη. 
played identical desmin and vimentin staining patterns, 
confirming that desmin and vimentin form heteropolymers 
in transfected HeLa cells (62). In most transfected HeLa 
cells expression of the mutant desmin subunits resulted in 
normal filamentous desmin staining, although for all mutant 
desmin subunits, patterns identical to those observed in 
MCF-7 cells were seen in a number of cells. Most likely, 
only a high ratio of mutant desmin subunits in the des-
min/vimentin heteropolymers resulted in the distorted des­
min (and vimentin) patterns identical to those seen in MCF-7 
cells. This view is sustained by preliminary results obtained 
with stably transfected HeLa cells expressing various 
amounts of mutant desmin. Comparison of the results ob­
tained by the in vivo assembly study with amino terminally 
deleted keratin subunits (3) and our data revealed a number 
of differences. Desmin subunits missing as little as amino 
acid residues 5-17 were, when expressed at high levels in 
HeLa cells, already capable of disrupting the preexisting 
vimentin network. Only deletions in the α-helical domain of 
keratin subunits affected filament morphology. Furthermore, 
expression of desmin subunits missing amino terminal 
residues 4-64 (ΝΔ60) showed the same desmin staining pat­
tern as observed after expression of desmin subunits missing 
their complete amino-terminal domain in addition to coil IB 
(ΝΔ145, Fig. 1 B). These differences might be caused by 
different assembly mechanisms of keratin and type III IF 
subunits. However, we do suspect that the endogenous kera­
tin network present in cells used for transfection of mutant 
keratin cDNAs (3) is largely responsible for the discrepancy. 
Effect of Mutant Desmin on Other IF Networks 
In MCF-7 cells expression of mutant desmin never affected 
endogenous keratin networks. However, in some areas of the 
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cell intact desmin filaments seemed to colocalize with kera­
tin filaments. 
In HeLa cells only expression of ΝΔ10 and ΝΔ13 did affect 
endogenous keratin filaments. Preliminary results with stably 
transfected HeLa cells expressing various levels of mutant 
desmin reveal that keratin IF are only affected at high mutant 
desmin expression, indicating that the desmin region between 
amino acid residues 17 and 64 is necessary for interaction. 
Whether the effect of mutant desmin on keratin filaments is 
mediated by endogenous vimentin, or represents an interac­
tion between desmin and a particular keratin type not present 
in MCF-7 cells, or is caused by an IF associated protein, re­
mains unsolved. In HeLa cells intact desimn/vimentin and 
keratin filaments seemed to colocalize completely. Although 
rather seldom, colocalization of vimentin and keratin fila­
ments has been reported previously (7, 43, 44). 
In MCF-7 Cells the Initiation of Desmin 
Filament Assembly Does Not Take Place at the 
Nuclear Envelope 
Our experiments, as well as preliminary results obtained 
with MCF-7 cells stably transfected with pRSVDes and ex­
pressing only low levels of intact desmin, revealed that des­
min filament assembly in MCF-7 cells does not start at the 
nuclear envelope as suggested previously for vimentin (29, 
74). In contrast, the initiation of desmin filament assembly 
seemed to occur in the cytoplasm. Hence we may conclude 
that in MCF-7 cells no vectorial assembly of desmin fila­
ments takes place. Moreover we noticed that the desmin and 
preexisting keratin networks seemed to colocalize largely 
when desmin filaments were scarce. However, abundant des­
min filaments, showed a different distribution as compared 
to the endogenous keratin networks, although some overlap 
was still observed. 
As vimentin and desmin are closely related (58-61), the 
mechanism of filament assembly was expected to be alike for 
both subumts. However, neither cytoplasmic rodlike struc­
tures as observed in MCF-7 cells, nor a nuclear IF cap as 
described for injected vimentin in BHK-21 cells (76) were 
observed upon desmin expression in HeLa cells. Only a 
gradual increase of desmin fluorescence intensity, which 
colocalized completely with the preexisting vimentin fila­
ments, was seen. This is in agreement with the recent obser­
vation that chicken vimentin does incorporate in preexisting 
mouse vimentin filaments at assembly sites on the vimentin 
network (56). However, no discontinuous localization of des­
min on the preexisting vimentin filaments at early times after 
transfection was observed. Uniform distribution of newly 
formed IF subunits within preexisting filaments has been 
reported for NF-L subunits too (5). 
Conclusions 
When searching for the function of IF domains in in vivo fila­
ment formation by means of transfection studies with modi­
fied genes, it is necessary to avoid cell systems in which in­
tact IF subunits capable of copolymenzation with mutant 
subunits are present. Our in vivo studies are in line with the 
in vitro finding that tetramera containing less than four mutant 
subunits with intact rod domains are still capable of normal 
filament formation (41), thereby masking the effects caused 
by mutant IF subunits. By using vimentin-free MCF-7 cells 
to express the various desmin constructs, we were able to 
localize the amino-terminal region necessary for desmin fila­
ment formation in vivo at amino acid residues 7-17. Most 
likely the conserved nonapeptide SSYRRTFGG present in 
desmin at position 12-20 is involved in desmin filament for­
mation in vivo. In MCF-7 cells desmin filament assembly 
starts in the cytoplasmic area, probably on endogenous kera­
tin filaments. In HeLa cells newly formed desmin filaments 
incorporate uniformly into the preexisting vimentin fila­
ments. In both cell types no initiation at the nuclear mem­
brane was observed. Further studies with stably transfected 
cells hopefully will reveal more details about certain features 
of the mutant IF subumts, such as protein stability, solubility, 
and the interaction with other cellular components. 
We thank Непло van den Hooven for his excellent assistance 
This work was supported by the Netherlands Organization for Scientific 
Research (NWO) through the Foundation for Chemical Research (SON, 
F R Pieper), and by the Netherlands Cancer Foundation (KWF, Κ N Ver-
njp and F Ramaekere) 
Received for publication 29 March 1990 and in revised form 3 July 1990 
References 
1 Aebi, U , M Haner, J Troncosco, R Eichner, and A Engel 1988 Unify­
ing principles in intermediate filament (IF) structure and assembly Pro-
loptosmn (Bert) 145 73-81 
2 Albers, К , and fc Fuchs 1987 The expression of mutant keratin cDNAs 
transfected in simple epithelial and squamous cell carcinoma lines / Ceil 
Biol 105 791-806 
3 Albers, К , and E Fuchs 1989 Expression of mutant keratin cDNAs in 
epithelial cells reveals possible mechanisms for initiation and assembly 
of intermediate filaments / Cell Biol 108 1477-1493 
4 Ando, S , К Tanabe, Y Oondd, С Sato, and M Inagaki 1989 Domain 
and sequence specific phosphorylation of vimcnun induces disassembly 
of the filament structure Biochemistry 28 2974-2979 
5 Angelides. К J , К E Smith, and M Takcda 1989 Assembly and ex­
change of tmermediate filament proteins of neurons Neuroñlaments are 
dynamic structures J Cell Biol 108 1495-1506 
6 Bader, В L . T M Magín, M Haufeld, and W W Franke 1986 Ammo 
acid sequence and gene organization of cytokeratin no 19, an exception-
ally tail-less intermediate filament protein EMBO (Eur Mol Biol Or-
gan ) J 5 1865-1875 
7 Bader, В L . L Jahn, and W W Franke 1988 Low level expression of 
cytokeralms 8, IBand 19 in vascular smooth muscle cells of human um­
bilical cord and m cultured cells denved therefrom, with an analysis of 
the chromosomal locus contaimng the cytokeratin 19 gene Eur J Cell 
Biol 47 300-319 
8 Banks Schlegel, S Ρ , and С С Hams 1983 Tissue-specific expression 
of keratin proteins m human esophageal and epidermal epithelium and 
their cultured keiatmocytes Exp Cell Res 146 271-280 
9 Bloemendal, H , and F R Pieper 1989 Intermediate filaments known 
structure, unknown function Biochim Biophys Acta 1007 245-253 
10 Broers, J L V . D N Carney, M Klem Rot, С Schaan, E В Lane, 
G Ρ Vooys, and F С S Ramaekers 1986 Intermediate filament pro­
teins m classic and venant types of small cell lung carcinoma cell lines 
A biochemical and immunochemical analysis using a panel of monoclonal 
and polyclonal antibodies J Cell Sci 83 37-60 
11 Capetanaki, Y , S Smith, and J Ρ Heath 1989 Overexpression of the 
vimentin gene m transgenic mice inhibits normal lens cell differentiation 
J Cell Biol 109 1653-1664 
12 Capetanaki, Y , S Starnes, and S Smith 1989 Expression of the chicken 
vimentin gene in transgenic mice efficient assembly of the avian protein 
into the cytoskeleton Proc Natl Acad Sci USA 86 4882-4886 
13 Cehs, J Ε , Ρ M Ursen. S J Fey. and A Cells 1983 Phosphorylation 
of keratin and vimentin polypeptides in normal and transformed mitotic 
human epithelial amnion cells behavior of keratin and vimentin filaments 
during mitosis J Cell Biol 97 1429-1434 
14 Chen, E Y , and Η Ρ Seeburg 1985 Supercoil sequencing a fast and 
simple method for sequencing plasmid DNA DNA (NY) 4 165-170 
15 Chou, Y H ,E Rosevear, and R D Goldman 1989 Phosphorylation and 
disassembly of intermediate filaments in mitotic cells Proc Natl Acad 
Sa USA 86 1885-1889 
16 Domenjoud, L , J L Jorcano, В Breuer, and A Alonso 1988 Synthesis 
and fate of keratin 8 and 18 in nonepithchal cells transfected with cDNA 
Ejp Cell Res. 179 352-361 
Raats et al. Mutata Desmin Assembly 119 
17 Evans, R M 1988 The intermediate-filament proteins vimeniin and des-
mio arc phosphorylated in specific domains Eur J Cell Bud 46 
152-160 
18 Evans, R M 1988 Cyclic AMP-depcndent protein kinase-induced vimen-
tm filament disassembly involves modification of the N terminal domain 
of intermediate filament subumts hEBS (Fed Eur Btochem Soc ) Lett 
234 73-78 
19 Evans, R M 1989 Phosphorylation of vimeniin in nulotically selected 
cells In vitro cyclic AMP independent kinase and calcium stimulated 
phosphatase activities J Ceil Biol 108 67-76 
20 Franke, W W , E Schmid, S Mmnacht, С Grund, and І L Jorcano 
1984 Integration of different keratins into the same filament system after 
microinjection of m RNA for epidermal keratins into kidney epilhehal 
cells Cell 36 813-825 
21 Franke, W W 1987 Nuclear lamins and cytoplasmic intermedíate fila-
ment proteins a growing muttigene family Celt 48 3-4 
22 Fraser, R , Ρ M Steinen, and А С Steven 1987 Focus on intermediate 
filaments Trends Bwchem Set 2 43-45 
23 Geisler, N , and К Weber 1982 The amino acid sequence of chicken mus­
cle desmm provides a common structural model for intermediate filament 
proteins EMBO (Eur Mol Biol Organ ) J 1 1649-1656 
24 Geisler, N . and К Weber 1986 Structural aspects of intermediate fila­
ments In Cellular and Molecular Biology of the Cytoskeleton G Shay, 
editor Plenum Publishing Corp , New York 41-64 
25 Geisler, N , and К Weber 1988 Phosphorylation of desmm in vitro in­
hibits formation of intermedíate filaments, identification of three kinase 
A sites m the amino terminal head domain EMBO (Eur Mol Biol Or 
gan)Jl 15-20 
26 Geisler, Ν , M Hatzfeld, and К Weber 1989 Phosphorylation m vitro 
of vunentin by protein kinase A and С is restricted to the head domain 
Eur J Btochem 183 441-447 
27 Georgatos, S D , and V Τ Marchesi 1985 The binding of vimentm to 
human erythrocyte membranes a model system for the study of inter 
mediate filament membrane interactions J Cell Biol 100 1955-1961 
28 Georgatos, S D . D С Weaver, and VT Marchesi 1985 Site specificity 
in vunentin membrane interactions intermediate filament subumts as­
sociate with the plasma membrane via their head domains J Cell Biol 
100 1962-1967 
29 Georgatos, S D , and G Blobel 1987 Two distinct attachment sites for 
vimentm along the plasma membrane and the nuclear envelope in avian 
erythrocytes a basis for vectorial assembly of intermediate filaments J 
Cell Biol 105 105-115 
30 Georgatos, S D.andG Blobel 1987 Lamm В constitutes an intermediate 
filament attachment site at the nuclear envelope J Cell Biol 105 117 125 
31 Georgatos, S D . K Weber, N Geisler, and G Blobel 1987 Birdingof 
two desmin derivatives to the plasma membrane and the nuclear envelope 
of avian erythrocytes evidence for a conserved site-specificity in inter­
mediate filament-membrane interactions Proc Nail Acad Sci USA 
84 6780-6784 
32 Giudice, G J , and E Fuchs 1987 The transfection of epidermal keratin 
genes into fibroblasts and simple epithelial cells Evidence for inducing 
a type I keratin by a type II gene Cell 48 453-463 
33 Glass, С , and E Fuchs 1988 Isolation, sequence and differential expres­
sion of a human K7 gene in simple epithelial cells J Cell Biol 
107 1337-1350 
34 Солгал, С M , G Τ Merlino, Μ С W WiUingham, I Pastan, and Β H 
Howard 1982 The Rous sarcoma virus long terminal repeat is a strong 
promoter when introduced into a variety of eukaryotic cells by DNA 
mediated transfection Proc Natl Acad Sci USA 79 6777-6781 
35 Hatton, M and Y Sakalu 1986 Dideoiy sequencing method using dena­
tured plasmid templates Anal Btochem 152 232-238 
36 Herrmann, Η , В Fouquet, andW W Franke 1989 Expression of inter­
mediate filament proteins during development of Xenopus laevu Π 
Identification and molecular characterization of desmin Development 
105 299-307 
37 Heuvel, van den, R Μ Μ , G J M M van Eys, F С S Ramaekers, 
W J Quax, W Τ M Vree Egberts, G Schaart, H T M Cuypers, 
and H Bloemendal 1987 Intermediate filament formation after transfec­
tion with modified hamster vunentin and desmin genes J Cell Sci 
88 475^*82 
38 Heuijerjans, J H , F R Pieper, F С S Ramaekers, L J M Timmer­
mans, H Kuypcrs. H Bloemendal, and W J van Venrooy 1989 As­
sociation of mRNA and elF 2a with the cytoskeleton in cells lacking 
vimentm Exp Cell Res 181317-330 
39 Inagaki, Μ , Y Nishi, К Nishizawa, M Matsuyama, and С Sato 1987 
Site specific phosphorylation induces disassembly of vimenun filaments 
Nature (Land ) 328 649-652 
40 Inagaki, M , Y Gonda, M Matsuyama, К Nishizawa, Y Nishi, and С 
Sato 1988 Intermediate filament reconstitution in vitro J Btot Oiem 
263 5970-5978 
41 Kaufmann, Ε , К Weber, and N Geisler 1985 Intermediate filament 
forming ability of desmin derivatives lacking either the armno-temunal 
67 or the carboiy terminal 27 residues J Mol Biol 185 733-742 
42 Kitamura, S , S Ando, M Shibata, К Tanabe, С Sato, and M Inagaki 
1989 Protein kinase-C phosphorylation of desmin at four serine residues 
within the non-a-hchcal head domain J Biol Chem 264 5674-5678 
43 Kiymkowiky.M W 1982 Vimenun and keratin intermediate filament sys­
tems m cultured PtKj epithelial cells are interrelated EMBO (Eur Mol 
Biol Organ) J 1 161-165 
44 Knapp, L W , and С L Bunn 1987 The experimenta] manipulation of 
keratin expression and organization in epithelial cells and somatic cell 
hybrids Curr Top Dev Biol 22 69-% 
45 Knmpenfon, Ρ J , G Schaart, F R Pieper, F С Ramaekere, Η Τ 
Cuypers, R Μ van den Heuvel, W Τ Vree Egberts, G J van Eys, 
A Berns, and H Bloemendal 1988 Tissue-specific expression of a 
vimentin-desmin hybrid gene m transgenic mice EMBO (Eur Moi Biol 
Organ) J 7 941-947 
46 Kulesh, D A , G Cecena, Y M Darmon, M Vasseur.andR G Oshima 
1989 Posttranslational regulation of keratins Degradation of mouse and 
human keratins 18 and 8 Mol Cell Biol 9 1553-1565 
47 Lamb, N J С , A Fernandez, J R Feramisco, and W J Welch 1989 
Modulation of vimentin containing intermediate filament distribution and 
phosphorylation in living fibroblasts by cAMP-dependent protein kinase 
J Cell Biol 108 2409-2422 
48 Lendahl, U , L В Zimmerman, and R D G McKay 1990 CNS stem 
cells express a new class of intermediate filament protein Cell 60 
585-595 
49 Li, Ζ . A Lilienbaum, G Butler Browne, and D Paulin 1969 Human 
desmin-coding gene complete nucleotide sequence, characterization and 
regulation of expression during myogenesis and development Gene 
(Amst ) 78 243-254 
50 Lippman, Μ , G Bolán, and К Huff 1976 The effects of estrogens and 
anti-estrogens on hormone responsive human breast cancer in long-term 
tissue culture Cancer Res 36 4595-4601 
51 Loewinger, L , and F McKcon 1988 Mutations in the nuclear lamín pro-
teins resulting m their aberrant assembly in the cytoplasm EMBO (Eur 
Mol Biol Organ ) J 7 2301-2309 
52 Mamatis. Τ Ε , E F Fntsch, and J Sambrook Molecular Cloning A 
Laboratory Manual Cold Spnng Harbor Laboratory, Cold Spring Har­
bor, NY 545 pp 
53 Moll, R.W W Franke, D L Schiller, В Geiger, and R Krepier 1982 
The catalog of human cytokeratins patterns of expression in normal 
epithelia, tumors and cultured cells Cell 31 11-14 
54 Monteiro, M J ,andD W Cleveland 1989 Expression of NF Land NF M 
in fibroblasts reveals coassembly of neurofilament and vunentin subumts 
J Cell Biol 108 579-593 
55 Nelson, W J, and Ρ Traub 1983 Proteolysis of vimentm and desmin by 
the Ca14-activated proteinase specific for these intermediate filament 
proteins Mol Cell Biol 3 1146-1156 
56 Ngai, J , Τ R Coleman, and E Lazandcs 1990 Localization of newly 
synthesized vunentin subumts reveals a novel mechanism of intermediate 
filament assembly Cell 60 415-427 
57 Pieper, F R , G Schaart, Ρ J Knmpenfort, } В Menden к, H J 
Moshage, A van de Kemp, F С S Ramaekers, A Berns, and H Bloe­
mendal Transgenic expression of the muscle specific intermediate fila­
ment protein desmin in nonmuscle cells J Cell Biol 108 1009-1024 
58 Quax, W , W Vree Egberts, W Hendnks, Y Quax-Jeuken, and H Bloe­
mendal 1983 The structure of the vunentin gene Cell 35 215-223 
59 Quax. W , R van den Heuvel. W Vree Egberts, Y Quax Jeuken, and H 
Bloemendal 1984 Intermediate filament cDNAs nom BHK 21 cells 
Demonstration of distinct genes for desmin and vimenun in all vertebrate 
classes Proc Natl Acad Set USA 81 5970-5974 
60 Quax, W , L van den Broek, W Vree Egberts, F Ramaekers, and H 
Bloemendal 1985 Characterization of the hamster desmin gene Expres­
sion and formation of desmin filaments in nonmuscle cells after gene 
transfer Cell 43 327-338 
61 Quax Jeuken, Υ , W Quax, and H Bloemendal 1983 Primary and sec­
ondary structure of hamster vimentm predicted from the nucleotide se­
quence Proc Natl Acad Set USA 80 3548-3552 
62 Quinlan, R A , and W W Franke 1982 Heteropolymer filaments of 
vimentin and desmin in vascular smooth muscle tissue and cultured baby 
hamster kidney cells demonstrated by chemical cross-linking Proc Natl 
Acad Set USA 79 3452-3456 
63 Ramaekers F С S , Α Huysmans, O Moesker, A Kant, Р Н К Jap, 
С J Herman, and G Ρ Vooijs 1963 Monoclonal antibody to keratin 
filaments, specific for glandular epithelia and their tumors Use in surgi­
cal pathology Lab invest 49 353-361 
64 Ramaekers, F С S , J J G Puts. О Moesker, A Kant, A Huysmans, 
D Haag, Ρ H К Jap, С 3 Herman, and G Ρ Vooys 1983 Antibodies 
to intermediate filament proteins in the immunohistochemical identifica­
tion of human tumors an overview Htstochem J 15 691-713 
65 Ramaekere, F С S , R Η M Verheyen, О Moesker, A Kant, G Ρ 
Vooys and С J Herman 1983 Mesodermal mixed tumor diagnosis by 
analysis of intermediate filament proteins Am J Surg PathoL 7 381-385 
66 Ramaekers. F С S , A Huysmans, G Schaart, О Moesker, and G Ρ 
Vooys 1987 Tissue dismtniuon of keratin 7 as monitored by в monoclo­
nal antibody Exp Cell Res 170 235-249 
67 Sou le, H D , J Vazquez, A Long, S Albert, and M Brennan 1973 A 
human cell line nom a pleural effusion denved from a breast carcinoma 
J Natl Cancer Inst 51 1409-1416 
120 
68 Southern, Ρ J .and Ρ Berg 1982 TiansfomiationofniaininaluD cells to 
antibiotic resistance with bacterial gene under control of the SV40 early 
region promoter J МЫ Appi Genet 1 327-341 
69 Steinen, Ρ M 1988 The dynanuc phosphorylation of the human inter­
mediate filament keratin 1 chain J Biol Chem 263 13333-13339 
70 Steinen, Ρ M , and D R Roop 1988 Molecular and cellular biology of 
inteimediate filaments Лпіш Rev Biodum 57 593-625 
71 Steinen, Ρ M , D A D Рапу, W W Idler, L D Johnson, A С Steven, 
and D R Roop 1985 Amino acid sequences of mouse and human 
epidermal type Π keratins of Mr 67 000 provide a systematic basis for 
the structural and functional diversity of the end domains of kerabn inter­
mediate filament subumts J Biol diem 260 7142-7149 
72 Steinen, Ρ M . А С Steven, and D R Roop 1985 The molecular biol­
ogy of intermedine filaments Cell 42 411-420 
73 Tokuyasu, Κ Τ , Ρ Α Mäher, and S J Singer 1985 Distributions of 
vimentin and desmin in developing chick myotubes in vivo Π Immuno-
electron microscopic study J Cell Biol 100 1157-1166 
74 Traub, Ρ 1985 Inlennediate Filaments A Review Springer Verlag, 
Berlin 
75 Traub, Ρ , and С E Vorpas 1983 Involvement of the N-terminal poly 
peptide of vimentin m the fomution of intermediate filaments J Cell Sa 
63 43-67 
76 Vikstrom, К L , G G Bonsy, and R D Goldman 1989 Dynamic 
aspects of intermediate filament networks m BHK-21 cells Proc Natl 
Acad Sci USA 86 549-553 
77 Weber, К , and N Geisler 1987 Biochemistry and molecular structure of 
intermediate filaments Fomchr ΖοβΙ 34 251-260 
78 Wigler, M , R Sweet, G К Kim. В Weld, A РеІІкег, E Lacy, Τ Mam­
aus, S Silverstein, and R Axel 1979 Transformation of mammalian 
cells with genes ftoni procatyotes and eucaryotes Cell 16 777-785 
laats et al Мшат Desmin Assembly 
121 
122 
CHAPTERS 
DISRUPTION OF VIMENTIN INTERMEDIATE FILAMENTS IN 
TRANSGENIC MICE BY EXPRESSION OF A DOMINANT 
NEGATIVE DESMIN SUBUNIT 
Submitted for publication. 
123 
124 
Disruption of vimentin intermediate filaments in transgenic mice 
by expression of a dominant negative mutant desmin subunit 
Frank R. Pieper1, Jos M. H. Raats, Gert Schaart1", Aimemiete van de Kemp, 
Anton Berns**, Frans С. S. Ramaekers* and Hans Bloemendal. 
Depaitment of Biochemistry, Univeraity of Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. * 
Department of Molecular Cell Biology, University of Limburg, P.O. Box 616, 6200 MD Maastricht, The 
Netherlands. ** Division of Molecular Oenetìcs, Netherlands Cancer Institute, and the Department of 
Biochemistry, University of Amsterdam, Antoni van Leeuwenhoekhuis, Plesmanlaan 121, 1066 CX, 
Amsterdam, The Netherlands. 1: Corresponding author. Present adress: GenePharming Europe B.V., 
Einsteinweg 5,2333 Leiden, The Netherlands. 
Abstract 
To investigate the functions of vimentin intermediate nlaments in the context of 
intact tissues and the developing organism, a construct (pVDV) driven by the 
vimentin promoter and encoding a truncated desmin subunit was introduced 
into the murine germline. The mutant desmin was assembly-incompetent and 
capable of disrupting preexisting vimentin filaments in a dominant negative 
fashion, both in transgenic mouse tissues and in cell lines derived from these 
mice. Mutant desmin expression strongly enhanced vimentin turnover. In 
mouse tissues, high level expression of pVDV occurred in 10-40% of 
vimentin-containing cells and, surprisingly, in 5-20% of the myotubes of 
skeletal muscle and tongue. Immunohistochemical staining of muscle tissue 
showed a diffuse staining pattern instead of the dots and clumps into which 
mutant desmin typically accumulates in other cell types. The overexpression of 
pVDV and the concomitant disruption of the endogenous vimentin filament 
network in a significant percentage of cells did not cause detectable 
developmental or morphological abnormalities. 
Introduction 
The cytoskeleton of eukaryotic cells is a dynamic stucture composed of 
microtubules, microfilaments, and intermediate filaments (IFs). Single IPs are 
10 nm in diameter, have a length of approximately 40 μτη and consist of 
20000-30000 subunits. IFs can comprise up to 85% of total cellular protein (6, 
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13, 18, 24, 25, 37, 38). 
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 proteins are encoded by a large (> 40 genes) multigene family and can be 
divided into six different types on the basis of gene structure and homology (6, 
18, 24, 25, 38). Apart from the lamins, these different types of IF subunits are 
expressed in a developmentally regulated and tissue-specific fashion. This 
highly conserved specificity of expression suggests that each type or 
combination of subunits plays a unique role in cellular differentiation (6,13,18, 
24, 25, 37, 38). Although all IF proteins have a highly conserved secundary 
structure, their physicochemical properties can be quite different. 
While the function of microtubules and microfilaments in cellular processes is 
well understood, the function of IFs has long remained elusive. Cytoplasmic IFs 
clearly do not fulfil a household function, since several cell lines do not contain 
any cytoplasmic IF network. In addition, disrupting IF networks in cultured 
cells does not affect cell morphology, motility or division (review: 18). This has 
led to the assumption that the function of IFs must be manifested at the level of 
the tissue or organ as a whole, possibly in providing mechanical strength, 
cellular organization and architecture (14, 24, 28). In agreement with this 
notion, vimentin IFs display unique viscoelastic properties allowing them to 
resist breakage and become even stronger under stresses that would rupture 
other cytoskeletal networks (16). 
To address the issue of IF function at this level, different approaches can be 
made. These include ectopic- or overexpression of IFs in transgenic mice (1,8, 
9, 12, 17, 19, 23, 27), specific interference with in vivo IF assembly by 
microinjection of IF-specific antibodies (reviewed in 18) or anti-sense RNA 
into zygotes or developing embryos (42), disruption of IF networks in 
transgenic mice or embryonic cells by expression of dominant-negative mutant 
IF subunits (9, 10, 14, 40, 43), and inactivation of IF genes via homologous 
recombination in embryo stem cells (4). 
We (30-32) and others (2, 10, 15, 20, 23, 36, 43, 45) have demonstrated that in 
cultured cells IF networks can be disrupted in a dominant-negative fashion by 
expression of IF gene constructs containing modifications or deletions in the 
carboxy-terminal part of the central α-helical 'rod' domain. Interaction of the 
mutant- and wildtype IF subunits results in disassembly of preexisting IF 
networks and inhibits de novo IF formation. 
Expression of such keratin gene mutants in skin of transgenic mice caused 
disruption of endogenous keratin IF assembly and resulted in a pathological 
condition equivalent to the human skin disease epidermolysis bullosa simplex 
(10,14,43). 
As an approach to studying the in vivo functions of vimentin, we have 
generated an IF gene construct based on the hamster vimentin promoter and a 
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truncated hamster desmin gene and introduced it into the murine germline. We 
have shown previously that in transgenic mice expressing wildtype desmin in 
vimentin containing cells no developmental or morphological abnormalities 
could be detected, except for cataract formation (12,27). 
Vimentin displays a complex expression pattern and is coexpressed with other 
IF subunits during various stages of development When coexpressed with type 
ΠΓ (desmin, glial fibrillary acidic protein and peripherin) or type IV 
(neurofilaments) IF proteins, coassembly of vimentin and the other IF subunits 
takes place (6, 13, 18, 38). Hence, expression of the construct described above 
is also expected to affect IF networks containing other type ΠΙ and IV IF 
subunits. 
We show here that expression of a truncated desmin in transgenic mice results 
in disruption of vimentin IFs in a significant percentage of vimentin containing 
cells without causing detectable developmental or morphological abnormalities. 
Results 
Construction and characterization ofpVDV 
We have demonstrated previously that in transgenic mice expression of the 
muscle-specific IF subunit desmin can be targeted to vimentin expressing cells. 
The transgene (pVDes) consisted of 3.2 kb of hamster vimentin promoter 
region fused to the structural hamster desmin gene (27). In separate studies we 
have shown that modifications of the carboxyterminal part of the desmin rod 
domain can severely affect the filament forming capacity of the desmin subunits 
(31, 32). Moreover, expression of the mutant desmin in vimentin containing 
cells caused complete disruption of the endogenous vimentin filament networks 
(31, 32, 36). 
A truncated version of the pVDes construct was generated by replacing pVDes 
desmin exons 6 to 9 with vimentin exon 9 (fig 1). Desmin exon 6 encodes a 
major part (64 of total 97 amino acids) of coil 2B of the central 'rod' domain, 
exons 7 to 9 encode the desmin carboxyterminal 'tail'. The resulting construct 
pVDV encodes a desmin protein which is truncated at amino acid 340, and 
contains 13 additional amino acids encoded by vimentin exon 9 (fig 1). 
The dominant-negative effects of pVDV expression on desmin and vimentin 
networks were confirmed by transiently transfecting four different cell types: 
hamster lens cells, HeLa cells, BHK-21 cells and undifferentiated C2C12 cells. 
Hamster lens cells express high levels of vimentin but no other cytoplasmic IF 
proteins, HeLa cells express both vimentin and keratins, BHK-21 cells and the 
myogenic cell line C2C12 express vimentin and desmin. For each cell type, 
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Figure 1: Schematic representation of the IF gene constructs pVDV and pVDes, and of the proteins 
encoded by these constructs. 
Constructs: black boxes represent desmin exons; white box: vimentin exon 9 (non-coding); striped 
box: coding region of vimentin exon 9; white bar: vimentin promoter region; L: ligation site; Xba: 
Xbal restriction site. IF proteins: white bar represents nelical 'rod domain; stippled boxes: 
non-helical regions; 1A, IB, 2A and 2B: α-helical regions; black lines: non-helical lead' and 'tall' 
end domains. Numbers refer to amino acid residues. 
expression of pVDV caused complete disruption of endogenous vimentin 
and/or desmin filament networks as determined by single- and double-label 
indirect immunofluorescence assays using antibodies against vunentin and 
desmin (fig 2). The mutant desmin and endogenous vimentin and desmin 
colocalized in fluorescent dots. 
Incubation of pVDV transfected cells with a monoclonal antibody against 
vimentin (mono-vim) resulted in very weak immunofluorescence (fig 2), while 
use of poly-vim yielded normal, intense vimentin staining. This suggests that 
the disruption of vimentin filaments and the concomitant relocation of vimentin 
rendered the epitope recognized by mono-vim less accessible to this antibody. 
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Figure 2: Single- and double-label indirect immunofluorescence assay of HeLa cells and hamster lens 
cells transiently transfected with pVDV. Cells were incubated with poly-des and mono-vim. 
(a-d): double-label staining with poly-des (a, d) and mono-vim (b, c) of pVDV transfected HeLa cells, 
showing punctuate staining pattern, (e, f and i, j): hamster lens cells, staining as for (a-d). Note 
complete disruption of vimentin filaments, absence of intact mutant desmin filaments, and 
colocalization of mutant desmin and vimentin. Vimentin staining of transfected cells was very weak. 
(g and h): poly-des staining of HeLa cells, expressing pVDV at relatively low (punctuate staining) or 
very high levels (cells filled with mutant desmin). Bar: 10 |xm. 
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Shortly (6-8 hours) after transfection very small desmin dots were observed, 
indicative of low level pVDV expression. At this stage complete disruption of 
endogenous vimentin/desmin networks was already observed, illustrating the 
dominant-negative effect of pVDV expression. Keratin filaments in HeLa cells 
remained undisturbed at this stage (not shown). Later after transfection (48 
hours) the majority of cells contained large clumps of mutant desmin, indicative 
of high levels of pVDV expression (fig 2). At this stage, not only endogenous 
vimentin but also the keratin filament network of HeLa cells appeared to be 
affected by this pVDV overexpression (not shown). 
Using stably transfected C2C12 cells it was shown that the mutant desmin is no 
more soluble than intact desmin and remains in the Triton X-100 insoluble 
fraction (Raats, unpublished results). 
Generation of transgenic mice 
After removal of plasmid sequences the pVDV construct was introduced into 
the mouse germ line via pronuclear microinjection. Southern blot analysis of 
tail DNA of mice bom from microinjected zygotes showed that 9 of 61 mice 
had incorporated copies of the construct into their genome. All transgenic mice 
produced offspring, 7 mice transmitted the transgene to their progeny (yielding 
strains 5, 7, 9, 33, 47, 50, and 55). Southern blot analysis revealed no 
rearrangements in the pVDV transgenes (not shown). Copy numbers varied 
from 2 to ~ 50. 
All transgenic mice appeared healthy. No attempt was made to detect cataract 
formation. 
pVDV expression in cultured fibroblasts: expression levels, stability of pVDV 
encoded protein and disruption of endogenous vimentin filaments 
Fibroblast cell lines were derived from 6 founder mice (no. 5, 7, 33, 50, 55 and 
58) by immortalization of ear-shell fibroblasts with SV40 virus. Northern- and 
Western blotting showed that pVDV was expressed in all but one (derived from 
mouse 58) cell lines. Southern blot analysis revealed that cell line 58 did not 
contain the transgene. Mouse 58 also did not transmit the transgene, indicating 
that it was mosaic for the transgene. 
Expression levels as estimated by Western blotting varied widely between cell 
lines (illustrated in fig 3), and to a lesser extend also per cell line between 
experiments. Generally, pVDV protein levels ranged from low (lines 5, 7, 33; 
0.1-1% of BHK-21 desmin levels) to relatively high (line 50: 5-10% of BHK-21 
desmin; line 55; 20-30%). 
Northern blot analysis using a probe (E49) which recognizes both endogenous 
vimentin and pVDV transcripts confirmed that lines 50 and 55 expressed the 
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highest levels of pVDV, but also revealed that pVDV transcript levels were in 
the same range as endogenous vimentin levels (fig 3). In fibroblast cell lines 
derived from pVDes transgenic mice, which express intact desmin, transcript 
levels similar to those of pVDV lines 50 and 55 resulted in much higher 
expression of transgene encoded protein (27). Taken together, these data 
suggest that the turnover of the pVDV encoded truncated desmin protein takes 
place at a higher pace than intact desmin turnover. 
vim 
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Figure 3: Expression of pVDV in ear-fibroblast cell lines derived from transgenic founder mice 5, 7, 
33,50,55 and 58, and a non-transgenic mouse (lane C). 
(a) Northern blot analysis of 1 to 5 μg of total RNA. The blot was hybridized to vimentin probe E49 
which recognizes both endogenous vimentin- and pVDV transcripts, (b) Western blot analysis of 
cytoskeletal fractions of fibroblast cell lines. Cell extract from the desmin expressing cell line 
BHK-21 is included as a marker. Samples from 2 independently isolated fibroblast cell lines were 
analyzed for each strain. Desmin (des) size: 53 kD. Mutant desmin (Mes, size 40 kD) was detected in 
the expected position. 
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To detennine the stability of the pVDV encoded protein and the effects of 
pVDV expression on endogenous vimentin turnover, the fibroblast cell line 55 
and a control fibroblast cell line derived from a non-transgenic mouse were 
subjected to pulse-chase labeling with [35S]-methionine, and total cell extracts 
were analyzed by immunoprecipitation with polyclonal desmin (poly-des) and 
vimentin (poly-vim) antibodies (figure 4). Measured over a 93 hour period, 
labeled endogenous vimentin levels of the control cell line decreased 1.6-fold. 
A similar turnover rate has been reported for intact desmin in vimentin 
expressing cells (32). In contrast, pVDV mutant desmin levels of fibroblast cell 
line 55 decreased 12-fold in the same period (figure 4b). Moreover, this cell line 
also exhibited a strong decrease in vimentin stability: a 12-fold reduction was 
observed (figure 4a). This indicates that pVDV expression increased 
endogenous vimentin turnover 7.5-fold. 
Fibroblast vimentin transcript levels were not influenced by pVDV expression 
(figure 4c). Similarly, vimentin and desmin transcript levels remained 
unchanged in C2C12 cells expressing the mutant desmin (figure 4c). 
Indirect immunofluorescence assays on the various fibroblast cell lines using 
poly-des, poly-vim, and mono-vim antibodies revealed that pVDV expression 
resulted in disruption of endogenous vimentin filament networks, even in lines 
5 and 7, which express the mutant desmin at relatively low levels (figure 5). 
However, cells in which the vimentin filaments had not been completely 
disrupted in spite of detectable levels of pVDV expression were also observed 
in each cell line, suggesting that pVDV expression levels varied between 
individual cells. Cell lines 50 and 55, which express relatively high levels of 
mutant desmin, contained only a small number of cells (1-10%) with 
undisrupted vimentin filaments. 
Cells containing strongly fluorescent, large clumps of mutant desmin, typically 
observed in transiently transfected cells, were not observed. Instead, relatively 
small fluorescent dots were detected in the fibroblast cells. This suggests that 
pVDV expression per cell is lower in the fibroblast cell lines than in the 
transfected cells. 
We conclude that the mutant desmin encoded by the pVDV transgene is 
capable of interacting with mouse vimentin and thereby disrupts the vimentin IF 
network. As a result, the vimentin turnover rate is greatly increased. This is not 
compensated for by increased vimentin transcription. 
Expression ofpVDV in mouse tissues 
The expression of the pVDV encoded protein was first analyzed by indirect 
immunofluorescence analysis on tail sections and blood cells from all founder 
mice and their offspring, using poly-des. Strongly fluorescent dots and clumps 
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Figure 4: Panels a and b: Stability of the pVDV encoded protein and of endogenous vimentin in 
fibroblast cell line 55 (lanes F55) and in control fibroblasts (lanes C), determined via pulse-chase 
labeling. Lysates of pulse-labeled cells were immunoprecipitated with poly-des (panel a) or poly-vim 
(panel b). Lysates contained equal amounts of protein for each time point. Time intervals are 
indicated above the lanes in hours. Shown are fluorographic exposures of SDS-gels. Positions of 
vimentin (vim, 55 kD), desmin (des, 53 Ш), mutant desmin (Ades, 40 kD), and a coprecipitating 
unidentified protein (•) are indicated. BHK-21 cell lysate, containing both desmin and vimentin, was 
included as a control. Note coprecipitation of vimentin and mutant desmin. Decrease of labeled 
mutant desmin in 93 hours was 12-fold (determined by scanning film in panel a), vimentm decrease 
in pVDV expressing cells also was 12-fold (panel b). In control fibroblasts, vimentm decrease was 
only 1.6 fold (panel b). 
Panel c: Effect of mutant desmin expression on endogenous vimentin transcript levels. Total RNA 
(10 μg/lane) from control fibroblast cell line 44, pVDV fibroblast line 55, stably transfected C2C12 
cells and untransfected C2C12 cells was analyzed by Northern blotting. The blot was subsequently 
hybridized to a desmin-, vimentin-, and actin probe and was stripped between hybridizations. 
BHK-21 RNA was included as a control. 
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Figure 5: Single- and double-label immunofluorescence assay of pVDV expressing fibroblast cell 
lines incubated with poly-des, mono-vim, or poly-vim. 
(a): poly-des staining, cell line 55. Note punctuate staining of mutant desmin in most cells (b) and (c): 
double-label staining with poly-des (b) and mono-vim (c), cell line 33. Note colocalization of desmin 
and vimentin staining and absence of intact vimentin filaments, (d): poly-vim staining, cell line 50. 
Note absence of vimentin filaments, (e): as (d), cell line 7. (f): poly-des staining, cell line 50. (g): 
poly-des staining, cell line 7. Bars: 10 μπα. 
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Legend: see page 136. 
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were detected in stromal cells in tail sections of strains 47, 50 and 55 (figure 6), 
whereas in strains 5, 7, 9, and 57 a weakly fluorescent, punctuate staining 
pattern was observed (not shown). Strain 33 displayed an intermediate staining 
pattern with regard to dot size and fluorescence intensity. No pVDV expression 
was detected in mosaic mouse 58. Expression levels in fibroblast cell lines and 
mouse tissues appeared to correlate. There was no relationship between 
transgene copy number and expression levels (data not shown). 
Surprisingly, pVDV expression could not be detected in all vimentin expressing 
cells of strains 47, 50 and 55. Only 10-40% of the stromal cells were stained 
with poly-des (figure 6, a-c). For strain 33 this was 1-5%. The percentage of 
cells containing detectable levels of mutant desmin varied between litter mates 
and even between tissue sections from the same individual mouse taken from 
different parts of the tail or at different time points. Although the much lower 
expression levels of strains 5, 7, 9 and 57 made it difficult to determine the 
percentage of expressing cells for these mice, it was clear that not all stromal 
cells expressed pVDV at detectable levels. 
Staining of tail sections from strains 47, 50 and 55 with a monoclonal and 
several polyclonal antibodies against vimentin revealed that endogenous mouse 
vimentin filament networks were severely affected by pVDV expression (figure 
6, d-f). 
Immunostaining of blood cells using poly-des confirmed the findings described 
above. Intensive staining of mutant desmin dots and clumps was observed in 
blood cells from strains 47, 50 and 55 (figure 6, g and h). All other strains 
displayed much weaker staining (not shown). 
Immunofluorescent staining of strain 47, 50 and 55 blood cells with poly-vim 
revealed that expression of the truncated desmin caused disruption of the 
Figure 6: Indirect immunofluorescence assays of tail sections (a-f) and blood cells (g-j) from mice 
transgenic for pVDV, using poly-des and poly-vim. 
(a-c): poly-des incubation of tail tissue sections from mouse strains 47 (a), 55 (b) and 50 (c). Note 
strongly fluorescent dots and clumps (not observed in control tissues) in stromal cells, (d-f): 
poly-vim incubation of tail sections from mouse strains 47 (d and e), and 55 (f)- Vimentin expression 
was detected in virtually all stromal cells (d), while pVDV expression was detected in a minority of 
stromal cells (compare a-c to d). Identification of stromal cells containing completely disrupted 
vimentin filaments using poly-vim was hampered by the presence of many cells containing intact 
filaments. However, in areas less densely packed with stromal cells complete vimentin filament 
disruption could be observed (e and 0- (g and h): poly-des incubation of blood smears from strains 
47 (g) and 55 (h). Note strongly fluorescent dots and clumps (not observed in control blood cells) in a 
small percentage of blood cells, (i-j): poly-vim incubation of blood smears from strains 47 and 55. 
Note complete disruption of vimentin filaments in i (strain 47; lower panel) and j (strain 55). Partial 
disruption was also observed (i, upper panel; strain 47). Bars: 4 μιη. 
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vimentin filaments in these cells (figure 6, i and j). 
The overexpression of pVDV and the concomitant disruption of the endogenous 
vimentin filament network in a significant percentage of stromal- and blood 
cells did not seem to cause detectable developmental, morphological or 
physiological abnormalities. 
Tissue-specificity and levels ofpVDV expression 
Since mouse strains 47, 50 and 55 exhibited the highest pVDV expression 
levels, they were used for a more detailed analysis of the tissue-specificity and 
levels of transgene expression (figure 7). 
Mouse tissues were split in two halves. One part was used for RNA analysis, 
the other part was sectioned and used for immunostaining. 
Total RNA samples from various tissues including heart, skeletal muscle, 
spleen, liver, testis or ovary, liver, and kidney were analyzed by Northern 
blotting (figure 7). The 3 independent strains displayed similar expression 
patterns of the correctly sized (1.7 kb) pVDV transcript. High levels of pVDV 
expression, in the same range as endogenous desmin, were detected in skeletal 
muscle and tongue tissue. In contrast, heart pVDV transcript levels were at the 
threshold of detection. Some pVDV expression was detected in oesophagus and 
testis, probably representing expression in smooth muscle and/or stromal cells. 
Clearly, pVDV expression did not follow the endogenous vimentin expression 
pattern. Skeletal muscle tissue expresses only very low levels of vimentin, 
while in heart tissue much more vimentin is present (figure 7b). 
Western blotting using poly-des confirmed these observations. Correctly sized 
(40 kD) pVDV encoded protein was detected in skeletal muscle and tongue 
(figure 8) and, at the threshold of detection, in eye lens (not shown). 
Sections from the same tissues used in Northern blot analysis were 
immunostained with poly-des and poly-vim. Significant expression was 
detected in skeletal muscle and tongue only (figure 9). In both tissues, most 
muscle fibers appeared not to express detectable levels of pVDV encoded 
protein. Expression of mutant desmin was observed in 5-20% of the fibers. 
Surprisingly, fluorescent dots or clumps were not detected. Instead, the staining 
pattern was diffuse and much more intense than endogenous desmin staining, 
suggestive of high levels of mutant desmin expression (figure 9). 
Non-transgenic mice and mice transgenic for pVDes (27) did not display this 
staining pattern (not shown). 
The diffusely staining desmin must for a major part represent the mutant 
desmin and not endogenous mouse desmin, since staining with polyclonal 
antibodies against vimentin, which in pVDV transfected cells and Western 
blotting had been shown to detect the pVDV encoded protein but do not react 
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Figure 7: Northern blot analysis of 5-20 μg of total RNA from pVDV mouse strains 47, 50 and 55 from heart, skeletal muscle, spleen (panel a), Uver, 
testis (lanes 1 and 4) and ovary (lanes c, 2 and 3; panel b); and from strain 55 only: brain, tongue and oesophagus (panel b). 
Blots were subsequently hybridized to a desmin-, a vimentin and an actin probe. The actin probe recognizes both a- (1.8 kb) and β/γ-actin transcripts 
(2.1 kb). Between hybridizations, the blots were stripped. Total RNA (1-2 μg) from desmin and vimentin expressing BHK-21 cells and from pVDV 
expressing fibroblast cell line 55 were included as controls. Lanes c: RNA from a non-transgenic mouse; lanes 1: founder mouse 55 (fO); lanes 2: 
strain 55 fl; lanes 3: strain 47 fl; lanes 4: strain 50 fl. Note high levels of pVDV expression in skeletal muscle and tongue. 
Figure 8: Western blot analysis of cytoskeletal fractions of tissues derived from a strain 47 mouse 
(f2). The blot was incubated with poly-des and poly-vim, subsequently. Positions of desmin (des; 53 
Ш) and the pVDV encoded protein (Ades; 40 kD) are indicated. Mutant desmin expression was 
detected in muscle and tongue tissue. Lens also contained correctly sized mutant desmin (not shown). 
with mouse desmin, resulted in the same diffuse, strongly fluorescent staining 
pattern as staining with poly-des (not shown). 
The striated pattern normally observed upon desmin staining of muscle fibers 
seemed to be present not only in fibers lacking pVDV expression, but also in 
pVDV expressing muscle fibers. This would indicate that location and 
structure and therefore the function of the endogenous desmin are not disturbed 
by pVDV overexpression. Morphological abnormalities were not observed in 
pVDV expressing tissues. 
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Figure 9: Indirect immunofluorescence assays of skeletal muscle (a and b) and tongue tissue sections 
(c and d) from pVDV transgenic mice 47 (a and c) and 50 (b and d), using poly-des. Note strongly 
fluorescent, diffuse staining pattern (not observed in non-transgenic or pVDes transgenic mice) in a 
minority of muscle fibers. The striated pattern normally observed upon desmin staining also seemed 
to be present in the strongly fluorescent muscle fibers (not shown). Stongly fluorescent mutant 
desmin dots or clumps were not observed. Bar: 4 μνα. 
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Discussion 
Disruption of mouse vimentin filaments 
As an approach to studying in vivo functions of vimentin, a construct (pVDV) 
encoding a truncated desmin protein was generated and introduced into the 
murine germline. Using cell lines derived from mice transgenic for pVDV, it 
was shown that relatively low levels of mutant desmin expression are sufficient 
for disruption of endogenous vimentin filaments. This is in agreement with 
previous studies, describing dominant-negative effects of similarly truncated IF 
subunits on endogenous IF filaments at levels of 1% of wild-type subunits (e.g. 
10,15,45). 
The stability of the pVDV encoded mutant desmin appeared to be much lower 
than that of wild-type desmin and vimentin. Expression of pVDV caused a 
strongly increased (7.5-fold) turnover of endogenous vimentin, not 
compensated for by increased vimentin transcription. 
In contrast, we previously demonstrated that different desmin mutants deleted 
in the C-terminal part of the central 'rod' domain capable of completely 
disrupting vimentin filaments, are protected from rapid turnover via interaction 
with wild-type vimentin (32). However, the pVDV encoded protein differs from 
the mutant desmin tested previously in two aspects. Most importantly, a larger 
part of coil 2B in the 'rod' domain has been deleted from pVDV (64 instead of 
39 amino acids). In addition, the pVDV C-terminal 'tail' consists of 13 amino 
acid residues derived from vimentin, instead of 23 amino acids derived from the 
C-terminus of desmin. 
We conclude that pVDV expression caused disruption of vimentin filaments 
and enhanced turnover of vimentin subunits. 
The different strains of mice transgenic for pVDV displayed varying expression 
levels. At least 3 independent strains expressed pVDV at relatively high levels 
as determined by Northern blot analysis and indirect immunofluorescence. In 
these strains, mutant desmin was detected in 10-40% of vimentin-containing 
stromal cells. Expression levels differed between individual cells, but were 
relatively high as judged from the size of the mutant desmin dots and clumps 
observed in the cytoplasm. As expected, endogenous vimentin filament 
networks were seriously affected by pVDV expression. However, this did not 
result in detectable developmental, physiological or morphological 
abnormalities. 
Regulation ofpVDV expression 
It remains to be elucidated why pVDV was expressed in a subset of 
vimentin-containing cells only. We have shown previously that in transgenic 
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mice a vimentin-desmin hybrid gene (pWiin2; 19) and a complete desmin 
gene (pVDes; 27), both under control of the vimentin promoter, were expressed 
in virtually all vimentin-producing cells. The pVDes expression pattern was 
slightly more restricted than that of endogenous vimentin and pWim2 (no 
pVDes expression in testis Sertoli and Leydig cells; expression in a subset of 
vimentin positive cells in some tissues; 12, 27), and pVDes expression levels 
were lower. The expression pattern of pVDV in turn appears to be more 
restricted than that of pVDes. In both cases, regulatory elements present in one 
construct may be missing from the other. In order to allow a comparison, these 
constructs are depicted in figure 10. 
Vimentin 
•IHKHHl· 
Desmin 
UH-+ —^f 
pWim2 
€HHl· H—h 
pVDes 
m-* +—f 
pVDV 
•ш-ю-
1 kb 
Figure 10: Schematic representation of the hamster vimentin and desmin genes and of the constructs 
derived from these genes which have been introduced into (he murine germline. 
White bar: vimentin gene 5' flanking region; black line: introns; white boxes: vimentin gene exons; 
black bar: desmin gene 5' flanking region; black boxes: desmin gene exons; L: ligation site. 
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Vimentin is not expressed in mature myotubes (18, 21, 26, 41). The expression 
of pVDV in myotubes (discussed below) might be caused be the lack of 
negative control elements from the vimentin gene suppressing expression in 
myotubes. However, we (26) and others (21) have shown previously that the 
vimentin promoter is sufficient for downregulation of vimentin expression 
during myogenesis. Alternatively, positive control elements stimulating 
muscle-specific expression may be present in the desmin gene derived part of 
pVDV. This would imply that regulatory elements located in different parts of 
the desmin gene are involved in in vivo desmin expression, since we (26) and 
others (22) have shown that the 5' flanking region of the desmin gene contains 
sequences capable of driving high level, muscle-specific expression in cultured 
myogenic cells. 
Expression ofpVDV in muscle fibers 
The pVDV enoded mutant desmin also appeared to be expressed in skeletal 
muscle and tongue. Surprisingly, instead of immunofluorescent dots and clumps 
a diffuse, intense staining pattern was observed. RNA analysis confirmed that 
pVDV was expressed at high levels in muscle tissue. pVDV transcript levels 
were equivalent to endogenous desmin transcript levels, while only 5-20% of 
the muscle fibers contained detectable amounts of mutant desmin, indicating 
that individual fibers overexpressed pVDV 5- to 20-fold. This did not seem to 
compromise the health of the transgenic animals. 
During myogenesis, the longitudinally oriented EFs undergo 
phosphorylation-mediated disassembly and are redeployed to a transverse 
association along the ΓΖ-Ι bands (41). While intact desmin filaments may be 
dispensible for in vitro myogenesis (36), it has been shown that in vitro 
myoblast fusion is inhibited when this disassembly of longitudinal desmin 
filaments is blocked by injecting desmin phosphorylation site-specific 
antibodies (39). The diffuse staining pattern observed by us may indicate that 
the mutant desmin is not capable of interacting with endogenous desmin, 
thereby leaving location and relocation, structure and function of endogenous 
desmin and therefore the process of myogenesis undisturbed. Conformation of 
this notion requires electron microscopic analysis of the pVDV expressing 
muscle fibers. 
The diffuse staining pattern observed in this study is in contrast to a previous 
report (36), describing formation of mutant desmin dots upon expression of a 
truncated desmin in muscle fibers of the myogenic cell line C2C12. The reason 
for this difference is currently unclear. However, it should be noted that the 
relatively immature muscle fibers formed in vitro are not completely equivalent 
to the muture in vivo muscle fiber. Culturing of muscle cells derived from 
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pVDV expressing mice and subsequent immunofluorescent desmin staining 
might shed more light on this issue. We consider it unlikely that the observed 
difference is caused by the size of the deletion in the desmin 'rod' domain, since 
the construct of Schultheiss et al. (36) contains a larger deletion than pVDV but 
is still capable of interacting with endogenous desmin. 
In vivo functions of vimentin 
It has recently been demonstrated that desmin and vimentin filaments are 
dispensible for in vitro myogenesis (36). Similarly, expression of a truncated 
vimentin did not cause detectable abnormalities during early embryogenesis in 
Xenopus (9). Furthermore, inactivation of both keratin 8 alleles in embryonic 
stem cells did not inhibit differentiation into yolk sac-like embryoid bodies (4). 
However, disruption of keratin filaments in the skin of transgenic mice (10, 14, 
43), in Xenopus oocytes (42) and in F9 embryonal cells (40) by dominant 
negative mutation revealed that keratins can have an important function in 
providing mechanical integrity to cells and/or tissues, demonstrating the 
feasibility of studying IF function by this approach. 
Why do the pVDV expressing mice not display a phenotype? Since pVDV 
expression was targeted to cells expressing vimentin and/or desmin as the only 
IF proteins, the lack of phenotype following vimentin filament disruption 
cannot be explained by functional redundancy. Mutant desmin expression levels 
do not seem to be an issue, since we observed relatively high pVDV expression 
in individual cells and concomitant disruption of vimentin filaments. In 
addition, the Pertubation of endogenous IFs need not be severe to cause 
dramatic effects (10). 
The pVDV transgenic mice described here expressed mutant desmin in a 
minority of vimentin-expressing cells. If vimentin functions at the level of 
tissues or organs (18), e.g. by imparting structural integrity to the cell in the 
context of its tissue, then the cells expressing the truncated desmin may be 
'rescued' by non-expressing neighboring cells. pVDV-expressing cells which 
do not constitute a solid tissue such as blood cells may be incompetent for 
certain functions, but non-expressing cells could substitute for the defective 
cells. 
If in analogy to the keratins of squamous epithelia (14) IFs serve primarily 
structural functions, physical stress may be necessary to discern a phenotype. 
For example, transgenic mice expressing dominant-negative keratin 14 mutants 
require mechanical trauma before the blistering phenotype becomes apparent. 
Even then, cytolysis remained dependent on factors additional to mutant keratin 
expression, such as cell shape (10). 
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Culturing of cells or tissues from the transgenic mice described in the present 
study and subjecting them to appropriate bio-assays may help in identifying 
subtle effects of vimentin IF disruption. Generating transgenic mice expressing 
the truncated desmin in all vimentin-containing cells or inactivating the mouse 
vimentin gene via homologous recombination in embryo stem cells may be 
necessary to elucidate the functions of vimentin IFs. 
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Materials and Methods 
Plasmid construction 
For construction of pVDV, the 6.2 kb Xbal fragment from pVDes (27) was 
subcloned into the Xbal site of pUC19, yielding pVDes-Xba. This fragment 
comprises the 3.2 kb hamster vimentin promoter and 3 kb of the hamster 
desmin gene. The upstream Xbal site is part of a polylinker, the Xbal site in the 
desmin gene is located in intron 5. A 3.4 kb НіпсП fragment containing the 
hamster vimentin exon 9, the vimentin 3' untranslated region, the 
polyadenylation signal and 2.6 kb of 3' flanking sequences (29) was subcloned 
into the Smal polylinker site of pVDes-Xba immediately 3' of the Xbal site. 
Vimentin exon 9 contains 39 bp of coding sequences. As a result, pVDV 
encodes a protein composed of 353 amino acid (aa) residues: desmin aa 1-340 
and vimentin aa 452-462 (fig 1). 
Generation and identification of transgenic mice 
Transgenic mice were generated by pronuclear microinjection and subsequently 
identified by Southern blotting as described previously (19, 27). Plasmid 
sequences were removed by BamHI'EcoRI digestion leaving a 9.6 kb truncated 
IF gene. Isolation and purification of this fragment were performed as 
described (19, 27). 
Cell culture 
Tissue culture and transfection of hamster lens cells, HeLa cells, BHK-21 cells 
and C2C12 cells was carried out as described previously (5, 26, 28, 30). Ear 
fibroblast cell lines were established and cultured as described by Bloemendal 
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et al. (5). 
Northern blot analysis 
Northern blotting and hybridization were performed as described previously 
(27). 
A mixture of PstI cDNA fragments derived from pViml (11) was used as a 
vimentin probe. As a desmin probe we used the 1.8 kb НіпсШГКрпІ fragment 
containing most of the hamster desmin cDNA (31). A 520 bp hamster vimentin 
Sau3A fragment (E49) ranging from -150 to + 370 relative to the transcription 
initiation site was used as a probe to simultaneously detect vimentin and pVDV 
transcripts. As an actin probe we used the 1.25 kb hamster actin cDNA 
fragment isolated by Dodemont et al. (11) , which hybridizes to α-, β- and 
γ-actin. 
Antibodies, immunohistochemical analysis and Western blotting 
Immunofluorescence staining of frozen tissue sections and cultured fibroblasts 
was carried out as described previously (19, 27). The following polyclonal and 
monoclonal antibodies were used in this study 1) a polyclonal rabbit antibody 
(poly-des) to chicken gizzard muscle desmin (33) 2) an affinity-purified 
polyclonal antibody (poly-vim) to bovine lens vimentin (34) 3) the monoclonal 
antibody RV202 to bovine lens vimentin (7) 4) the affinity purified polyclonal 
antibody (poly-ker) to human skin keratins (34) and 5) the monoclonal 
antibodies RCK106 (35) and RCK103 (44) to human keratins. 
Western blotting and preperation of IF fractions from mouse tissues and 
cultured fibroblasts was carried out as described previously (7, 19, 27, 30). 
Determination of solubility of intact and mutant desmin proteins was carried out 
as described by Gill et al. (15). Briefly, cells were lysed in Triton buffer by 
sonification for 1 minute and the insoluble fraction was removed by 
centrifugation and subsequently resuspended in 0.5% SDS buffer. Again, the 
insoluble fraction was removed by centrifugation. To the Triton X-100 soluble 
as well as the 0.5% SDS-soluble fraction 1 volume of 2x sample buffer was 
added. Equal amounts of protein from the Triton X-100 and the 0.5%SDS 
buffer fractions were analyzed by Westen blotting. 
Cell labeling, extraction and immunoprecipitation of IF proteins 
Metabolic labeling of cultured cells, and preparation of IF fractions and total 
cell extracts were performed as described previously (3, 30, 31). 
For pulse-chase labeling of cultured fibroblasts, cells were grown in six-well 
dishes to 80% confluency, starved for one hour in methionine-free EMEM, 
washed twice with PBS and labeled for 30 minutes with 20 mCi 
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[35S]-methionine per well (specific activity > 1000 Ci/mMol, Amersham) in 
methionine-free EMEM containing 6% dialized FCS. After Ais 30 minute pulse 
cells were washed twice with PBS and grown in EMEM containing 10% FCS 
for different times (ranging from 0.5 to 93 hrs). Cells were harvested after 
washing twice with PBS by addition of 70 ml of lysis buffer (20 mM Tris, 1 
mM PMSF, 2% SDS and 10 mM DTE). 
Radiolabeled IF proteins were obtained selectively by immunoprecipitation 
with specific antibodies (poly-des: K5; poly-vim: K36) as described (3, 30). 
Aliquote containing 5 to 50x106 cpm of the labeled total cell extract were 
immunoprecipitated. Equal amounts of protein were used for each precipitation. 
The immunoprecipi tales were analyzed on one-dimensional 12% 
SDS-polyacrylamide gels. After separation, the gels were fluorographed, dried 
and exposed to Kodak X-OMAT AR-5 film. 
Quantitation was performed by densitometric scanning of autoradiographs. 
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Summary 
Together with microtubules and microfilaments, intermediate filaments (IFs) 
represent a group of cytoskeletal structures which occur in virtually all 
mammalian cells. The IF proteins are encoded by a large multigene family and 
can be divided into five classes, the members of which are expressed in a 
developmentally regulated, cell type-specific fashion. All IF subunits share the 
same basic structure. This highly conserved structure and specificity of 
expression are suggestive of an important role for IFs in development and 
differentiation of cells and tissues. However, in spite of a large body of data 
concerning IF structure and assembly, IF functions have long remained elusive. 
The investigations described in this thesis were aimed at identifying the 
mechanisms that underly vimentin and desmin expression (type III IFs) and 
thereby intermediate filament formation. In addition, they were designed to 
contribute to providing the tools needed to elucidate IF functions. 
Using various types of gene transfer experiments, regulatory elements 
controling desmin and vimentin expression, and protein domains involved in IF 
assembly were identified. The functional roles of desmin and vimentin IFs in 
the context of intact tissues were examined through expression of various IF 
gene constructs and disruption of endogenous vimentin networks in transgenic 
mice. 
In the first chapter of this thesis we provide an overview of the present 
knowledge of IF structure, expression, and function. 
In the second chapter we describe the characterization of two differentiating 
myogenic cell lines with respect to their desmin and vimentin expression 
patterns. The mouse teratocarcinoma skeletal muscle cell line T984 appeared to 
represent an earlier developmental stage in myogenesis than myogenic C2C12 
cells, which in contrast to T984 cells already express desmin at the myoblast 
stage and differentiate more rapidly and extensively. Using these cell lines, it 
was demonstrated that control elements mediating muscle-specific expression of 
desmin and down-regulation of vimentin gene expression during myogenesis 
are located in the 5' flanking regions of these genes. 
Most cell-types initiate vimentin expression when cultured. In chapter three we 
focus on the mechanisms underlying this process. In addition to more general 
control elements, we describe the identification of both positive and negative 
regulatory elements in the vimentin gene which are involved in the regulation 
of vimentin expression in cultured epithelial cells. An AP-l/jun binding site 
appeared to be specifically involved in the induction process. In vimentin-
negative cells the enhancing capacity of this element can be repressed by 
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silencing elements. Expression of heterologous type III IF genes in T24 cells, 
an epithelial cell line lacking vimentin filaments, not only resulted in the 
assembly of bona fide IFs but also in increased endogenous vimentin levels via 
a post- or co-translational process. 
Culturing of SV40-transformed ear-fibroblasts or primary hepatocytes derived 
from transgenic mice carrying IF gene constructs containing the vimentin 
promoter, further demonstrated its capacity to drive expression of heterologous 
genes in tissue-culture (chapters five and eight). The same 3.2 kb promoter 
region appeared capable of driving expression of IF gene constructs in a tissue-
specific fashion in transgenic mice (chapters four, five, and eight). 
Overexpression of a vimentin-desmin hybrid gene in all vimentin-containing 
cells of transgenic mice, resulting in hybrid IF formation, did not interfere 
with normal differentiation and development (chapter four), except in the eye 
lens (chapter six). Similarly, no abnormalities other than cataract formation 
were detected upon ectopic expression and IF formation of the muscle-specific 
IF protein desmin in non-muscle cells in transgenic mice (chapter five). 
Overexpression of desmin in a portion of the lens epithelial and fiber cells of 
these transgenic mice eventually resulted in cataract formation (chapter six). 
By expressing mutant IF subunits, protein domains involved in IF assembly 
were identified (chapters seven and eight). In chapter seven a study of the role 
of the aminoterminal head domain of desmin in IF assembly is presented. Via 
transient expression of various desmin deletion constructs in cells devoid of 
copolymerizable IF subunits, as well as in vimentin containing cells, it was 
demonstrated that the desmin head domain is required for de novo IF assembly, 
but not for coassembly with intact IF subunits. Furthermore, we show that in 
neither cell type interaction between desmin and the nucleus is required for IF 
assembly. 
Depending on nature and extend of the mutation, assembly incompetent mutant 
IF subunits can cause disruption of preexisting IFs (illustrated in chapters seven 
and eight). To investigate the functions of vimentin IFs in tissues and the intact 
organism, an IF gene construct driven by the vimentin promoter and encoding 
a carboxyterminally deleted mutant desmin subunit, capable of disrupting 
vimentin IFs in a dominant-negative fashion, was expressed in transgenic mice 
(chapter eight). Mutant desmin expression strongly enhanced mouse vimentin 
turnover and caused disruption of vimentin filaments. However, this did not 
result in detectable developmental or morphological abnormalities. 
Future experiments, aimed at modifying or deleting IF genes in mouse embryo 
stem cells, may help to shed some light on vimentin IF function. 
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Samenvatting 
Evenals de microtubili en de microfilamenten vormen de intermediaire 
filamenten (IFs) een groep cytoskeletaire structuren die voorkomen in vrijwel 
alle cellen van hogere eukaryoten. De IF-eiwitten worden gecodeerd door een 
multi-genfamilie die in vijf klassen is onderverdeeld. De individuele genen 
daarvan komen tot expressie op weefsel- en ontwikkelingsstadium-specifieke 
wijze. Alle IF-eiwitten hebben dezelfde basisstructuur. Deze sterk 
geconserveerde structuur en expressiepatronen geven aan dat IFs een 
belangrijke rol vervullen in ontwikkeling en differentiatie van cellen en 
weefsels. Echter, ondanks de grote hoeveelheid kennis betreffende structuur en 
assemblage van IFs zijn hun functies lang onduidelijk gebleven. 
Het in dit proefschrift beschreven onderzoek was gericht op het identificeren en 
ontrafelen van de processen die ten grondslag liggen aan de expressie van 
vimentine en desmine (type III IFs) en daarmee aan IF-vorming. Daarbij werd 
het onderzoek zo opgezet dat het uiteindelijk bij zou dragen aan het 
ontwikkelen van middelen die nodig zijn voor de opheldering van IF-functies. 
Regulatoire elementen die desmine- en vimentine expressie controleren en 
eiwitdomeinen die betrokken zijn bij IF-assemblage werden geïdentificeerd 
door middel van experimenten waarbij IF-genconstucten tot expressie werden 
gebracht in weefselkweek en in transgene muizen. De biologische rol van 
desmine en vimentine IFs in intacte weefsels werd onderzocht door expressie 
van verschillende IF-genconstructen en verstoring van vimentine netwerken in 
transgene muizen. 
In het eerste hoofdstuk van dit proefschrift wordt een overzicht gegeven van de 
huidige kennis van IF-structuur, expressie en functie. 
In het tweede hoofdstuk beschrijven we de karakterisatie van twee myogene 
cellijnen met betrekking tot hun desmine en vimentine expressiepatronen. De 
muize- teratocarcinoma cellijn T984 bleek een vroeger ontwikkelingsstadium te 
vertegenwoordigen dan de myogene C2C12 cellijn, die in tegenstelling tot de 
T984 cellen reeds desmine expressie vertoonde in het myoblast stadium, en zich 
sneller en verder ontwikkelde. Met behulp van deze cellijnen werd aangetoond 
dat DNA sequenties die de spierspecifieke expressie van desmine en vimentine 
controleren zich bevinden in de 5' flankerende gebieden van de beide genen. 
Vrijwel alle celtypes brengen vimentine tot expressie in weefselkweek. In de in 
hoofdstuk drie beschreven studies werd dit proces nader bestudeerd. Naast 
algemene controlerende elementen beschrijven we de identificatie van zowel 
positieve als negatieve regulatoire sequenties, die betrokken zijn bij de regulatie 
van vimentine expressie in epitheliale cellen in weefselkweek. Een AP-l/jun 
bindingsplaats bleek specifiek bij dit proces betrokken te zijn. In sommige 
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celtypes werd de aktiviteit van dit element onderdrukt door negatieve 
regulatoire elementen. Expressie van heterologe type III IFs in T24 cellen, een 
epitheliale cellijn zonder vimentine IFs, resulteerde niet alleen in de vorming 
van normale intermediare filamenten maar ook in verhoging van endogene 
vimentine nivo's via een post- of cotranslationeel proces. 
Het vermogen van de vimentine promoter om heterologe genexpressie in 
weefselkweek te induceren, werd aangetoond via kweek van oorfibroblasten en 
levercellen van transgene muizen, die IF-genconstructen bevatten gebaseerd op 
de vimentine promoter (hoofdstuk vijf en acht). Dezelfde 3.2 kb promoter 
stuurde weefselspecifieke expressie van IF-genconstructen in transgene muizen 
(hoofstuk vier, vijf en acht). 
Overexpressie van een desmine-ν imentine hybride gen in vimentine bevattende 
cellen van transgene muizen, resulterend in intacte hybride IFs, interfereerde 
niet met normale differentiatie en ontwikkeling (hoofdstuk vier), behalve in de 
ooglens (hoofdstuk zes). Expressie van het spierspecifieke IF-eiwit desmine in 
niet-spiercellen van transgene muizen leverde soortgelijke resultaten (hoofdstuk 
vijf). Overexpressie van desmine in een deel van de lenscellen van deze muizen 
leidde uiteindelijk tot het ontstaan van cataract (hoofdstuk zes). 
Door mutant IF-eiwitten tot expressie te brengen, werden domeinen die zijn 
betrokken bij de assemblage van IFs geïdentificeerd (hoofdstuk zeven en acht). 
In hoofdstuk zeven wordt een studie naar de rol van het aminoterminale 
domein van desmine in de filamentvorming gepresenteerd. Via transiente 
expressie van desmine deletieconstructen in cellen die geen IFs bevatten 
waarmee desmine kan copolymeriseren, en in cellen die vimentine bevatten, 
werd aangetoond dat het aminoterminale domein van desmine noodzakelijk is 
voor de novo IF- assemblage, maar niet voor incorporatie in reeds bestaande 
filamenten. Daarnaast werd aangetoond dat in beide celtypes interactie tussen 
desmine en de celkern niet nodig is voor IF-vorming. 
Sommige mutant IF-eiwitten die zelf niet in staat zijn tot IF-vorming, kunnen 
bestaande filamenten vernietigen (zie hoofdstuk zeven en acht). De biologische 
rol van vimentine IFs in intacte weefsels en organismen werd nader onderzocht 
door een IF-genconstruct, gebaseerd op de vimentine promoter en coderend 
voor een carboxyterminaal gedeleteerd desmine, tot expressie te brengen in 
transgene muizen (hoofdstuk acht). Expressie van dit dominant-negatieve 
mutant desmine veroorzaakte versnelde vimentine afbraak en vemietiging van 
vimentine netwerken. Dit resulteerde echter niet in detecteerbare 
ontwikkelingsstoornissen of morphologische afwijkingen. 
Toekomstige experimenten, gericht op modificatie of deletie van IF-genen in 
muize- embryo-stamcellen, zullen mogelijk bijdragen tot het ophelderen van de 
functie van vimentine IFs. 
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